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Summary 
 
Recombinant proteins are gaining in importance for therapeutic applications. The 
proteins are expressed in stable cell lines, within which recombinant DNA has 
incorporated into the host cells genome. Identification and isolation of extremely high 
producers from transfected cell populations is a tedious and time-consuming effort. 
We proposed two different approaches for the establishment of recombinant cell lines: 
affinity cell sorting and microinjection. 
 
Even with the help of single cell sorting and analysis systems (flow cytometry) rarely 
more than thousand different cell clones, stably expressing a desired gene can be 
evaluated. We are considering a new approach in which polyclonal cell populations 
will be established which co-express a protein of interest and an epitope-tagged cell 
surface receptor. A microbead fixed antibody specific to the epitope tag is hoped to 
assist in the isolation of rare, but highly productive cells from large suspensions of 
transfected cells. For this reason we have also developed an efficient method for the 
bulk transfection of CHO cells. On the side of vector-development for this approach, 
we have chosen to investigate the utility of a mouse serotonin 5-HT3 receptor as a cell 
surface marker. This receptor can be expressed at very high levels (up to 1 x 107 
receptors per cell) in heterologous systems. The receptor is detectable on the cell 
surface by means of fluorescent ligands, which allows the determination of 
transfection efficiencies in suspension cultures. A Flag-tag was fused to the amino 
terminal end of the receptor without adverse effects on receptor function or ligand 
binding. Only 5 % of receptor DNA in the transfection cocktail was sufficient to detect 
positive cells in a population. The specific interaction of the epitope-tagged receptor 
with the cognate antibody fixed to microbeads was tested in comparison to non-
transfected control cells using laser scanning confocal microscopy. A 80% enrichment 
of cells expressing GFP and the 5-HT3 receptor was achieved in 30 minutes.  
 
We have investigated microinjection as a gene transfer method for the establishment 
of recombinant mammalian cell lines. The conditions for the injection of plasmid 
DNA into either the nucleus or the cytoplasm of CHO-DG44 cells were established 
using pMYK-EGFP, an expression vector with the enhanced green fluorescent protein 
(EGFP) gene under the control of the murine CMV promoter and the puromycin 
resistance gene for selection. To estimate plasmid copy number during microinjection, 
it was first necessary to determine the injection volume by fluorescence quantification 
of injected FITC-dextran. For microinjection into the cytoplasm the volume ranged 
from 200 to 350 fl and for nuclear microinjection it was about 180 fl. We then 
investigated the impact of DNA concentration and injection pressure on transient 
EGFP transient expression following microinjection into the cytoplasm or nucleus. As 
a general rule, we observed that concentration of the DNA solution injected into the 
cells was the most important parameter regardless of the pressure or the volume of 
injection. Recombinant cell lines expressing intracellular EGFP were established 
following microinjection into the nucleus and the cytoplasm with linear and circular 
DNA. Selection with puromycin, clonal expansion, and cell banking were completed 
within three to four weeks post-microinjection. In parallel, recombinant cell lines were 
established after calcium-phosphate transfection with linear and circular DNA. The 
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number of plasmid copies integrated was determined by Southern blot and the number 
and localization of integration sites was determined by fluorescence in-situ 
hybridization (FISH). Growth of the cells and stability of EGFP expression were 
investigated by cultivation over a two-month period. This approach presents several 
advantages over other DNA delivery methods such as control of the quantity and 
localization of DNA delivered into the cell and speed of recovery of recombinant cell 
lines. This approach may be relevant for the establishment of recombinant cell lines 
from cells that are not easily transfected by classical methods. 
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Résumé 
 
Les protéines recombinantes deviennent de plus en plus importantes pour les 
applications thérapeutiques. Les protéines sont exprimées dans des lignées cellulaires 
stables, dans lesquelles un ADN recombinant a été incorporé au génome de la cellule 
hôte. L’identification et l’isolation de clones grands producteurs, au sein d’une 
population transfectée, est un travail pénible et de longue haleine. Nous proposons 
deux approches pour l’établissement de lignées cellulaires recombinantes : le tri 
cellulaire par affinité et la micro-injection.  
 
Même avec l’aide d’un tri individuel des cellules et un système d’analyse, tel que la 
cytométrie en flux, il reste très rare de pouvoir analyser plus d’un millier de clones, 
exprimant de manière stable le gène désiré. Nous nous intéressons à une nouvelle 
approche qui consiste en l’établissement de populations de cellules poly-clonales, qui 
co-expriment une protéine d’intérêt et un récepteur cellulaire de surface, marqué avec 
un épitope. L’utilisation de microbilles, sur lesquelles sont fixés des anticorps 
spécifiques de l’épitope, permet l’isolation de cellules rares mais très hautes 
productrices, à partir d’une grande population de cellules transfectées. C’est pour cette 
raison, que nous avons aussi développé une méthode efficace de transfection, adaptée 
aux cellules CHO en suspension. Nous avons choisi d’étudier l’apport d’un récepteur 
5HT3 de souris à la sérotonine en tant que marqueur de la surface cellulaire. Ce 
récepteur peut être exprimé à un niveau très élevé (jusqu’à 107 récepteurs par cellules) 
dans des systèmes hétérologues. Le récepteur est détectable à la surface de la cellule à 
l’aide de ligands fluorescents, ce qui permet de déterminer l’efficacité de la 
transfection sur des cultures en suspension. Un marqueur FLAG a été fusionné à 
l’extrémité N-terminale du récepteur, sans effets adverses sur sa fonction ou sa 
capacité à s’associer à un ligand. Seulement 5%, dans le cocktail de transfection, 
d’ADN, codant pour le récepteur, sont suffisants pour détecter des cellules positives 
au sein d’une population. L’interaction spécifique entre le récepteur marqué avec 
l’épitope et l’anticorps apparenté, fixé sur les microbilles, a été testée, en comparaison 
de cellules contrôles non transfectées, en utilisant la microscopie confocale à balayage 
laser. Un enrichissement à hauteur de 80%, de cellules exprimant la GFP et le 
récepteur 5HT3, a été réalisé dans un délai de 30 minutes. 
 
Nous avons testé la micro-injection comme méthode de transfert de gène pour 
l’établissement de lignées de cellules recombinantes de mammifères. Les conditions, 
pour l’injection de plasmide à ADN dans le noyau ou le cytoplasme des cellules CHO-
DG44, ont été établies en utilisant le pMYK-EGFP, un vecteur d’expression avec le 
gène de la GFP améliorée (EGFP) sous contrôle du promoteur murin CMV et du gène 
de résistance à la puromycine pour la sélection. Pour estimer le nombre de copies du 
plasmide durant la micro-injection, il était d’abord nécessaire de déterminer le volume 
d’injection par quantification de la fluorescence après injection de dextran couplé au 
FITC. Pour la micro-injection dans le cytoplasme, le volume était de 200 à 350 
femtolitres et de 180 femtolitres dans le noyau. Nous avons ensuite étudié l’impact de 
la concentration en ADN et de la pression d’injection sur l’expression transitoire 
d’EGFP, consécutivement à une micro-injection dans le cytoplasme ou le noyau. En 
règle générale, nous avons constaté que la concentration en ADN, de la solution 
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injectée dans la cellule, était le paramètre le plus important en regard de la pression ou 
du volume d’injection. Des lignées de cellules recombinantes, exprimant l’EGFP de 
manière extracellulaire, ont pu être établies après injection d’ADN linéaire et 
circulaire dans le noyau et le cytoplasme. Une sélection à la puromycine, une 
expansion clonale et la constitution d’une banque de cellules ont été accomplies en 
trois à quatre semaines après la micro-injection. En parallèle, des lignées de cellules 
recombinantes ont été établies après transfection au calcium-phosphate avec de l’ADN 
linéaire et circulaire. Le nombre de copies de plasmide intégrées a été déterminé par 
« Southern blot » et le nombre de sites d’intégration et leur localisation l’a été par 
hybridation de sondes fluorescentes in situ (technique FISH). La croissance des 
cellules et la stabilité d’expression de l’EGFP ont été étudiées sur les cellules en 
culture durant une période de deux mois. Cette approche présente plusieurs avantages, 
en comparaison d’autres méthodes de transfection, comme le contrôle de la qualité de 
l’ADN administré et sa localisation dans la cellule ou encore la vitesse d’obtention de 
lignées de cellules recombinantes. Cette manière d’aborder le problème peut s’avérer 
approprié pour l’établissement de lignées de cellules recombinantes, à partir de 
cellules qui ne sont pas aisément transfectables par les méthodes classiques. 
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Zusammenfassung 
 
Rekombinante Proteine werden immer wichtiger für therapeutische Anwendungen. 
Diese Proteine werden oft in stabilen Zelllinien exprimiert, in deren Genom 
rekombinante DNS eingebracht wurde. Die Identifikation und das Isolieren von 
Zellen, die das Protein gut produzieren, aus einer Population transfizierter Zellen ist 
mühsam und zeitaufwendig. In dieser Arbeit werden zwei alternative Verfahren für die 
Etablierung von stabilen Zelllinien vorgeschlagen: ‚Affinity cell sorting’ und 
Microinjektion. 
 
Selbst mit der Hilfe von Flusszytometern und Zellsortern ist es oft unmöglich mehr als 
tausend verschiedene Zellklone auf eine gewünschte Genexpression zu untersuchen. 
Wir stellen in dieser Studie eine neue Strategie vor. Es werden polyklonale 
Zellpopulationen generiert die neben dem Nutzprotein zusätzlich auch noch ein 
spezifisches Oberflächen-Epitop exprimieren. Zellen, die nun das Epitop 
überexprimieren, können dann mit spezifischen Antikörper, die ihrerseits an 
magnetischen Microbeads haften, gefischt und angereichert werden. Es gilt die raren 
‘Superproducer’ Zellen zu finden. In einem ersten Schritt wurde eine hocheffiziente 
Transfektionsmethode für CHO Zellen in Suspension entwickelt. Als Epitop-Marker 
wurde ein Maus Serotonin 5-HT3 mit Flag-tag verwendet. Dieser Rezeptor wird von 
CHO sehr gut exprimiert (bis 1 x 107 Rezeptoren pro Zelle) und kann mit 
fluoreszenten Liganden detektiert werden. Dies erlaubt die Transfektionseffizienz in 
Suspensionskulturen zu messen. Das an den Aminoterminus fusionierte Flag-tag zeigte 
keinen negativen Effekt auf die Funktion oder das Bindungsverhaltern des Rezeptors. 
5 % Rezeptor DNS im Transfektionscocktail genügten um positive Zellen zu 
identifizieren. Die spezifische Interaktion des mit dem Epitop markierten Rezeptors 
und des konjugierten Antikörpers wurde gegen nicht exprimierende Zellen mit Hilfe 
eines konfokalen Laser-Scanning-Mikroskopgetestet. Mit dieser Methode war es 
möglich in 30 Minuten alle nicht-exprimierenden Zellen zu verwerfen und 80% der 
hoch-exprimierenden Zellen anzureichen.  
 
Weiter wurde die Mikroinjekton als Gentransfer-Methode für das Etablieren von 
rekombinanten Säugetier Zelllinien untersucht. pMYK-EGFP, ein Expressionsvektor 
für EGFP (enhanced green fluorescent protein) mit einem murine CMV-Promoter und 
einer Puromyzinresistanz, wurde in den Kern und das Zytoplasma von CHO DG44 
Zellen injiziert. Es wurde sowohl lineare als auch zirkulare Plasmid DNS verwendet. 
Mit FITC-Dextran Injektionen und Fluoreszenzmessungen wurde das 
Injektionsvolumen gemessen, um so die injizierte Plasmidkopienzahl zu ermitteln. Für 
das Zytoplasma wurden Injektionsvolumina von 200 bis 350 fl gefunden, für 
Kernmikroinjektionen waren es um die 180 fl. Im Weitern wurde der Einfluss der 
DNS-Konzentration und des Injektionsdruckes auf die transiente GFP-Expression 
untersuch. Dabei stellte sich heraus, dass die Konzentration der injizierten DNS den 
wichtigsten Parameter, unabhängig von Druck und Injektionsvolumen, darstellt. 
Transfektion mit Mikroinjektion, Selektion, Klonierung und das Erstellen einer 
Zellbank dauerten nur 3 bis 4 Wochen. Zum Vergleich wurden Zelllinien mit 
klassischer Kalzium-Phosphat-Transfektion erstellt. Mit Hilfe von Southern Blots 
wurden die Kopienzahl des rekombinanten DNS im und mit FISH (fluorescence in-
 
Zusammenfassung 
8 
situ hybridization) deren Lokalisierung auf dem Genom ermittelt. Zellwachstum und 
GFP-Expressionsstabilität wurden mit einer zweimonatigen Dauerkultur überprüft. 
Die Mikroinjektion hat gegenüber allen andern Transfektionsmethoden mehrere 
Vorteile, so können Volumen und der Ort der DNS-Injektion bestimmt werden, weiter 
wird das Isolieren von so entstandenen Zellklonen erleichtert und beschleunigt. Diese 
Technik könnte für das Etablieren von Zelllinien, die bis dato mit klassischen 
Methoden als schwer transfizierbar galten, grosse Bedeutung gewinnen. 
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1. Abbreviations 
ACS  affinity cell sorting 
BP  bandpass 
CaPi  calcium phosphate-DNA-coprecipitation  
CHO  Chinese hamster ovary cells 
CMV  human cytomegalovirus  
dhfr  dihydrofolate reductase (gene) 
DHFR  dihydrofolate reductase (protein) 
DMSO  dimethylsulfoxide 
EF1-α  human elongation factor 1-α 
ELISA  enzyme linked immuno sorbent assay 
FBS  fetal bovine serum 
FISH  fluorescence in-situ hybridization 
GFP  green fluorescent protein 
HBS  hepes buffered saline 
IgG  immunoglobin G 
mCMV murine cytomegalovirus 
PBS  phosphate buffered saline 
PEI  polyethylenimine 
RFP  red fluorescent protein 
TBS  tris buffered saline 
UHP  ultra high purity water 
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2. Introduction 
Recombinant proteins (r-proteins) are gaining importance for the treatment and 
prevention of various human diseases. Currently, 78 r-proteins are available on the 
Swiss market as human medication. Different expression systems have been 
developed for the market-scale production of these proteins with mammalian, bacterial 
and fungal systems being the major ones. However, if glycosylation and other post-
translational modifications are required for the biological activity of an r-protein, 
mammalian cells are preferred for expression (see section 2.1). Despite the increasing 
development of transient gene expression in mammalian cells as a method to rapidly 
produce a small quantity of protein, the main approach to the expression of r-proteins 
in mammalian cells remains the establishment of a cell line in which the transgene(s) 
is integrated into the host genome and stably expressed over time. An alternative is to 
generate stably expressing cell lines harboring extrachromosomal vectors. Plasmid 
DNA is not capable of replication in mammalian cells without an origin of replication 
(ori). Only a few mammalian ori have been characterized and none of them allow 
episomal plasmid replication in mammalian cells. Extrachromosomal DNA replication 
has been achieved using ori elements from different DNA viruses, e.g. vectors that 
carry the Epstein-Barr virus nuclear antigen-1 (EBNA-1) and the oriP. Such plasmids 
can be maintained episomally in primate and canine cells but not in rodent cells (Yates 
et al. 1985). Recently, a vector has been described which contains the SV40 origin of 
replication and the scaffold/matrix attachment region from the human interferon-β 
gene (Piechaczek et al. 1999). This vector does not express any viral protein and was 
shown to replicate at very low copy numbers (less than 20) in CHO cells. It has been 
stably maintained without selection for more than 100 generations (Piechaczek et al. 
1999). 
 
The time consuming and labor intensive process of establishing a stable cell line 
producing a recombinant protein of interest is based on the isolation, characterization, 
and expansion of a highly productive clonal cell line from a pool of cells transfected 
with the gene of interest. Several steps are necessary before stable transfection and 
selection can begin. The vectors (see section 2.2) and the transfection methods (see 
section 2.4) have to be optimized for the chosen expression system, preferably with a 
fast and easy quantifiable reporter protein (see section 2.3). Then the selection method 
must be adapted to the cells and the vectors used (see section 2.5) and applied with or 
without gene amplification (see section 2.5.2). The strategy for the isolation of high 
producing cells has also to be defined (see section 2.6). The term stable cell line 
should in this case be defined as a cell line in which the transfected plasmid has 
integrated into the host genome and shows a constant level of protein production over 
a long period of time (months to years). Decreases of protein productivity up to 50% 
have been reported in recombinant CHO cell lines (Strutzenberger et al. 1999). 
Unfortunately, there are currently no methods to predict the stability of recombinant 
cell lines. The identification of a stable cell line is presently performed after following 
cell growth and production over an extended period of time.  
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2.1 Recombinant mammalian cell lines for therapeutic protein 
production  
Theoretically, any cell which can be maintained in culture can also be manipulated to 
express foreign genes. However, depending on the cell type used and its origin, the 
efficiencies of gene transfer, the protein expression levels and stability of the 
transgene expression will differ considerably. Furthermore, the pattern of 
posttranslational modification such as protein folding, glycosylation, phosphorylation 
and acetylation may also vary. 
 
Approximately 24% of the 78 recombinant drugs available on the Swiss market are 
produced in Escherichia Coli. The remaining are produced in eukaryotic cells such as 
Sacchoromyces cerevisiae, NSO (murine myeloma cells, plasmacytoma), BHK (baby 
hamster kidney cells), CHO (Chinese hamster ovary), SP2/0 (mouse myeloma cells, 
lymphoblast), and more recently (2002), a serine protease is produced in a human cell 
line HEK 293 (human embryonic kidney cells) by Eli Lilly SA. Nevertheless, CHO 
cells remain the preferred host for therapeutic protein production. Around 34% of the 
recombinant proteins in Switzerland are produced in this host. 
 
The parental CHO cell line was initiated from a biopsy of an ovary of an adult Chinese 
hamster (Cricetulus griseus) (Puck 1958). Since then, the cells have been well 
characterized with regard to the karyotype, chromosome structure, gene map, general 
culture conditions, and cell physiology (Gottesman 1985). In the late 1960s the first 
nutritional mutant (CHO-K1) was isolated (Kao and Puck 1968). It requires proline in 
the medium in order to grow. In the early 1980s, the original CHO cell line was 
mutagenized with radiation and by chemical treatment, and a CHO mutant carrying a 
double deletion for the dihydrofolate reductase gene was isolated and characterized 
(Urlaub and Chasin 1980; Urlaub et al. 1983). This cell line was subsequently used for 
the high level expression of human tissue-type plasminogen activator in the middle 
1980s (Kaufman R.J. et al. 1985). In this case, a plasmid carrying the dhfr gene was 
cotransfected with a plasmid encoding the tPA gene. After genetic selection for the 
presence of the dhfr gene, the positive transformants were amplified with methotrexate 
(MTX) (Alt et al. 1978). Methotrexate is a competitive inhibitor of DHFR: it binds to 
and inhibits the DHFR activity stoichiometrically (see below). In order to be able to 
grow in the presence of MTX, cells must contain multiple copies of the dhfr gene (Alt 
et al. 1978). Recombinant tPA (rtPA) produced by Genentech was the first 
recombinant therapeutic protein derived from mammalian cells. Sales under the name 
Activase® started in 1986. For approval Genentech provided the regulatory agencies 
with important information such as the product purity, the batch-to-batch 
reproducibility of the production process, and recombinant cell line stability.  
 
On the US Food and Drug Administration (FDA) website (FDA 1996) there is a short 
summary of the criteria required to commercialize a recombinant drug. The origin and 
sequence of the nucleotides coding for the protein and for the expression construct 
should both be described in detail. The recombinant cell line must be analyzed for 
copy number, for genetic insertions or deletions, and for the number of integration 
sites. With protein analytical techniques, the amino acid sequence and other structural 
features of the r-protein need to be investigated. A master cell bank, aliquots of a 
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single pool of cells generally prepared from the selected cell clone under defined 
conditions, should be established and characterized. The working cell bank must be 
prepared from aliquots of a homogeneous suspension of cells obtained from culturing 
the master cell bank under defined conditions. The r-protein should also be tested for 
the presence of infectious human endogenous retroviruses (HERVs) and other human 
virus such as HIV, as well as for human prion proteins. The CHO genome does 
contain retrovirus-like sequences, but infectious particles have never been found in 
this cell line (Anderson et al. 1990; Anderson et al. 1991). Furthermore, due to the 
host range restriction of retroviruses and other mammalian viruses, potential CHO 
viruses are considered a low risk for humans.  
 
2.2 Vectors 
Besides the recombinant gene of interest, mammalian expression vectors must contain 
other genetic elements for high-level transcription including a strong 
promoter/enhancer and sites for transcription termination polyadenylation. In addition, 
a bacterial origin of replication and a gene for selection in bacteria are also required. A 
number of strong viral and cellular promoters are available to control transgene 
transcription. The most widely used viral promoters are the simian virus (SV40) early 
promoter, the human and murine cytomegalovirus (hCMV and mCMV) major 
immediate early promoters and the Rous sarcoma retrovirus (RSV) long terminal 
repeat promoter (LTR) (Makrides 1999). The promoters of some constitutive 
housekeeping genes like the human elongation factor 1α (EF-1α) gene and the chicken 
β-actin gene also provide a high level of transgene transcription (Makrides 1999). The 
promoter strength is highly cell line dependant (Wenger et al. 1994) and cell culture 
system dependant (Feng et al. 2003). Feng et al. found that the β-actin and the SV40 
promoters exhibited suppressed gene expression, 70 and 56% respectively, in mouse 
epidermal cells suspended in agar compared to adherent cells (Feng et al. 2003). In 
contrast, CMV promoter activity was not influenced by the culture system (Feng et al. 
2003). However the activity of the CMV promoter is cell cycle dependent, with the 
highest transcription activity in CHO cells during the S phase (Brightwell et al. 1997; 
de Boer et al. 2004). In CHO cells different promoters were tested for their ability to 
support high transcription activity. Rotondaro and co-workers concluded that the 
mCMV promoter was more active than either the hCMV or the SV40 promoter 
(Rotondaro et al. 1996). Recently, the specific transcription rate for a gene transfected 
into CHO cells was increased by flanking the gene with sequences from the highly 
expressed Chinese hamster elongation factor EF-1α (CHEF1) (Running Deer and 
Allison 2004). The resulting expression levels were 6- to 35-fold higher than 
expression levels from commercial vectors that utilized the hCMV or the human EF-
1α promoter (Running Deer and Allison 2004 389).  
 
As mentioned above, other genetic elements are also important for the construction of 
an expression vector. mRNA splicing is linked to efficient mRNA export. It has been 
demonstrated that splicing increases the level of mature mRNA in the cytoplasm 
(Buchman and Berg 1988; Luo and Reed 1999). Splicing factors can also interact with 
mRNA export factors (Le Hir et al. 2001). The presence of the human EF-1α intron 
between mCMV promoter and a transgene enhances expression in CHO cells (Kim et 
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al. 2002), and high level glycoprotein expression was achieved in CHO cells after a 
hybrid intron was included in a construct having the CMV promoter (Melcher et al. 
2002). 5’- and 3’- untranslated regions (UTR) are involved in the regulation of mRNA 
translation (Wilkie et al. 2003). The poly(A) tail of an mRNA is important for its 
stability and translation (Jackson and Standart 1990). Lastly, the Kozak sequence at 
the translation initiation codon plays a role in the optimal initiation of the translation 
(Kozak 1987). Finally, a prokaryotic origin of replication and a selection marker are 
required for plasmid production in bacteria. For stable transfection, a eukaryotic 
selection marker is also required.  
 
2.3 Reporter Proteins 
The main properties of reporter proteins are the absence of their expression in the 
mammalian cells and the convenience of their quantification. The use of reporter 
proteins in mammalian cells was introduced in the early 1980s with the development 
of plasmids carrying the genes encoding bacterial chloramphenicol acetyltransferase 
(CAT) (Gorman et al. 1982) and β-galactosidase (An et al. 1982) for eukaryotic gene 
regulation studies. Most of the available reporter proteins are intracellular (Table 1) 
except for secreted alkaline phosphatase (SEAP) (Berger et al. 1988). Green 
fluorescent protein (GFP) was isolated in the early 1960s from the jellyfish Aequorea 
victoria (Shimomura et al. 1962). The gene encoding GFP was cloned and sequenced 
twenty years later (Prasher et al. 1992). Many different variants of the GFP are now 
commercially available e.g yellow, red and blue fluorescent proteins. The main 
advantage of these fluorescent proteins is that they can be detected, monitored and 
quantified in a non-invasive manner.  
 
Table 1. Summary of frequently used reporter proteins 
Reporter Gene Origine Localization Advantage Disadvantage 
Chloramphenicol 
acetyltransferase 
(CAT) 
Bacterial Intracellular No endoge-
nous activity 
Cell lysis 
required 
β-Galactosidase 
(β-Gal) 
Bacterial Intracellular Simple 
quantification 
Endogenous 
activity 
Luciferase (LUC) Firefly Intracellular High activity 
No endoge-
nous activity 
Substrate and 
O2 required 
 
Alkaline phos-
phatase (SEAP) 
Human Secreted Easy 
quantification 
Endogenous 
activity 
Green fluorescent 
protein (GFP) 
Jellyfish Intracellular Strong 
fluorescence 
Accumulation 
 
2.4 Gene Transfer 
There are two major approaches to the delivery of transgenes into cultured mammalian 
cells: infection with a virus vector that encodes the transgene or transfection with a 
plasmid clone of the transgene. For viral vectors the size of the DNA insert is limited 
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and preparation of the vector is complex. The most commonly used non-viral gene 
transfer methods are calcium phosphate DNA co-precipitation (CaPi), lipofection, and 
polyfection. All three methods rely on the formation of positively charged 
nanoparticles which can enter cells following binding to the negatively charged cell 
surface. CaPi transfection is based on the co-precipitation of DNA with calcium–
phosphate while lipofection and polyfection are based on the compaction of DNA with 
liposomes (lipoplexes) and cationic polymers (polyplexes), respectively (Graham and 
Eb 1973; Jordan et al. 1996; Thomas and Klibanov 2003). In general, the transfection 
method must be chosen with regard to the cell line and the application. 
 
For non-viral gene delivery the transport of plasmid DNA to the nucleus is a critical 
step in the establishment of a stable cell line (Gasiorowski and Dean 2003). Following 
uptake by endocytosis, the DNA must escape the endosome to be released into the 
cytosol and enter the nucleus. A high percentage of the DNA that enters the cell, 
however, is degraded before it reaches the nucleus (Lechardeur et al. 1999; Pollard et 
al. 2001). For each transfection method, the mechanisms involved in these events may 
differ. For example, the cationic polymer polyethylenimine (PEI) is thought to 
promote escape of DNA from the endosome by binding protons following its 
acidification, promoting an influx of chloride ions into the organelle. This “proton 
sponge effect” results in osmotic swelling and subsequent disruption of the endosome, 
allowing the release of the DNA (Boussif et al. 1995; Kichler et al. 2001). The 
efficiency of gene delivery by CaPi, lipofection and polyfection is cell cycle-
dependent. Higher recombinant protein expression is observed after CaPi transfection 
of adherent CHO cells during the S phase of the cell cycle (Grosjean et al. 2002). 
Transfection with liposomes and branched PEI was more efficient in cells in late S 
phase (Brunner et al. 2000). These observations indicate that for all of these 
transfection methods plasmid DNA probably enters the nucleus after the breakdown of 
the nuclear membrane during mitosis. The exact mechanisms involved in these events 
remain to be investigated. 
 
The delivery of plasmid DNA into the nucleus is not the last obstacle in the 
establishment of recombinant cell line. The DNA must also be integrated into the host 
genome. This mechanism of this step is still not known. It is not clear when and how 
the plasmid becomes integrated. The integration event could be cell cycle related. 
Chida et al. injected linearized DNA into nuclei of various synchronized cells. The 
number of neomycin resistant colonies increased dramatically when the nuclear 
microinjection was performed during the early S phase (Chida et al. 1998).  
 
For mechanical gene transfer, microinjection is the most direct method for delivery of 
naked DNA into a cell. Furthermore, microinjection allows control on the subcellular 
localization of the gene transfer. To microinject, a fine glass capillary is inserted 
directly into the cell during a short timeframe, and the DNA is pressure-injected into 
the cell. This method was first described in the middle 1970s (Diacumakos 1973; 
Graessmann et al. 1980; Graessmann and Graessmann 1975). In the late 80s semi-
automatic microinjection was optimized (Ansorge and Pepperkok 1988; Pepperkok et 
al. 1991). 
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Microinjection is a commonly used technique for introducing genes into mammalian 
eggs to generate transgenic animals (Brinster et al. 1985; Co et al. 2000). 
Microinjection was also used for gene transfer into cells such as human vascular 
smooth muscle cells and human mesenchymal stem cells that were difficult to 
transfect by other methods (Nelson and Kent 2002; Tsulaia et al. 2003). Furthermore, 
this technique has been used as a research tool to study DNA degradation in the 
cytoplasm (Lechardeur et al. 1999), the transport pathway of plasmid DNA from the 
cytoplasm to the nucleus (Dean 1997), and the mechanism of DNA integration in 
mammalian cells (Folger et al. 1982).  
 
Beside the control of the subcellular compartment of the gene delivery, microinjection 
has several other advantages compared to transfection methods. First, any aqueous-
soluble molecule such as DNA, RNA, and protein can be injected. The amount of 
material delivered into each single cell can be controlled. Finally, each microinjected 
cell can be followed specifically and analyzed for early gene expression and cell 
growth. However, the infrastructure required for microinjection is expensive and the 
technique itself is laborious. The number of cells that can be manipulated is also very 
limited compared to other transfection methods.  
 
2.5 Selection 
For all available gene transfer methods, the efficiency for obtaining stable 
transformants, which have the exogenous plasmid DNA integrated in their genome, is 
very low. To identify and isolate the cells which have taken up the transferred DNA, a 
selection system must be used. Such systems are based on the co-delivery of a 
selectable gene. The choice of the selectable gene depends on the cell line and the 
selection strategy. Dominant markers can be used to render cells resistant to 
compounds such as antibiotics (2.5.1). A different category of selection marker is 
based on the complementation of a genetic deficiency of the host cell. This selection 
approach is restricted to cell lines with such a deficiency. The use of dominant 
selectable markers overcomes this limitation. The two different approaches can also be 
combined, especially in the case of co-transfection with more than one plasmid DNA. 
Lastly, selection markers for a genetic deficiency have the advantage of being 
amplified (2.5.2).  
 
2.5.1 Chemical selection agents 
With dominant selectable markers the cells become resistant to substances that are not 
usually found in the environment of the cells. This allows the selection of the 
transformant from a heterogeneous population after gene transfer. The selection agent 
inhibits the growth of not stably transfected cells. Antibiotic resistance genes allow 
cells expressing them to neutralize the toxic effect of the antibiotic. Most antibiotic 
resistance genes used in biotechnology were originally isolated from bacteria. Table 2 
summarizes the most commonly used antibiotics, their mode of action, the working 
concentration range, the name and the origin of the gene conferring resistance to the 
antibiotic. 
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Table 2. Antibiotics used for selection of stable transformant and their mode of action.  
Antibiotic Gene Mode of Action Conc. 
µg/ml 
Blasticidin Blasticidin deaminase 
from Bacillus cereus 
Inhibit protein synthesis by 
interfering with the peptidyl 
transfer reaction causing 
premature translation 
termination (Gould et al. 
1989) 
2-10 
Hygromycin B Hygromycin 
phosphotransferase 
from Escherichia coli 
Inhibit protein synthesis by 
disrupting ribosome 
translocation and promoting 
mistranslation (Shuman 
1991) 
10-400 
Geneticin 
(G418) 
Neomycin 
phosphotransferase 
from Tn5 aph2 
Blocks protein synthesis by 
interfering with ribosomal 
functions (Kolodziej and 
Young 1991) 
50-1000 
Puromycin Puromycin 
acetyltransferase from 
Streptomyces 
Blocks protein synthesis by 
causing premature 
translation termination 
(Niman et al. 1983) 
2.5-10 
Zeocin Sh ble from 
Streptaolloteichus 
hindustanus 
Intercalates into the DNA 
and causes strand cleavage 
(Porath et al. 1975) 
50-1000 
 
2.5.2 Genetic selection agents and amplification 
A gene complementing a deficiency in the chosen cell line can be used as a selection 
marker. The most widely used CHO cell is one with a deficiency in DHFR activity. 
This results in an inability for those cells to grow without medium supplemented with 
hypoxanthine, thymidine and glycine. DHFR is indirectly involved in nucleotide 
biosynthesis. It catalyzes the conversion of folate to tetrahydrofolate which is required 
for the biosynthesis of glycine, thymidine monophosphate and purines. After co-
transfection of the gene of interest with a vector carrying the dhfr gene, positive 
transformants are selected in a medium lacking the supplements required for cell 
growth of the auxotrophic cells. MTX can also be added to increase the selection 
pressure. It is a folic acid analog which binds to DHFR and inhibits its activity. 
Increasing its concentration can result in gene amplification, the overreplication of 
genetic material in a specific part of a genome. Spontaneous gene amplification can 
occur and was reported for the lac operon in E. coli (Tlsty et al. 1984). Among the 
various gene amplification systems listed in Table 3, CHO-DHFR and NS0-GS are the 
most widely used.  
 
The major drawback of gene amplification remains the stability of the transgene 
expression. The instability of production after DHFR amplification has been reported 
 
Introduction 
23 
for c-myc, tPA, and antibodies (Pallavicini et al. 1990; Fann et al. 2000; ) Kim et al. 
1998). Genomic rearrangements such as polyploidy, duplication and translocation 
were observed after amplification, (Wurm et al. 1992;)Davies and Reff 2001).  
 
Table 3. Amplifiable and selectable markers for mammalian cells; Adapted from (Omasa 2002) 
Host cells Amplified gene Inducer of gene amplification 
CHO, human, 
mouse 
Dihydrofolate reductase 
(DHFR) 
 Methotrexate (MTX) 
CHO, myeloma Glutamine synthetase 
(GS) 
Methionine sulfoximine (MSX) 
CHO, human 
tumor 
Aspartate 
transcarbamylase (CAD) 
N-Phosphonacetyl-L-aspartate (PALA)
Human, yeast, 
CHO, mouse 
Metallothionein Cadmium (Cd2+) 
Human, mouse, 
CHO 
Adenosine deaminase 
(ADA) 
Adenosine, alanosine, 2’-
deoxycoformycin 
Hamster Adenylate deaminase 
(AMPD1,2) 
Adenine, azaserine, coformycin 
Mouse UMP synthetase 6-Azauridine, pyrazofuran 
CHO, 
carcinoma 
Asparagine synthetase 
(AS) 
β-Aspartyl hydroxamate, albizziin 
Human, 
hamster, mouse 
Ornithine decarboxylase 
(ODC) 
α-Difluoromethyl-ornithin (DFMO) 
 
2.6 Strategy for the establishment of stable cell lines 
The two strategies commonly used for the isolation of stable recombinant cell lines are 
the colony picking and the limited dilution. In the first strategy, transfected cells are 
cultivated at low densities in Petri dish under selection pressure. After 7-15 days, 
depending on the selection pressure and the initial cell density used, growing colonies 
become visible. It is assumed that one colony is issued from one transfected cells. The 
colonies are then transferred in larger container and kept in culture for preliminary 
screening analysis. In the limited dilution approach, the transfected cells are 
distributed into multi-well plates at very low cell densities, in order to have one cell 
per well. Cell growth is observed usually 15-30 days later. In the two methods, there is 
no guarantee that the population is from a single cell. Once the first screening has been 
performed, usually several limited dilution steps are added in order to assure the 
clonality of the recombinant cell lines.  
 
Recently, different new approaches were developed to isolate high producing cells 
using flow cytometry or fluorescence activated cell sorting (FACS). For example, a 
surface affinity matrix to trap secreted product on the surface of secreting cells, thus 
allowing direct analysis of single cell specific productivities has been developed 
(Borth et al. 2000). A 9 fold decrease of the number of plates required to obtain a high 
producing clones was observed when using FACS compared to classical limited 
dilution method (Borth et al. 2000). GFP, cloned on a bicistronic vector with the 
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protein of interest, has also been used as selectable marker for FACS sorting (Meng et 
al. 2000). The established clone had specific productivity 6 fold higher than the one 
obtained from randomly picked colonies (Meng et al. 2000). Fluorescein 
isothiocyanate-labeled methotrexate was used to distinguish between highly 
productive CHO cells and the other cells and thus establish stable cell lines within a 
few weeks (Yoshikawa et al. 2001). A cell surface labeling technique using 
fluorescently tagged antibodies that bind to target proteins at low temperature has also 
been proposed (Brezinsky et al. 2003). Using FACS sorting, they isolated population 
with a 20-fold higher specific productivity (Brezinsky et al. 2003). 
  
A second method to allow the capture of secreted products on the surface of the 
secreting cells is the microbead technology (Weaver et al. 1988). This method was 
used to select high producing hybridoma cells (Gray et al. 1995). Another approach, 
similar to the one proposed in this work, is to use surface protein as a “molecular 
hook”. This approach was used to isolate transiently transfected cells with a membrane 
anchored single-chain antibody, which binds to hapten-coated magnetic beads 
(Chesnut et al. 1996). Despite all these novel approaches, the screening procedure for 
high producing cell lines remains extremely time and labor-intensive and costly.  
 
2.7 Goal of the thesis 
The labor intensive screening steps required for the establishment of cell lines that 
produce high levels of recombinant protein hinders the potential to screen numerous 
candidate clones and to manufacture r-proteins in a timely and cost-effective manner. 
New approaches that are able to rapidly identify clones producing a high level of an r-
protein are needed to overcome this bottleneck. In this project, two different 
approaches are suggested to establish highly productive stable cell lines in a rapid and 
inexpensive way. Typically, the probability to find a clone from one transfection is 
very low. The goal of this project was to increase either the number of potential 
positive cells or the probability of transgene integration.  
 
2.7.1 Gene transfer to large cell populations for affinity cell sorting 
The first objective was to increase the number of positive transfectants (e.g. clones) by 
10-100 fold over presently available techniques. Thus, the probability to isolate highly 
productive and stable cells would be improved. The idea was to increase the number 
of transfected cells for screening without increasing the workload. To avoid problems 
related to the adaptation of cells to suspension growth after transfection and to 
transfect and screen a large number of cells, the transfection and selection steps were 
performed in a suspension system. This required a culture medium that stimulated cell 
growth and supported a high cell density. In this study, we executed single-procedure 
transfections of suspension culture at the 100 ml scale (e.g. with 2∗108 cells), the 
equivalent to the transfection of sixty-six 10 cm culture dishes. 
 
The major challenge to accomplish the goal was the isolation of clones from the bulk 
transfection. The positive cells were recovered from the population with a tagged cell 
surface receptor co-expressed with the gene of interest. In the experiments described 
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here we used the FLAG-tagged mouse serotonin 5-hydroxytriptamine 3 (5-HT3) 
receptor. The FLAG peptide with 8 hydrophilic residues (DYKDDDDK) was fused to 
the N-terminal of 5-HT3 (Hopp et al. 1988). The anti-FLAG M1 antibody binds to its 
epitope in a calcium-dependant manner (Hopp et al. 1996). We attempted to use this 
property to separate the cells into different fractions. The population of cells 
expressing the surface receptor and the protein of interest were enriched on a resin 
coated with the M1 antibody. Then, the cells were to be eluted from the resin with 
increasing concentrations of EDTA to chelate calcium and to allow fractionation of 
cells expressing the surface receptor at different levels.  
 
The first step of this project was the development of a transfection protocol for CHO 
DG44 cells growing in suspension. Then the expression of the 5-HT3 receptor was 
evaluated, and finally the binding of 5-HT3-positive cells to antibody coated beads 
was investigated. The feasibility of the latter approach was studied with transiently 
transfected cells. 
 
2.7.2 Gene transfer into single cells 
The second objective was to develop microinjection of DNA into the nucleus of a 
CHO cell as a gene transfer method for the establishment of recombinant cell lines. 
Plasmid DNA is actively degraded in the cytoplasm (Lechardeur et al. 1999; Pollard et 
al. 2001), and classical transfection methods do not allow control of the of DNA 
amount delivered into the cell. By comparison, microinjection allows control of the 
plasmid DNA copy number introduced into the nucleus. The hypothesis was that 
delivery of very high copy number of plasmid DNA into the nucleus would result in 
an increased frequency of stable chromosomal integration. 
 
We have investigated several critical parameters of microinjection of plasmid DNA 
into CHO DG44 cells to evaluate the possibility of using this technique for the 
establishment of highly productive stable cell lines. Using the GFP gene as a reporter, 
the effects of DNA concentration, injection pressure, and the subcellular location of 
the injection on transgene expression were evaluated. This approach resulted in the 
recovery of recombinant CHO cell lines stably expressing GFP. The stability of the 
GFP expression, the copy number integrated and the site of integration were analyzed 
and compared to cell lines established after CaPi transfection. It should be noted here 
that Southern blot analysis was performed in our laboratory by Martin Bertschinger, 
and localization of the plasmid integration sites in the recombinant cell lines generated 
in this study was performed at the laboratory of cytogenetic in the CHUV (Lausanne, 
Switzerland) by Dr Danielle Martinet and co-workers. The affinity cell sorting 
experiments (chapter 5) were performed in close collaboration with Dr Horst Pick. 
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3. Materials and Methods 
3.1 Cell lines and cell culture 
3.1.1 Cell lines 
A CHO cell line (CHO DG44) deficient in DHFR activity was used for the 
establishment of recombinant cell lines (Urlaub and Chasin 1980; Urlaub et al. 1983; 
Urlaub et al. 1986). CHO DG44 cells have a double deletion of the dhfr gene and 
contain no endogenous dhfr sequences. The hybridoma cell line 4E11 (ATCC number: 
HB-9259) was kindly provided by Dr. C. Vandevyver and used for the production of 
the anti-FLAG M1 monoclonal antibody.  
3.1.2 Cell cultivation 
CHO DG44 cells were adapted to serum-free suspension growth in ProCHO5 CDM 
medium (BioWhittaker Inc., Walkersville, MD) supplemented with 0.68 g/l 
hypoxanthine and 0.194 g/l thymidine (HT) (Sigma Chemical Co, St. Louis, MO). 
Initially, the culture was maintained in a 250 ml spinner flask (Bellco Glass Inc, 
Acton, MA) agitated at 80 rpm in an atmosphere containing 5% CO2 with a relative 
humidity of 95%. The cells were passaged every 3-4 days at an inoculation density of 
2.5∗105 cells/ml. The maximum cell density achieved was 3∗106 cells/ml. Later the 
culture was maintained in a square-shaped glass bottle with a screw cap (Schott Glass, 
Mainz, Germany) mounted on an orbital shaker rotating at 160 rpm in an incubator 
without a controlled atmosphere (Muller et al. 2004). The cap was kept closed for 24 h 
following inoculation. The cells were passaged every 3-4 days at an inoculation 
density of 3∗105 cells/ml. The maximum cell density achieved was 4-5∗106 cells/ml. 
 
Recombinant cell lines were cultivated as adherent cultures in T-flasks (TPP AG, 
Trasadingen, Switzerland) in DMEM/F12 supplemented with HT and 5% fetal bovine 
serum (FBS) (JRH Biosciences, Lenexa, KS). The cells were passaged every 3-4 days 
at an inoculation density of 1∗105 cells/ml. Re-adaptation of the recombinant cell lines 
to growth in suspension culture was performed in agitated 50 ml centrifuge tubes 
(TubeSpin) in the presence of 5% CO2 (De Jesus et al. 2003). The cultures were 
inoculated at 1∗106 cells/ml. When a cell density of about 4∗106 cells/ml was reached, 
the cells were transferred in a final volume of 20 ml into a 100 ml round-shaped glass 
bottle with a screw cap. After 4-5 days of cultivation in a CO2 atmosphere with 
agitation at 160 rpm, the cells were transferred to a square-shaped bottle at an initial 
density of 1∗106 cells/ml and cultivated in the absence of CO2. During the first two 
weeks of culture, the cells were inoculated in square bottles at a cell density of 5∗105 
cells/ml. 
 
The 4E11 hybridoma cells were cultivated in a T-flask in RPMI 1640 medium 
(Applichem, Darmstadt, Germany) supplemented with 10% FBS, 2 mM L-glutamine 
(GibcoBLR Life Technologies, Paisley, Scotland), 1 mM sodium pyruvate 
(GibcoBRL), and 1% non-essential amino acids (GibcoBRL). The cells were either 
passaged twice a week at a dilution of 1:5 or transferred to a 300 ml roller bottle 
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(TPP). In the roller bottle the cultivation period was split into two main phases: one of 
four days for the production of cell mass and the other of two days for antibody 
production. For the latter, the cells were washed and resuspended in serum-free 
Pro293s CDM medium (BioWhittaker Inc.) before being returned to the roller bottle 
for 48 h. The supernatant was then harvested, and the antibody was recovered by 
affinity chromatography using protein A. 
3.1.3 Cell counting 
Cell growth was determined either by the manual counting of cells with a 
haemocytometer (Neubauer chamber) or by determination of the packed cell volume 
(PCV) using mini PCV tubes (TPP AG). The first method simultaneously allowed the 
cell viability to be determined by Trypan blue exclusion. The PCV method measured 
the percentage of the total volume that was occupied by a cell pellet after 
centrifugation of an aliquot of a suspension culture. For example, a PCV of 0.1% 
indicated that 1 µl of cell pellet was present per ml of cell culture. Briefly, the cells 
were centrifuged during one minute at 2650 g in a mini PCV tube and the volume of 
the cell pellet was measured in order to determine the percentage of PCV. The cell 
density for adherent recombinant cells was assessed with a CASY®1 TTC cell counter 
following trypsinization of the cells (Schärfe System GmbH, Reutlingen, Germany).  
3.1.4 Cell transfection 
Different media supplemented with HT were tested for the transfection of cells in 
suspension. DMEM/F12 and RPMI were purchased from Applichem (Darmstadt, 
Germany). mDMEM was purchased from Cell Culture Technologies GmBH (Zürich, 
Switzerland). The FMEM medium was DMEM/F12 medium supplemented with 10 
mM Hepes (Applichem), 2.5 mg/l insulin (Sigma), 2.5 mg/l holo-transferin (Sigma), 
0.1 mM diethanolamine, 0.1 mM L-proline (Sigma), 2.5 mM glutamine (Applichem) 
and 1.85 g/l glucose (Applichem). For all transfections, the cells were passaged one 
day prior to transfection at 1∗106 cells/ml. 
 
3.2 Plasmids 
As previously described, the human anti-Rhesus D IgG light and heavy chain genes 
were separately cloned into pEAK8 (Edge Biosystems, Gaithersburg, MD) to produce 
pLH1 and pLH2, respectively (Miescher et al. 2000; Zahn-Zabal et al. 2001). To 
produce pKML and pKMH the cDNAs of the IgG light chain and heavy chain genes 
were cloned individually into pMYK/EF-I (kindly provided by Dr. Y.-S. Kim, Korea 
Research Institute of Bioscience and Biotechnology (Kim et al. 2002)) as EcoRI/XbaI 
fragments recovered from the digestion of pLH1 and pLH2. pEGFP-N1 and pDsRed-
Express, carrying the enhanced green fluorescent protein (GFP) and the red 
fluorescent protein (RFP) genes, respectively, were purchased from Clontech (Palo 
Alto, CA). pEAK8-EGFP encodes the enhanced green fluorescent protein (GFP) gene. 
The GFP gene from pEGFP-N1 was cloned as an EcoRI/NotI fragment into 
EcoRI/NotI-digested pMYK/EF-I (Kim et al. 2002) and pEAK8 to produce pMYK-
EGFP and pEAK8-EGFP, respectively. The neomycin resistance gene was removed 
from pMYK-EGFP by digestion with BspH1 and PvuII and replaced by the puromycin 
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resistance gene that was recovered from pEAK8 as an Hpa1 fragment. The resulting 
plasmid was designated pMYK-EGFP-puro. pCEP4 was purchased from Invitrogen 
(Carlsbad, Ca). A clone of the Gam1 gene expressed from the hCMV immediate early 
promoter (pMCGam1) was a gift from Dr. Matt Cotten (Axxima Pharmaceutical, 
München, Germany). The FLAG-tagged 5-HT3 mouse serotonin receptor gene was 
cloned in pEAK8 to produce p5HT3. The expression of the gene was under the control 
of the human EF-1α promoter. p5HT3-GFP was obtained after cloning the FLAG-
tagged 5-HT3 mouse serotonin receptor gene and the EGFP gene in the first and 
second positions of pTrident 13 (a generous gift from Prof. Fussenegger, ETH Zürich, 
Switzerland) (Moser et al. 2000). The expression of the bicistronic mRNA was driven 
by the human EF1-α promoter. 
 
Plasmid DNA was purified on a Nucleobond®Ax anion exchange column (Macherey-
Nagel GmbH, Düren, Germany) according to the manufacturer’s protocol and stored 
at -20°C at a concentration of 1 mg/ml in TE buffer (10 mM Tris-HCL, 1 mM EDTA, 
pH 7.4). DNA used for microinjection was stored in UHP water rather than TE. 
 
3.3 Gene transfer into bulk populations of cells 
Unless otherwise stated, the DNA concentration in the transfection medium was kept 
constant at 2.5 µg/ml. For IgG production, pKMH and pKML were transfected at a 
ratio of 50:50 and pLH1 and pLH2 at a ratio of 70:30.  
3.3.1 Calcium phosphate-DNA co-precipitation 
One solution of 250 mM CaCl2 and another of 50 mM HEPES and 140 mM NaCl 
were prepared with UHP H2O. For the latter, the pH was adjusted to 7.05 with 1 M 
NaOH. Then Na2HPO4 was added from a 300 mM stock solution to a final 
concentration of 1.4 mM. For the preparation of the phosphate stock solution either 
Na2HPO4 or NaH2PO4 was used. For 1 ml of transfection volume, the transfection 
cocktail was prepared by gently mixing 2.5 µg DNA with 50 µl of 250 mM CaCl2. 
Then 50 µl of the HEPES-phosphate solution was added to form the precipitate. After 
exactly 60 seconds, the transfection cocktail was transferred to the suspension culture 
in a 50 ml centrifuge tube (TubeSpin) in DMEM/F12 supplemented with 2% FBS. 
The cells were incubated at 37°C for 4 h with agitation at 140 rpm. The cells were 
exposed to an osmotic shock by replacement of the transfection medium with 10, 20, 
or 30% DMSO (Fluka Chemie AG, Buchs, Switzerland) or glycerol (Fluka) in 
DMEM/F12 medium for 1 min. The culture was then centrifuged, and the cell pellet 
was resuspended in serum-free ProCHO 5 medium. 
 
For the transfection of cells to establish recombinant cell lines, an optimized protocol 
for adherent cells was used (Grosjean 2003). Briefly, at 4 h prior to transfection 
suspension cells were plated at 4.5∗106 cells/ml in a 12-well plate. After 3 to 4 h 
incubation with the precipitate, the cells were exposed to 10% glycerol in PBS for 1 
min. After removal of the glycerol solution, the cells were washed once with 5 mM 
EGTA in PBS for 1 min (Grosjean 2003). After removal of the EGTA, pre-warmed 
DMEM/F12 supplemented with HT and 5% FBS was added. 
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3.3.2 Lipofection 
Different liposomes were tested for their ability to promote gene transfer in suspension 
cultures of CHO cells. Lipofectamine 2000 was purchased from Invitrogen (San 
Diego, CA), DOTAP and DOSPER from Roche (Rotkreuz, Switzerland), GenePorter 
from Gene Therapy System Inc. (San Diego, CA) and TransFast from Promega Corp. 
(Madison, WI). The transfections with liposomes were performed in non-treated 24-
well microtiter plates (Integra Bioscience, Wallisellen, Switzerland) in order to avoid 
cell adherence. The cells were transfected in 500 µl of DMEM/F12 and then diluted 4 
h post-transfection with 500 µl ProCHO5 CDM medium supplemented with HT. For 
each liposome formulation the protocol from the provider was used. In each case the 
DNA concentration was 2 µg/ml, and the incubation of the DNA with liposomes was 
performed at room temperature for 15 minutes. For each liposome formulation the 
transfection protocol is described below for the transfection of 8 wells of a 24-well 
microtiter plate (4 ml of medium). With TransFast, 48 µl liposomes were added to the 
DNA in 1936 µl medium, and 250 µl were added to each well where the cells were 
previously distributed in 250 µl medium. With GenePorter 8 µl of liposomes was 
added to 2 ml medium and DNA was added to a second 2 ml aliquot of medium. The 
two solutions were mixed, incubated for 15 minutes, and 500 µl of the mix was 
distributed to each well containing cells in 100 µl medium. For DOSPER the DNA 
and 16 µl liposomes were each added separately to 200 µl of HBS (150 mM NaCl and 
20 mM Hepes). The two solutions were then added together and vortexed. After 
incubation at room temperature for 15 minutes, 50 µl of the mix was added to cells in 
500 µl of medium. For DOTAP 30 µl of liposomes were added to 70 µl HBS, and the 
DNA was added to 42 µl HBS. The two solutions were mixed and then incubated for 
15 minutes at room temperature prior to addition of 18 µl to each well containing cells 
in 500 µl medium. For Lipofectamine 200, two solutions containing either 400 µl 
medium and the DNA or 400 µl medium and 8 µl liposomes were mixed, and 100 µl 
was added to cells in 500 µl of medium. 
3.3.3 Polyfection 
Stock solutions of linear 25 kDa PEI (Polysciences, Eppelheim, Germany), JetPEI 
(PolyPlus Transfection, Illkirch, France), and branched PEIs with molecular weights 
of 0.423, 0.6-0.8, 1.2, 1.8-2, and 10-25 kDa (Sigma Chemical Co., St. Louis, MO) 
were prepared in UHP water at a final concentration of 1 mg/ml. The pH was adjusted 
to 7.0 with HCl. The solutions were filter sterilized with a 0.22 µm filter, and aliquots 
were stored frozen at –80oC. JetPEI was stored at 4°C. Stock solutions of poly-D-
lysine (70-150 kDa) and polybrene (Sigma) were prepared in UHP water at 100 µg/ml 
and 10 mg/ml, respectively, and stored at -20°C. The transfections with polycations 
were performed in 12-well microtiter plates. 
 
One day prior to transfection, cells were seeded at 1*106 cells/ml in ProCHO5 CDM 
medium supplemented with HT. On the day of transfection the cells were washed once 
with either a DMEM/F12-based medium (Applichem, Darmstadt, Germany) or RPMI 
1640 medium (Applichem) supplemented with hypoxanthine and thymidine as 
described above. CHO cells were suspended in the same medium at a density of 1-
2*106 cells/ml as indicated in the text, and cells (1 ml) were then dispensed into 12-
well plates (TPP, Wohlen, Switzerland) for transfection.  
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DNA and PEI (or poly-D-lysine) were diluted separately in sterile 150 mM NaCl or 
278 mM glucose as indicated. The final volume of each solution was equivalent to 5% 
of the volume of the culture to be transfected. The PEI was then added to the diluted 
DNA, and the mixture was incubated at room temperature for 10 min unless otherwise 
noted. Finally, 100 µl of the DNA-PEI mix was added to each well, and the plates 
were incubated with agitation (200 RPM) for five hours at 37oC in an atmosphere with 
5% CO2 and 95% humidity (MicroSpin) (Girard et al. 2001). The cells were then 
diluted with 1 ml of ProCHO5 CDM medium supplemented with HT, and the 
incubation was continued for three days. For transfections with polybrene, the DNA 
was mixed directly with the polybrene solution and added to the cells after a 1 min 
incubation. The volume added was equivalent to 5% of the volume of the culture.  
 
3.4 Gene transfer into single cells  
3.4.1 Quantification of injection volume 
A 5 mg/ml solution of 150 kDa FITC-dextran in UHP water (Fluka) was injected into 
CHO DG44 cells as described in Section 1.4.3 below. The FITC-dextran stock 
solution was stored protected from light at 4°C. The injection volume was related to 
the fluorescence intensity based on the pixel intensity quantified with LabVIEW 
IMAQ Vision (National Instruments, Austin, TX). The injection time was kept 
constant at 0.1 s and injection pressures were varied from 70 to 100 hPa. CHO DG44 
cells were injected either into the nucleus or the cytoplasm. 
3.4.2 Cells 
For transient expression studies, suspension CHO DG44 cells were plated in a Petri 
dish (TPP AG) at 5∗104 cells/ml in DMEM/F12 medium (Applichem) supplemented 
with HT, 5% FBS and 25 mM HEPES pH 7 one day prior to microinjection. Usually 
100 cells per dish were injected at room temperature over a period of 30 to 60 min. 
Immediately after microinjection, the medium was exchanged with fresh pre-warmed 
DMEM/F12 medium containing 5% FCS and antibiotic-antimycotic solution (10,000 
units/ml penicillin, 10 mg/ml streptomycin, and 25 µg/ml amphotericin B) (Sigma 
Chemical). For the generation of recombinant cell lines, cells in suspension were 
diluted to a concentration of 5 cells per 20 µl in DMEM/F12 medium supplemented 
with 10% FBS. Several 20 µl droplets were deposited on a 100 mm Petri dish. After 
the cells adhered (about 4 h after transfer) 4 ml of DMEM/F12 medium supplemented 
with HT, 10% FBS and 25 mM HEPES was added to each dish, and the culture was 
incubated overnight at 37°C. Prior to injection an additional 5 ml of DMEM/F12 
medium supplemented with HT, 10% FBS, 25 mM Hepes and antibiotics was added 
to the dish. On average 16-20 cells were injected in each dish over a period of 15-30 
min. Immediately after injection, the medium was exchanged with pre-warmed 
medium. In order to stimulate cell growth 50% of the medium added was DMEM/F12 
containing 10% FBS that had been conditioned for 5-7 days with CHO DG44 cells. 
The other 50% was fresh DMEM/F12 medium supplemented with 10% FBS and HT. 
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3.4.3 Microinjection 
Microinjection was performed semi-automatically with a FemtoJet (Eppendorf AG, 
Hamburg, Germany) connected to an InjectMan NI 2 (Eppendorf AG) mounted on a 
motorized Axiovert 200M inverted fluorescence microscope (Carl Zeiss AG, 
Oberkochen, Germany). To avoid any external vibrations, the microscope was placed 
on a BenchtopTM breadboard (Newport Corporation, Irvine, CA).  
 
With the Femtojet the injection pressure, injection time and compensation pressure 
were controlled. The injection pressure was varied from 70 to 100 hPa as indicated in 
each experiment for transient gene expression and was kept constant at 70 hPa for 
injection for stable gene expression. The injection time was constant at 0.1 s, the 
lowest value possible, for all the microinjection experiments. The compensation 
pressure was kept at 35 hPa. All the injections were performed at a 45° angle. The 
InjectMan NI 2 allowed the control of the manipulator, the fixation of the injection 
level and the determination of the injection depth in 200 nm steps. Femtotips II 
(Eppendorf AG) with an inner diameter of 500 nm and an outer diameter of 700 nm 
were used for all injections (Fig. 1). The DNA concentration used for microinjection 
was between 30 and 1.8 µg/ml. For transient microinjection DNA was circular. Unless 
otherwise noted DNA was linearized for stable microinjection.  
 
The microinjection process is illustrated in Fig. 2. Briefly, the capillary was lowered to 
the cell surface (search level or injection limit). Then depending on the subcellular 
localization of the injection, the injection depth was fixed (Z-limit). Cytoplasmic 
injections were usually performed at 200 to 800 nm below the search level, whereas 
nuclear injection was performed at 1000 to 2200 nm below the search level.  
 
 
Fig. 1. Femtotip II capillary used for the microinjection. The inner and outer diameters are 500 nm and 
700 nm, respectively.  
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Fig. 2. Schematic diagram of the microinjection process. The capillary was brought to the search level 
above the cell surface (injection limit), and the injection depth was fixed (z-limit) (A). The injection 
itself was then performed automatically. The capillary moved backward along the x axis (B) and then 
pierced the cell at a 45° angle to the determined depth on the vertical plane where the injection limit 
was fixed (C). Then the fixed pressure was applied for 0.1 s. When the injection was complete the 
capillary returned to the starting position (D). The drawings were adapted from www.eppendorf.com. 
 
3.5 Selection of recombinant cell lines 
The stock solution of puromycin (Fluka) was prepared at 2 mg/ml in UHP water and 
stored at -20°C. The working concentration for selection of stable recombinant CHO 
DG44 cells was 3 µg/ml. The cells were exposed to the selection pressure beginning at 
4 days post-microinjection. The colonies were transferred to a 96-well microtiter plate 
with a round bottom (Nalge Nunc International, Rochester, NY) at 8 days after 
microinjection. Then the cells were expanded sequentially into 24- and 12-well 
microtiter plates and finally into a 25 cm2 T-flask. The cells were grown under 
selection until the clonal population was analyzed by flow cytometry, usually about 21 
days post-microinjection. 
 
3.6 Protein quantification 
IgG concentration was determined by sandwich ELISA using goat anti-human kappa 
light chain antibody for capture (BioSource, Lucerne, Switzerland) and alkaline 
phosphatase-conjugated goat anti-human IgG for detection (BioSource). For the 
analysis of GFP expression, 1 ml of cells in 12-well microtiter plates was lysed by 
addition of 1 ml of 1% Triton X-100 (Sigma) in TE. After incubation at room 
temperature for 1 h, the fluorescence was measured using a CytofluorTM 4000 plate-
reading fluorometer (Applied Biosystems, Foster City, CA). The excitation 
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wavelength was 485 nm with a bandwidth of 20 nm, and the emission fluorescence 
was measured at 530 nm with a bandwidth of 25 nm. The background fluorescence 
from cultures transfected in the absence of plasmid was subtracted from each value. 
Fluorescence intensity was reported in relative fluorescence unit (RFU) with the 
measurements made at a gain of 80. For some recombinant cell lines, the fluorescence 
signal was saturated at a gain of 80, and the gain was decreased to 70. The correction 
factor for a gain different from 80 was obtained using Formula 1 (Girard 2001). 
 
   Fcorr = 7.808 ∗ 1013 ∗ Gactual-7.3 
Formula 1. Correction factor for the fluorescence measurement at a gain different from 80. Gactual is the 
gain value used for the measurement. 
The relative fluorescence corrected to gain 80 was obtained by multiplying the 
measured fluorescence at gain 70 with the calculated correction factor. 
 
3.7 Affinity cell sorting 
The 5-HT3 serotonin receptor is composed of 5 identical subunits. For this experiment 
the monomer was modified with an N-terminal FLAG-tag. The receptor was stained 
with GR-Cy5 (GR-FITC) a specific antagonist (Wohland et al. 1999). Three different 
resins were tested for affinity cell sorting. Streamline and 6 MB beads were purchased 
from Amersham Biosciences (Piscataway, NJ) and Dynabeads from Dynal Biotech 
(Oslo, Norway). The 6 MB resin was packed in a 1 ml column. The resin in TBS (pH 
8.0) was incubated at room temperature with 1 mg anti-FLAG monoclonal antibody. 
The column was stored at 4°C in 20% ethanol. The Streamline and the Dynabeads 
were coated in a microcentrifuge tube in 1 ml culture medium. Either 10 µl Dynabeads 
or 20 µl Streamline beads were incubated at room temperature with 50 µg anti-FLAG 
monoclonal antibody for 30 min or for 1 h, respectively. Then the resin was washed at 
least three times with the binding medium and incubated with 2∗106 transfected cells 
in 1 ml medium for 30 min. 
 
Two different anti-FLAG monoclonal antibodies were used for these studies. 
Antibody M2 conjugated to the fluorophore Cy3 was purchased from Sigma. The 
binding of this antibody to the FLAG epitope was not calcium dependant. The anti-
FLAG antibody M1 was purified with protein A from serum-free culture medium of 
4E11 hybridoma cells. Its binding to the FLAG epitope was calcium dependant.  
 
Routine transfections for affinity cell sorting were performed in 50 ml centrifuge tubes 
(TubeSpin) with a culture volume of 5 ml at a density of 2∗106 cells/ml in RPMI 1640 
medium with a DNA:PEI ratio of 1:2 (w/w). At 4 h after transfection, each tube was 
diluted with 5 ml ProCHO5 medium, and then the volume was reduced to 5 ml. At 
two days after transfection the cells were sorted (See Section 3.3.3 of this chapter). 
Different media including DMEM/F12, ProCHO5, and a modified Ex-CellTM 325 
(JRH) without calcium and phosphate were used for the binding of the cells expressing 
the FLAG-tagged 5-HT3 to the resin coated with the M1 antibody. For the M2 
antibody, the cells were sorted in ProCHO5 medium. Prior to sorting the antibody-
coated resin was equilibrated in the binding medium. Image acquisition was 
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performed using a Zeiss LSM510 laser scanning confocal microscope (Carl Zeiss 
AG). 
 
3.8 Fluorescence microscopy 
Microscopy acquisitions were performed with a motorized Axiovert 200 M 
fluorescent microscope (Carl Zeiss AG) equipped with an incubation chamber in 
which the temperature was controlled and a smaller chamber for dishes and plates in 
which the temperature, CO2 and humidity were controlled. A HBO 100 lamp was used 
as a fluorescence excitation source. A Zeiss AxioCa HRm camera was mounted on the 
microscope, and image acquisition was controlled by the Axiovision 4.1 software 
(Carl Zeiss AG). FITC and GFP were analyzed using bandpass (BP) filter set #17 
(excitation: BP 485/20 nm and emission: BP 515-565 nm) and RFP was analyzed 
filter set #43 (excitation: BP 545/25 and emission: BP 605/70). The acquisition time to 
record fluorescence for the determination of the injection volume was 2000 ms, for 
imaging GFP expression it was 300 ms, and for the time lapse acquisition it was 100 
ms. Time lapse imaging was initiated 1 h after microinjection with one acquisition 
every 20 min for 18 h. For time lapse imaging the focus was controlled by an 
autofocus module.  
 
3.9 Stability study for the recombinant cell lines 
The recombinant cell lines were kept in culture for 8 to 12 weeks and passaged twice a 
week. Once per month the number of GFP-positive cells and the fluorescence intensity 
per cell were determined by flow cytometry at the Ludwig Institute for Cancer 
Research in Lausanne on a BD FACS Scan benchtop analyzer (BD Biosciences, San 
Jose, CA). Every one to two weeks the specific fluorescence was determined by 
fluorometry. 1 ml cells that had been cultured for 3 days were transferred to a 12-well 
microtiter plate in DMEM/F12 medium for adherent growing cells or ProCHO 5 for 
suspension cells. For each cell line one well of cells was lysed with Triton X-100 as 
described in Section 3.6. The plate was incubated under a humidified atmosphere with 
CO2 for 4 h. This was the time required for the cells in the non-lysed well to become 
adherent. Then the relative fluorescence was measured with a plate-reading 
fluorometer (see Section 3.6). The cell density was assessed manually for suspension 
cultures and with the CASY®1 for adherent cultures. The specific fluorescence 
corresponded to the relative fluorescence units divided by the number of cells 
multiplied by 100.  
 
3.10 Fluorescence in-situ hybridization (FISH) 
The FISH experiments were performed at the cytogenetic laboratory of the “Hôpital 
Cantonal Universitaire de Lausanne”. The protocol was similar to the one described by 
Wurm and Schiffmann (Wurm and Schiffmann 1999). Briefly, adherent dividing cells 
were exposed for 1.5 h to colchicine at a final concentration 0.16 µg/ml to block cell 
division during the metaphase stage by binding to microtubules. To obtain a better 
distribution of the chromosomes in a swollen cell, the cells were exposed to a 
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hypotonic shock in the presence of 37.5 mM KCL for 20 min. Two fixation steps were 
then performed with an acetic acid:methanol solution having a 1:3 ratio (v/v). After 
fixation the chromosomes were spread on a glass slide. For karyotype analysis, a G 
band staining was prepared. Briefly, the slides were first exposed during 10-20 s to 
trypsin (1% in EDTA) and washed with 150 mM Nacl then dried. The slides were then 
stained with Giemsa solution (2% in PBS) during 8 min. 
 
For FISH analysis, the probes were prepared by direct labeling of pMYK-EGFP-puro. 
The plasmid DNA was nick translated in the presence of spectrum green dUTP 
following the information of the provider (Abbott AG, Baar, Switzerland). The probe 
size ranged from 100 to 300 bp. After denaturation and overnight hybridization at 
37°C directly on the glass slides, the chromosome spreads were counterstaining with 
DAPI as described by the provider (Abbott). The stained chromosomes were observed 
using a 100x oil immersion objective on a Axioscope II microscope (Zeiss). A HBO 
100 lamp was used as a fluorescence excitation source. Image acquisition and analysis 
were performed with Applied Imaging Cytovision Genius Genetic Image Analysis 
workstation (Zeiss). 
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4. Gene transfer to large cell populations 
In this chapter the transfection of large CHO DG44 cell populations grown in 
suspension under serum-free condition is described. To our knowledge, a cost-
effective transfection method for serum-free suspension growing CHO has not been 
published. The purpose of this study was to determine the conditions for delivering 
functional DNA to the highest possible cell number and to identify methods for the 
isolation of a large number of independent clonal cell lines from the transfection of a 
suspension culture of CHO DG44 cells (Chapter 5 on affinity cell sorting). Several 
parameters were evaluated for their effects on transfection efficiency for three 
different transfection methods. For the assessment of the different methods transient 
reporter protein levels in transfected cell populations were compared. All three 
transfection methods rely on the formation of positively charged nanoparticles which 
can enter cells following binding to the negatively charged cell surface. CaPi 
transfection is based on the co-precipitation of DNA with calcium phosphate while 
lipofection and polyfection are based on the compaction of DNA with liposomes 
(lipoplexes) and cationic polymers (polyplexes), respectively (Graham and Eb 1973; 
Jordan et al. 1998; Thomas and Klibanov 2003). Some of the data presented here have 
been published in Biotechnology & Bioengineering (Derouazi et al., 2004). 
 
4.1 Results 
4.1.1 Cell culture for transfection 
After the adaptation of adherent CHO DG44 cells to serum-free suspension culture, 
the seed train was initially maintained in a spinner flask with a nominal volume of 100 
ml. It was then discovered that for HEK 293 cells, high cell densities and transfection 
efficiencies were achieved by cultivation of cells in square-shaped bottles agitated on 
an orbital shaker (Muller et al., 2004). For this reason CHO DG44 cells were 
subsequently cultivated in square-shaped bottles rather than in spinner flasks. In the 
square bottle system the cell density was 20-30% higher (data not shown) and the 
transfection efficiency was approximately 40% higher as compared to the values 
obtained from CHO DG44 cells grown in spinner flasks (Fig. 3). Furthermore, the 
impact of the culture age at the time of transfection was less critical for cells grown in 
square-shaped bottles than in spinner flasks. GFP expression following transfection 
with pEGFP-N1 was only 25% less for five day-old cultures than for one day-old 
cultures (Fig. 3). In contrast little GFP expression was observed following transfection 
of cells cultivated for 5 days in spinner flasks (Fig. 3).  
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Fig. 3. Transfection of CHO DG44 cells after different cultivation times in two different cultivation 
systems. Suspension cultures of CHO DG44 cells were maintained for one or five days in either a 
spinner flask or a square-shaped bottle. The cells were then transferred to 12-well microtiter plates at a 
density of 2*106 cells/ml in RPMI 1640 medium and then transfected with pEGFP-N1 (2.5 µg/ml) at a 
DNA:PEI ratio of 1:2 (w/w). GFP expression was quantified at three days post-transfection. Each bar 
represents the average of 3 independent transfections. 
 
4.1.2 CaPi transfection 
CaPi transfection of mammalian cells cannot be performed efficiently under serum-
free conditions. For this reason, it is necessary to include serum during the first 4 h of 
the transfection process. Furthermore, an osmotic shock is required in order to observe 
significant reporter protein expression following CaPi-mediated transfection of CHO 
DG44 cells. Therefore, two centrifugation steps were required to transfect CHO DG44 
cells in suspension using the CaPi method, one before and one after the osmotic shock. 
For this reason, the most appropriate culture system for these optimization studies was 
the 50 ml centrifuge tube (TubeSpin), allowing easy handling for the centrifugation 
steps (De Jesus et al., 2003). 
 
Various conditions were tested in order to eliminate the osmotic shock from the 
transfection protocol for CHO DG44 cells. These included increasing the DNA 
concentration from 2.5 µg/ml to 10 µg/ml, varying the CaPi precipitate volume from 
50 µl to 300 µl in 50 µl steps, lowering the final calcium concentration from 12.5 mM 
to 8.33 mM, lowering the final phosphate concentration from 1 mM to 0.5 mM, 
increasing the cell density at the time of transfection from 5∗105 to 1∗106 cells/ml, and 
addition of chloroquin, β-cyclodextrin, sucrose or glycerol to either the transfection 
medium or the dilution medium. None of these changes resulted in a reporter protein 
expression level comparable to that observed following the standard transfection with 
an osmotic shock (data not shown). In addition, suspension cultures of CHO DG44 
cells were transfected with pEGFP-N1 in the presence or absence of an osmotic shock 
using various concentrations of either DMSO or glycerol. Under most conditions, a 2-
3 fold increase in GFP expression was observed after an osmotic shock (Fig. 4). These 
results suggest that an osmotic shock is necessary for efficient transfection of CHO 
DG44 cells by CaPi-DNA co-precipitation. 
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Fig. 4. Transfection of CHO DG44 cells in the presence or absence (control) of an osmotic shock. 
Suspension cultures of CHO DG44 cells were transferred to 50 ml centrifuge tubes at a density of 5∗105 
cells/ml in DMEM/F12 supplemented with 5% FBS. The cells were transfected with pEGFP-N1 using 
the CaPi. GFP expression was measured by fluorometry at day 3 post-transfection. For the control, the 
medium was exchanged 4 h after addition of the CaPi precipitate. Otherwise, the cells were exposed to 
for 1 min to an osmotic shock with various concentrations of DMSO or glycerol in the transfection 
medium. The medium was then removed, and the cells were resuspended in serum-free ProCHO5 
medium. Each bar represents the average of 3 independent experiments. 
 
4.1.3 Lipofection 
To investigate the transfection of suspension cultures of CHO DG44 by lipofection, 
several different liposomes were tested following the protocols provided by the 
manufacturers. However, the protocols were optimized for the ratio of DNA to 
liposomes and for the amount of DNA per transfection. A wide range in the GFP 
expression level was observed at three days post-transfection (Table 4). The highest 
expression level was seen in the presence of Lipofectamine 2000 (Table 4). In 
contrast, no measurable GFP expression was observed following transfection with 
TransFast (Table 4). Specifically for Lipofectamine 2000 and DOTAP, various 
transfection parameters were investigated. These included the cell concentration 
(5∗105 or 1∗106 cells/ml), the DNA concentration (0.5 to 4 µg/ml), and the ratio of 
DNA to liposome (1:2 to 1:3.5 (w/w)). The best results for both liposomes were 
obtained with a cell density of 1∗106 cells/ml, a DNA concentration of 2 µg/ml, and 
DNA:liposome ratio of 1:2 (w/w). For Lipofectamine 2000 the optimal DNA:liposome 
ratio was dependent on the DNA concentration. Similar GFP expression levels were 
achieved after transfection with a DNA concentration of 2 µg/ml at a DNA:liposome 
ratio of 1:2 and with a DNA concentration of 1 µg/ml at a DNA:liposome ratio of 
1:3.5 (w/w). Storage of the liposomes over a period of 6 months resulted in reduced 
levels of GFP expression (data not shown). However, for such batches, increasing the 
liposome amount resulted in an increase in the expression level (data not shown). 
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Table 4. Transfection of suspension CHO DG44 cells with pEGFP-N1 using different liposomes.  
Supplier Name GFP Expressiona 
Invitrogen Lipofectamine 2000 +++ 
Roche DOTAP ++ 
Roche DOSPER + 
GTS GenePorter + 
Promega TransFast - 
aLevel of GFP expression: high (+++), medium (++), low (+), and not detected (-) 
 
4.1.4 Polyfection 
Different polymers including polybrene, poly-D-lysine, and polyethylenimine (PEI) 
were tested for their ability to promote transfer of pEGFP-N1 into CHO DG44 cells in 
suspension. The PEI compounds ranged in size from 0.4 to 25 kDa, and both branched 
and linear molecules were considered. The transfections were performed in 
DMEM/F12 serum-free medium with a final DNA concentration in the transfection 
medium of 2.5 µg/ml. Transfections with poly-D-lysine and polybrene were 
performed with a DNA:polymer ratio of 1:2 (w/w), while those with PEI were 
performed at ratios ranging from 1:1 to 1:4 (w/w). Gene transfer in the presence of 
polybrene, poly-D-lysine, and most of the branched PEIs did not result in detectable 
levels of GFP expression at 3 days post-transfection (Table 2). Measurable levels of 
GFP expression were only observed following transfection with the two linear PEIs 
and with the 25 kDa branched PEI (Table 5). All the branched PEIs promoted 
adherence of the cells despite agitation of the cultures (Table 5).  
 
Table 5. Transfection of suspension CHO DG44 cells with pEGFP-N1 using different polymers.  
Polymer Chemical 
structure 
GFP Expressiona Cell condition 
after 
transfection 
Polybrene linear - suspension 
Poly-D-lysine  branched - suspension 
PEI 0.423 kDa branched - adherent 
PEI 0.6-0.8 kDa branched - adherent 
PEI 1.2 kDa branched - adherent 
PEI 1.8-2 kDa branched - adherent 
PEI 10-25 kDa branched + adherent 
PEI JetPEI linear ++ suspension 
PEI 25 kDa linear +++ suspension 
aLevel of GFP expression: high (+++), medium (++), low (+), and not detected (-) 
 
Three polymers (branched and linear 25 kDa PEI and JetPEI) were further analyzed 
for their ability to promote gene transfer into suspension CHO DG44 cells. The cells 
were seeded in 12-well microtiter plates at a density of 5∗105 cells/ml in serum-free 
DMEM/F12 medium. Complex formation between the polymer and pEGFP-N1 was 
done in either 150 mM NaCl or 278 mM glucose (personal communication of Pascale 
Belguise, Polyplus-Transfection, Ollkirch, France) at a final DNA concentration of 2.5 
µg/ml and at a DNA:PEI ratio of 1:3 (w/w). It was reasoned that PEI-DNA complexes 
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formed in glucose would be smaller than those formed in NaCl and thus would remain 
in suspension longer. For all three polymers tested, GFP expression was higher in 
complexes formed in NaCl rather than in glucose (Fig. 5). The highest GFP expression 
level resulted from the transfection in the presence of 25 kDa linear PEI (Fig. 5). 
Based on these results, all further optimization studies were carried out with this 
compound. Suspension cultures of CHO DG44 cells were inoculated into 12-well 
microtiter plates and transfected with polyplexes formed with pEGFP-N1 in a range of 
DNA:PEI ratios from 2:1 to 1:3 (w/w) in either 150 mM NaCl or 278 mM glucose. 
The final DNA concentration in the transfection medium was 2.5 µg/ml. For complex 
formation in either NaCl or glucose, the DNA:PEI ratio of 1:2 (w/w) resulted in the 
highest GFP expression level (Fig. 6). As in the previous experiment, GFP expression 
was generally higher following complex formation in NaCl as compared to glucose 
(Fig. 6). For transfection with DNA:PEI ratios less than 1:2, very little GFP expression 
was observed (Fig. 6).  
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Fig. 5. Transient GFP expression in suspension CHO DG44 cells. The cells were transfected with 
different PEIs following PEI:DNA complex formation in 278 mM glucose or 150 mM NaCl at a final 
pEGFP-N1 concentration of 2.5 µg/ml in the medium. The DNA:PEI ratio was 1:3 (w/w). In each well 
5∗105 cells per ml of serum-free DMEM/F12 were transfected. Fluorescence was quantified at day three 
post-transfection. Each bar represents the average of 3 independent experiments. 
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Fig. 6. Transient GFP expression in CHO DG44 cells. The cells were transfected with polyplexes 
formed in either 278 mM glucose or 150 mM NaCl between linear 25 kDa PEI and pEGFP-N1 at 
various DNA:PEI ratios ranging from 2:1 to 1:3 (w/w). The cell density at transfection was 5∗105 
cells/ml in serum-free DMEM/F12. The final DNA concentration in the transfection medium was 2.5 
µg/ml. The fluorescence was measured at three days post-transfection. Each bar represents the average 
of 3 independent experiments. 
 
All of the transfections described above were performed in serum-free DMEM/F12 
medium. To determine if the medium influences the efficiency of PEI-mediated gene 
delivery, four different media were tested for their capacity to support transfection of 
suspension CHO DG44 cells. Three of these media were DMEM/F12 based (AZBL, 
mDMEM, and FEME) and the fourth was RPMI 1640. mDMEM contained no 
calcium and phosphate. AZBL is an industrial property medium based on DMEM/F12 
and is calcium-free. FEME is an enriched DMEM/F12 routinely used for the 
transfection of HEK 293 with CaPi (Girard et al., 2002). Of these four media, only 
RPMI 1640 has been reported to support serum-free transfection of mammalian cells 
when using PEI as a delivery vehicle (Schlaeger and Christensen, 1999). Following 
the transfection of cells with polyplexes formed between pEGFP-N1 and linear 25 
kDa PEI at ratios of 1:2 and 1:3 (w/w), the highest GFP expression was observed in 
RPMI 1640 medium (data not shown). For this reason, all further optimization 
experiments described below were performed in this medium.  
 
Next, the effect of cell density on the efficiency on PEI-mediated gene delivery was 
investigated. Cultures at a density of either 1 or 2∗106 cells/ml were transfected with 
complexes formed between pEGFP-N1 and linear 25 kDa PEI using a range of 
DNA:PEI ratios from 1:2 to 1:5 (w/w) and a range of final DNA concentrations from 
1.5 to 5.0 µg/ml. For most conditions tested, GFP expression was higher when cells 
were transfected at 2*106 cells/ml (Fig. 7). At this cell density the highest GFP levels 
were observed at DNA concentrations of 2.0 and 2.5 µg/ml and at a DNA:PEI ratio of 
1:2 (Fig. 7). These conditions also yielded the highest GFP expression levels when the 
cell density was 1∗106 cells/ml (Fig. 7). 
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Fig. 7. Transient GFP expression following transfection of CHO DG44 cells at different cell densities. 
The transfections were performed in RPMI 1640 medium with varying amounts of pEGFP-N1 and 
varying DNA:PEI ratios. GFP expression was measured at day 3 post-transfection. Each bar represents 
the average of 3 transfections. 
 
The effect of pH on complex formation was tested by varying the pH of Hepes or 
MES buffered 150 mM NaCl from 5 to 6.5. The transfections were done with 
DNA:PEI ratios of 1:2 and 1:3 and a final DNA concentration in the medium of 2.5 
µg/ml. No significant differences were observed in GFP expression under the 
conditions tested (Fig. 8). Based on these results, further optimization studies were 
performed with DNA-PEI complexes formed in 150 mM NaCl at pH 5.5. 
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Fig. 8. Transient GFP expression in CHO DG44 cells following transfection with polyplexes formed in 
150 mM NaCl. The polyplexes were formed between linear 25 kDa PEI and pEGFP-N1 at DNA:PEI 
ratios of 1:2 and 1:3 (w/w) in 150 mM NaCl with varying pH at a final DNA concentration in the 
medium of 2.5 µg/ml. The cell density was 2∗106 cells/ml in RPMI 1640 medium. The fluorescence 
was measured at three days post-transfection. Each bar represents the average of 3 independent 
experiments. 
 
In the experiments described above, the PEI and DNA were mixed and then incubated 
for 10 min at room temperature prior to addition to the cells as previously reported 
(Boussif et al. 1995). To determine if this was the optimal time for formation of the 
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DNA-PEI complex, the incubation time after mixing was varied from 5 to 20 min. The 
complexes between pEGFP-N1 and linear 25 kDa PEI were formed at two different 
DNA:PEI ratios and used to transfect CHO DG44 cells. At a DNA:PEI ratio of 1:2 
(w/w), the 5 and 10 min incubations yielded GFP levels that were about 15% higher 
than those observed following incubation times of 15 or 20 min (Fig. 9). Less 
variability in GFP levels was observed for the different incubation times when a 
DNA:PEI ratio of 1:3 (w/w) was used (Fig. 9). Based on these results, the time of 
incubation of the DNA:PEI mixture was maintained at 10 min for subsequent 
experiments. 
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Fig. 9. Effect of DNA:PEI complex incubation time on transfection efficiency. CHO cells at a density 
of 2∗106 cells/ml in RPMI 1640 medium were transfected with pEGFP-N1 at different DNA:PEI ratios 
in 150 mM NaCl with a final DNA concentration in the medium of 2.5 µg/ml. The DNA-PEI solution 
was allowed to incubate at room temperature for various times. GFP expression was measured at day 3 
post-transfection. Each bar represents the average of 3 independent transfections. 
 
Overall, the optimal conditions for PEI-mediated transfection of suspension-adapted 
CHO DG44 cells were found to be a DNA:PEI ratio of 1:2 (w/w) with a final DNA 
concentration in the culture medium of 2.5 µg/ml. The DNA and PEI were mixed in 
the presence of 150 mM NaCl and allowed to incubate for 10 min prior to addition to 
the culture. The CHO DG44 cells were grown in ProCHO5 CDM medium and then 
transferred at a cell density of 2∗106 cells/ml to RPMI 1640 containing 25 mM 
HEPES at pH 7.1. At 5 h post-transfection, the cells were diluted with one volume of 
ProCHO5 CDM medium. These conditions were used for the transfections for affinity 
cell sorting that are described in Chapter 5. 
 
4.2 Discussion 
CaPi is a gene transfer method routinely used for the transfection of adherent cultures 
of CHO cells. However, for the transfection of suspension cultures in serum-free 
medium this method presented two major drawbacks. First, the transfection efficiency 
in serum-free medium was very low (data not shown). Very large CaPi-DNA 
precipitates were observed in serum-free media, and it is thought that these complexes 
are responsible for the high level of cell death associated with CaPi-mediated 
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transfection under these conditions (data not shown). For CaPi-mediated transfection 
of suspension cultures of HEK 293 cells in serum-free medium, the optimal conditions 
include low DNA and calcium concentrations (Girard et al., 2001). The second 
drawback of CaPi transfection in CHO cells is the requirement for an osmotic shock. 
Osmotic shock was reported to increase protein expression after gene transfer in 
different cell lines with various transfection vehicles including DEAE-dextran 
(Malienou-Ngassa et al., 1990), polybrene (Chaney et al., 1986) and poly-L-ornithine 
(Dong et al., 1993). The exact function of the osmotic shock is not known, but Batard 
et al. reported no increase in plasmid uptake with an osmotic shock after CaPi 
transfection of CHO DG44 cells (Batard et al., 2001). Decrease of the cell volume by 
55% was observed after exposure of CHO DG44 cells to a 10% glycerol solution after 
CaPi transfection (Grosjean, 2003). Since CaPi-DNA complexes enter cells by 
endocytosis (Loyter et al., 1982) and the DNA amount in the cytosol does not change 
after exposure to glycerol (Batard et al., 2001), it is possible that the osmotic shock 
destabilizes endosomes following transfection, resulting in plasmid release into the 
cytoplasm (Grosjean, 2003).  
 
Of the different PEIs tested, the linear ones were better than the branched ones for 
promoting gene transfer under serum-free conditions in CHO DG44 cells. With the 
branched PEIs, reporter protein expression was only observed with the one having the 
highest molecular weight (10-25 kDa) as has been previously reported (Godbey et al., 
1999). Furthermore, the use of branched PEIs induced cell adherence in agitated 12-
well microtiter plates in the absence of serum. However, the reason for this effect on 
suspension cells is not known. The linear 25 kDa PEI was chosen for optimization 
studies since it yielded the highest levels of reporter protein expression while 
preventing cell aggregation and adherence. The most important parameters for 
optimum recombinant protein expression following PEI-mediated transfection were 
the DNA amount, the DNA:PEI ratio, and the cell density at the time of transfection. 
Parameters that were less critical included the incubation time of the PEI with the 
DNA prior to transfection and the pH of the NaCl solution used for PEI and DNA 
dilution. 
 
The three critical parameters identified in this study may be interrelated and may 
depend on the physical and chemical properties of PEI and DNA-PEI complexes. 
Complete DNA condensation was observed at a DNA:PEI ratio of 1:0.3 (w/w). This 
corresponds to an N/P ratio (PEI nitrogen to DNA phosphate) of 2 (Derouazi et al., 
2004). Nearly complete DNA condensation has also been found with branched 25 kDa 
PEI at an N/P ratio of 3 (Kunath et al., 2003). In our hands, however, successful gene 
transfer was only observed with N/P ratios of 6 or more, and the optimal N/P ratio for 
the transfection of CHO DG44 cells was found to be 13. Others have observed optimal 
N/P ratios of 9 to 13 for the transfection of various cell lines with PEI (Boussif et al., 
1995). The excess PEI needed to promote gene transfer relative to the amount needed 
to condense a quantity of DNA may indicate the importance of positive surface charge 
effects on the behavior of the transfection-active particle. For example, the overall 
charge of the complex may be important for release from the endosome following its 
uptake by the cell. PEI is thought to inhibit the acidification of endosomes by binding 
protons, leading to an influx of chloride ions into the endosome. This results in 
osmotic swelling and eventual rupture of the organelle (“proton sponge effect”) and 
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release of the complex into the cytoplasm (Boussif et al., 1995; Kichler et al., 2001). 
Alternatively, the surface charge of the DNA-PEI complex may play a role in its 
nuclear transport since it has been shown that the nucleus is accessible to DNA-PEI 
complexes without the breakdown of the nuclear membrane during mitosis (Brunner et 
al., 2002; Godbey et al., 1999; Pollard et al., 1998). In contrast, CaPi and liposome 
mediated transfections are known to be cell cycle dependant (Brunner et al., 2000; 
Grosjean et al. 2002). Thirdly, the excess of PEI may be important in determining the 
size and/or shape of the transfection-active particle. Particle size has been shown to be 
influenced by the DNA:PEI ratio, with the size decreasing as the ratio of PEI to DNA 
is increased (Dunlap et al., 1997). In turn, smaller particles have been shown to be less 
efficient for transfection (Kircheis et al., 2001). Finally, PEI has been shown to be 
cytotoxic to endothelial cells and L929 fibroblasts (Godbey and Mikos, 2001; Kunath 
et al., 2003). This may be due to damage to the plasma membrane following exposure 
to PEI (Choksakulnimitr et al., 1995). In support of these findings, we consistently 
observed higher recombinant protein yields following transfections with a DNA:PEI 
ratio of 1:2 than with a ratio of 1:3 or higher (cf. Fig. 6 and Fig. 7). These results may 
be explained by an increase in cell death following transfection with the higher 
amounts of PEI. Each of these properties of PEI and DNA-PEI complexes may 
therefore pose constraints on the critical parameters for PEI-mediated transfection of 
cells in serum-free medium. 
 
The amount of plasmid DNA taken up by CHO cells following transfection with PEI 
was not determined. It has been shown, however, that after CaPi transfection of CHO 
DG44 cells about 5% of the plasmid DNA is taken up by about half the cells in the 
population. This corresponds to an uptake of about 10’000 to 50’000 copies of 
plasmid per cell (Batard et al., 2001). Although an osmotic shock following 
transfection substantially increases recombinant protein expression (Fig. 4), this step 
does not result in higher plasmid uptake by the cells (Batard et al., 2001). Following 
CaPi-mediated transfection with the GFP gene, GFP-positive cells were detected as 
early as 6 to 8 h post-transfection (Grosjean, 2003). Interestingly, most, if not all, of 
these cells underwent cell division prior to expressing GFP (Grosjean, 2003). For 
CHO cells transfected with pEGFP-N1 in the presence of PEI, GFP-positive cells were 
observed at 4 h post-transfection (data not shown). Considering that the GFP needs a 
maturation time of 60 minutes before becoming fluorescent (Tsien, 1998), delivery of 
the plasmid DNA into the nucleus must have occurred less than three hours after 
transfection. However, it is not known if GFP-positive cells underwent mitosis 
between transfection and the onset of GFP expression. Similarly, Godbey et al. found 
DNA-PEI complexes in cells at 2 to 3 h post-transfection and in nuclei at 3.5 to 4.5 h 
post-transfection (Godbey et al., 1999). These results suggest that the mechanisms of 
gene transfer by CaPi and PEI are distinct.  
  
In conclusion, we optimized transient gene expression in suspension cultures of CHO 
DG44 cells using linear 25 kDa PEI in serum-free medium. CaPi-mediated 
transfection was not considered useful for DNA transfer to suspension cultures of 
CHO DG44 cells in serum-free medium due to the requirement for two centrifugation 
steps and to the observation of low recombinant protein expression levels. 
Furthermore, liposomes were too expensive to be considered for large-scale 
applications. The optimal transfection conditions with 25 kDa PEI were a cell density 
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of 2x106 cells/ml in RPMI 1640 medium with a DNA:PEI ratio of 1:2 (w/w) and a 
final DNA concentration in the culture medium of 2.5 µg/ml. The cells were diluted 
five h post-transfection with one volume of serum-free ProCHO5 medium. The 
method was found to be scalable to 20 l (Derouazi et al., 2004). Transfection using 
liner 25 kDa PEI is cost-efficient and suitable for serum-free operations. It offers high 
transfection efficiency with a simple and reproducible procedure. These features make 
PEI a more suitable transfection vehicle than liposomes or CaPi for large-scale 
transient gene expression with CHO DG44 cells.  
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5. Affinity Cell Sorting 
This chapter describes studies to establish a novel cell identification and selection 
system based on the expression of a FLAG-tagged mouse serotonin 5-HT3 receptor as 
a cell surface marker for the affinity-based capture of cells overproducing a co-
expressed recombinant protein. Here the feasibility of this approach was investigated 
with transiently transfected CHO DG44 cells in suspension culture. Cells co-
expressing the epitope-tagged surface protein and a model recombinant protein were 
sorted from cells lacking the 5-HT3 receptor using anti-FLAG antibody-coated beads. 
Two different anti-FLAG monoclonal antibodies were evaluated. The binding to the 
FLAG epitope is Ca2+ dependant for M1 anti-FLAG antibody and not for M2 
antibody. Different resins and cell-binding media were evaluated to optimize the 
method. A bicistronic vector was used to co-express the 5-HT3 receptor and a model 
recombinant protein (GFP) 
 
5.1  Results 
5.1.1 Co-expression of the 5-HT3 receptor and model recombinant proteins 
5.1.1.1 Effect of the 5-HT3 receptor on model recombinant protein expression 
Suspension-adapted CHO DG44 cells were co-transfected with varying amounts of 
p5-HT3 (0-10% of the total DNA) and pEGFP-N1 (90-100% of the total DNA) to 
determine if the expression of the receptor had a negative impact on the expression of 
the model recombinant protein (GFP). The cells were transfected with PEI using the 
TubeSpin method, and GFP expression was quantified at 48 h post-transfection. By 
increasing the amount of p5-HT3 the level of GFP expression was reduced (Fig. 10A). 
Similar results were observed when p5-HT3 was replaced by varying amounts of a 1:1 
(w/w) ratio of pKML and pKMH (0-10% of the total DNA) expressing the IgG light 
and heavy chain genes, respectively (Fig. 10A). When p5-HT3 (0-10% of the total 
DNA) was co-transfected with varying amounts of a 1:1 ration of pKML and pKMH 
(90-100% of the total DNA), a three fold decrease in IgG expression was observed as 
compared its level in the absence of p5-HT3 at 48 h post-transfection (Fig. 10B).  
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Fig. 10. (A) GFP expression in CHO DG44 cells co-transfected with varying amounts of pEGFP-N1 
and either p5-HT3 (dark grey) or a 1:1 mixture of pKMH and pKML (light grey). The cells were lysed 
and GFP expression was measured by fluorometry at 48 h post-transfection. The level of GFP 
expression in the presence of 100% pEGFP-N1 is shown in black. (B) IgG expression in CHO DG44 
cells co-transfected with varying amounts of p5-HT3 and a 1:1 mixture of pKMH and pKML. The 
concentration of IgG in the culture medium was determined by ELISA at 48 h post-transfection.  
 
In the experiments described in Fig. 10, 5-HT3 expression was driven by the EF1-α 
promoter, while the GFP gene and the IgG light and heavy chain genes were under the 
control of the hCMV and mCMV immediate early promoters, respectively. In order to 
exclude the possibility that the effect of 5-HT3 on model recombinant protein 
expression was promoter-dependent, the experiments described in Fig. 10 were 
repeated with each reporter gene under the control of the EF1-α promoter in pEAK8. 
CHO DG44 cells were co-transfected with pEAK8-EGFP and p5-HT3. A decrease in 
GFP expression compared to the control (100% pEAK8-EGFP) was only observed in 
the presence of the highest level of p5-HT3 (Fig. 11A). Similar results were observed 
when p5-HT3 was replaced with a 3:7 mix of the IgG light and heavy chain vectors 
pLH1 and pLH2 (Fig. 11A). In contrast, up to a 30% decrease in IgG expression was 
seen in CHO DG44 cells co-transfected with pLH1 and pLH2 and either p5-HT3 or 
pEAK8-EGFP (Fig. 11B). Based on these results, subsequent experiments were 
performed with transgenes expressed from the EF1-α promoter. 
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Fig. 11. (A) GFP expression in CHO DG44 cells co-transfected with varying amounts of pEAK8-EGFP 
and either p5-HT3 (dark grey) or a 3:7 mixture of pLH1 and pLH2 (light grey). The cells were lysed and 
GFP was measured by fluorometry at 48 h post-transfection. The level of GFP expression in the 
presence of 100% pEGFP-N1 is shown in black. (B) IgG expression in CHO DG44 cells co-transfected 
with a combination of pLH1 and pLH2 and either p5-HT3 (dark grey) or pEAK8-EGFP (light grey). 
The concentration of IgG in the culture medium was determined at 48 h post-transfection. The level of 
GFP expression in the presence of 100% pEGFP-N1 is shown in black. 
 
5.1.1.2 Co-expression of the 5-HT3 receptor and GFP in the same cell 
The next question to address was whether or not 5-HT3 and the target recombinant 
protein were expressed in the same cell at similar expression levels. Suspension-
adapted CHO DG44 cells were co-transfected with a 1:1 (w/w) mixture of p5-HT3 and 
pEAK8-EGFP. At 48 h post-transfection, the cells were stained with GR-Cy5, a 
fluorescent 5-HT3-specific antagonist (Vallotton et al., 2001) and analyzed using laser 
scanning confocal microscopy (Fig. 12). No clear correlation between GFP expression 
and 5-HT3 expression was observed (Fig. 12). The cells positive for GFP were also 
expressing the 5-HT3 receptor. However, cells with high surface receptor expression 
were not necessarily expressing GFP at a high level (Fig. 12).  
 
To ensure that the 5-HT3 receptor and the recombinant protein were expressed in the 
same cell at similar expression level, a bicistronic vector p5HT3-EGFP was 
constructed with the genes for the 5-HT3 receptor and GFP. The bicistronic mRNA 
was expressed from the human EF1-α promoter with the receptor gene located in the 
5’ position and the GFP gene in the 3’ position of the bicistronic mRNA. The latter 
was translated by ribosome binding to an internal ribosome binding site (IRES) 
located between the two open reading frames (Moser et al., 2000). CHO DG44 cells in 
suspension were transfected with p5HT3-EGFP using PEI. At 48 h post-transfection 
the cells expressing the 5-HT3 receptor were stained with GR-Cy5 (Vallotton et al., 
2001). As shown in Fig. 13 the expression levels of the 5-HT3 receptor and GFP 
correlated well in most cells. Cells having a high level of one protein also had a high 
level of the second protein (Fig. 13).  
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Fig. 12. Suspension-adapted CHO DG44 cells were co-transfected with 50% p5-HT3 and 50% pEAK8-
GFP using PEI as a delivery vehicle. At 48 h post-transfection the presence of the 5-HT3 receptor was 
determined by confocal microscopy after staining with GR-Cy5 The excitation and emission 
wavelengths were 649 nm and 670 nm, respectively (upper left panel). The presence of GFP was also 
determined by confocal microscopy using excitation and emission wavelengths of 489 nm and 508 nm, 
respectively (upper right panel). The overlay of fluorescence from GFP and 5-HT3 is shown in the 
lower right panel, and the bright field acquisition in the lower left panel. 
 
Fig. 13. Suspension-adapted CHO DG44 cells were transfected with p5HT3-EGFP using PEI. At 48 h 
post-transfection the presence of the 5-HT3 receptor was determined using confocal microscopy after 
staining with GR-Cy5. The excitation and emission wavelengths were 649 nm and 670 nm, respectively 
(upper left panel). The presence of GFP was also determined by confocal microscopy using excitation 
and emission wavelengths of 489 nm and 508 nm, respectively (upper right panel). The overlay of GFP 
and 5-HT3 is shown in the lower right panel, and the brightfield image is shown in the lower left panel. 
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5.1.2 Selection of resin for binding cells expressing the 5-HT3 receptor 
Several resins were tested for their ability to be coated with the anti-FLAG antibody 
and to bind cells expressing the FLAG-tagged 5-HT3 receptor. The properties of these 
resins are summarized in Table 6. Streamline particles are commonly used for protein 
purification. They have a diameter between 80 and 165 µm and contain a metal core 
which allows rapid separation by sedimentation (Table 6). Dynabeads are used for 
small scale IgG purification and for the immunoprecipitation of proteins. They are 30-
80 fold smaller than Streamline particles and are magnetized (Table 6). The 6 MB 
resin is used for cell separation by affinity chromatography. Specific cells such as 
lymphocyte T or B (Chess et al., 1975; Schrempf-Decker et al., 1980) have been 
enriched on 6 MB column. The size of the beads ranges from 250 to 400 µm (Table 6). 
 
Table 6. Different resins used for affinity cell sorting. 
 Streamline Dynabeads 6 MB 
Composition 4% Agarose Polystyrene Sepharose 
Characteristic Metal core Magnetized Macrobeads 
Capacity 50 mg IgG/ml medium 
250 µg IgG/ml 
beads 
5 mg IgG/ml bed 
volume 
Coating Protein A Protein G Protein A 
Size 80-165 µm 2.8 µm ± 0.2 µm 250-400 µm 
Use Batch Batch Column 
 
Several attempts were made using a batch approach to recover cells expressing the 5-
HT3 receptor using Streamline beads coated with either the anti-FLAG M1 or M2 
antibody. The number of cells was varied from 2 to 8∗106 cells/ml, and the incubation 
time was varied from 30 min to 2 h. In all cases, there was a low level of selection of 
cells expressing 5-HT3. Less than 1% of the cells expressing the receptor bound to the 
resin (data not shown). In Fig. 14 a CHO DG44 cell transfected with p5HT3 is shown 
binding to a Streamline bead coated with the anti-FLAG M2 monoclonal antibody 
conjugated with Cy3. The receptor was stained with GR-FITC (Vallotton et al., 2001). 
A yellow overlay of the green fluorescence from the receptor and the red fluorescence 
from the anti-FLAG antibody was visible at the surface between the two components 
(Fig. 14). 
 
The 6 MB column was first tested with cells which were not expressing the surface 
receptor. Initially, 5∗106 CHO DG44 cells were passed through the column in a 
volume of 300 µl. Then the cells were eluted by addition of 20 ml DMEM/F12 
medium in 1 ml increments. However, 20% of the cells were retained on the column. 
Since removal of cells from the column was problematic, this resin was not considered 
for affinity cell sorting experiments. 
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Finally, CHO DG44 cells were transfected with the bicistronic expression vector 
p5HT3-EGFP. At 48 h post-transfection the cells were incubated for 30 minutes with 
Dynabeads coated with the anti-FLAG M2 antibody conjugated with Cy3. In general, 
80% of the cells expressing high levels of GFP and 5-HT3 were bound to beads (Fig. 
15). Dynabeads were superior to the other resins for binding CHO DG44 cells 
expressing the cell surface receptor and were thus chosen for further characterization. 
 
 
Fig. 14. Affinity cell sorting with Streamline beads visualized by laser-scanning confocal microscopy. 
CHO DG44 cell were transfected with p5HT3. At 48 h post-transfection the cells were labeled with a 
FITC-conjugated ligand for the receptor (GR-FITC) with excitation and emission wavelengths of 488 
and 510 nm, respectively. The cells were then mixed with Streamline beads coated with anti-FLAG M2 
monoclonal antibody that was conjugated with Cy3 having emission and excitation wavelengths of 543 
and 560 nm, respectively. The scale bar equals 5 µm. 
 
 
Fig. 15. Affinity cell sorting with Dynabeads visualized by laser-scanning confocal microscopy. CHO 
DG44 cells were transfected with p5HT3-EGFP. At 48 h post-transfection the cells were mixed with 
Dynabeads coated with anti-FLAG M2 monoclonal antibody conjugated with Cy3 having emission and 
excitation wavelengths of 543 and 560 n, respectively. The scale bar equals 10 µm. 
 
5.1.3 Selection of medium for affinity cell sorting 
For the binding of the cells expressing the surface receptor to Dynabeads coated with 
the M1 antibody, different cell culture media were tested (Table 2). In order to have 
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similar conditions as for protein purification, all the media were supplemented with 
150 mM NaCl, 50 mM Tris, and 10 mM CaCl2 and the pH was adjusted to 7. The 
beginning and final Na+ and Ca2+ concentrations and osmolality of each medium are 
reported in Table 7.  
 
 
Table 7. Media for affinity cell sorting with Dynabeads coated with anti-FLAG M1 antibody. 
 Initial [mM] Final [mM] Osmolality 
 Na+ Ca++ Na+ Ca++ Initial Final 
DMEM/F12 131 0.83 281 10.83 296 585 
ProCHO5 108 1.12 258 11.12 322 633 
mJRH 133 0 283 10 311 631 
Buffer 150 10 150 10 409 409 
 
Suspension-adapted CHO DG44 cells were co-transfected with a 1:1 (w/w) mix of 
p5HT3 and pEAK8-EGFP. The Dynabeads were equilibrated in different media and 
coated with the anti-FLAG M1 monoclonal antibody. At 48 h post-transfection the 
cells were mixed with Dynabeads in the different media for 30 minutes. After several 
wash steps only a few cells were bound to the beads (data not shown). The best 
medium was DMEM/F12 with about 10% of the GFP-positive cells bound to the 
Dynabeads (data not shown). For the four binding media, no negative effect on cell 
viability was observed despite the exposure to conditions of high osmolality. Indeed, 
after addition of NaCl, all the culture media showed almost a two fold increase in 
osmolality (Table 7). Varying the number of cells mixed with the beads from 2 to 8 
∗106, the incubation time from 30 minutes to 2 h, and the volume from 0.8 to 2 ml did 
not result in higher binding efficiencies in the four different media.  
 
5.1.4 Affinity cell sorting 
To test the efficiency and feasibility of affinity cell sorting, suspension-adapted CHO 
DG44 cells were transfected with the bicistronic vector p5HT3-EGFP. AT 48 h post-
transfection about 50% of the cells were positive for GFP expression as determined by 
flow cytometry (data not shown). Then 2∗106 cells (0.8% PCV) were incubated for 30 
min in ProCHO 5 medium with 10 µl Dynabeads coated with the anti-FLAG M2 
antibody. After washing the beads in the same medium, the bound cells and those in 
the flowthrough were analyzed by confocal microscopy. Almost all the cells 
expressing GFP were bound to the beads (Fig. 16). Only cells weakly expressing GFP 
and GFP-negative cells were found in the flowthrough fraction (Fig. 16). As 
determined by mini-PCV, 60% of the biomass from the transfected population was 
present in the flowthrough and 40% was bound to the beads. Since 50% of the 
 
Results and Discussion 
63 
transfected cells were GFP-positive, an 80% enrichment of cells expressing GFP and 
the 5-HT3 receptor was achieved in 30 minutes. 
 
  
Fig. 16. Affinity cell sorting visualized by laser-scanning confocal microscopy. Suspension-adapted 
CHO DG44 cells were transfected with p5HT3-EGFP. At two days post-transfection the cells were 
mixed with Dynabeads coated with anti-FLAG M2 monoclonal antibody conjugated with Cy3 with 
excitation and emission wavelengths of 543 and 560 nm, respectively. Most of the cells expressing GFP 
were recovered with the beads (left) while most of the cells which expressed little or no GFP were 
present in the unbound fraction (right). The scale bar equals 10 µm. 
 
5.2 Discussion 
The FLAG-tagged 5-HT3 surface receptor was used to capture cells in a population of 
transfected cells that co-expressed a recombinant protein. This novel method allowed 
the enrichment of cell populations that expressed the protein of interest. One 
advantage of this technique is the ability to recover positive cells following 
transfection of a serum-free suspension culture. This approach is similar to 
fluorescence activated cell sorting (FACS), but affinity cell sorting can be optimized 
for large-scale application and so surpasses the screening capacity of FACS.  
 
It was necessary to demonstrate that expression of the 5-HT3 receptor did not have an 
inhibitory effect on the co-expression of the model recombinant protein. Co-
expression of 5-HT3 did result in a substantial decrease in either GFP or IgG 
expression when the reporter genes were expressed from either the hCMV promoter or 
the hybrid mCMV/EF1-α promoter but not when they were expressed from the EF1-α 
promoter. These results suggest that the negative effect of 5-HT3 expression can be 
avoided by utilizing the EF1-α promoter for expression of the receptor and the model 
recombinant protein from separate plasmids. We also demonstrated the possibility of 
co-expression of the receptor and GFP from a bicistronic mRNA. It should be noted 
that expression of GFP also interfered with the expression of IgG in co-transfected 
HEK 293 cells (Pick et al., 2002). It is not known if the interference is due to 
transcriptional or post-transcriptional effects, but either is possible. 
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For our application, we needed to have similar expression levels of the recombinant 
protein and the 5-HT3 receptor. We decided to use GFP as a model recombinant 
protein since its analysis was fast, simple, and non-invasive, and its expression could 
be used to easily monitor cell sorting. After co-transfection of the GFP and 5-HT3 
genes on separate plasmids, most of the cells expressing one protein were also positive 
for the second one (Fig. 12). However, the expression levels were not always the same 
for the two proteins. Several cells were low producers of GFP and high producers of 
5-HT3 (Fig. 12). The opposite pattern was also seen. With such a variation in the 
expression levels, we decided not consider co-transfection for our experiment. A 
bicistronic vector was expected to be a better alternative for the study of affinity cell 
sorting. The co-expression of intracellular luciferase and secreted alkaline phosphatase 
from a bicistronic vector has been shown to be coordinated (Dirks et al., 1993), and 
the application of bicistronic vectors was even extended to the establishment of stable 
cell lines with the co-expression of a resistance marker and the protein of interest 
(Rees et al., 1996). By using a bicistronic vector we achieved a good correlation 
between the expression of GFP and that of 5-HT3 (Fig. 13). 
 
The conditions for the binding of cells expressing FLAG-tagged receptor to a resin 
were difficult to determine. However some points were defined such as the resin of 
choice. Streamline beads were shown to be inadequate for our procedure. They were 
developed for expanded bed protein purification rather than for cell separation 
(Amersham website). It was reported in the late 1960s that less than 1% of the 
derivatization positions of polystyrene beads were on the bead surface (Fig. 17) 
(Merrifield and Littau, 1968). It is likely that the pores of Streamline beads are smaller 
than the diameter of mammalian cells. Therefore, the number of derivatization 
positions available for cell binding may have been too low, making it unsuitable for 
our purposes. 6 MB beads have been used for the enrichment of lymphocytes from 
blood (Ghetie et al., 1978). Lymphocytes have a diameter between 7 and 15 µm and 
most blood cell have diameters below 10 µm. Since CHO cells have a mean diameter 
of 15 µm, it is possible that the cells were not able to go through the column easily. 
The most promising results were obtained with the Dynabeads. The beads are typically 
used for immunomagnetic cell selection either to enrich for cells of interest (Anderson 
et al., 1994) or to deplete unwanted cells (Busch et al., 1994). 
 
 
Fig. 17. Autoradiography of a cross section through a polystyrene bead (Merrifield and Littau, 1968). 
The majority of the peptides are located inside the beads and less than 1% are on the bead surface. 
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Affinity cell sorting was successful performed with the M2 anti-FLAG antibody. 
About 80% of the GFP-positive cells were enriched from the population of transfected 
cells within 30 minutes. Similarly, HEK 293 and SK-BR-3 cells expressing a hapten-
binding single-chain antibody (sFv) on the cell surface were selected with phOx 
coated magnetic beads (Chesnut et al., 1996). The sFv was directed against the hapten 
4-ethoxymethylene-2-phenyl-2-oxazolin-5-one (phOx). All of the selected cells also 
expressed the reporter protein (Chesnut et al., 1996). Schlatter and co-workers 
achieved a 6-8 fold enrichment of CHO cells expressing the hapten-biding sFv, the 
SEAP and the human cyclindependant kinase inhibitor p27 using the same system 
(Schlatter et al., 2001). However the removal of the phOx-coated magnetic beads 
could be achieved only with an excess of free phOx (Schlatter et al., 2001).  
  
The isolation of cells fraction give to M1 antibody one main advantage compared to 
M2 anti-FLAG antibody. The FLAG-tagged membrane protein was expected to bind 
to the anti-FLAG M1 antibody in the presence of a bivalent metal cation, preferably 
Ca+ (Einhauer and Jungbauer, 2001). Therefore during elution we could theoretically 
fractionate the cell population by varying the concentration of the chelating agent (e.g. 
EGTA). With low EGTA concentration the low producers would elute first then with 
increasing the EGTA concentration we could isolate population of high producers.  
 
In conclusion, we showed that the relative level of fluorescence for the 5-HT3 receptor 
and GFP was similar in most cells after transfection of a bicistronic vector. As a proof 
of principle the epitope-tagged 5-HT3 receptor served as cell surface target to allow 
the trapping of transiently transfected cells from polyclonal cell suspensions using 
antibody-coated magnetic beads. Affinity trapping of transfected cells with subsequent 
antibiotic selection for cells expressing high levels of the recombinant protein is 
expected to be an attractive procedure for the rapid production of recombinant cells 
from suspension cultures.  
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6. Gene transfer into single cells 
As an alternative approach to transfection of large mammalian cell populations, the 
direct delivery of DNA by microinjection into either the cytoplasm or the nucleus of 
individual cells was investigated. The purpose of this study was to optimize the 
microinjection conditions into adherent CHO DG44 cells to evaluate the potential of 
this gene transfer method for the establishment of recombinant cell lines. To be able to 
quantify the amount of DNA being delivered into cells, it was necessary to estimate 
the volume of injection. This was achieved using a fluoresceine labeled dextran 
(FITC-dextran). This polymer has a molecular weight which prevents it from freely 
diffusing through nuclear pores, allowing visualization of the subcellular localization 
of the injection using fluorescence microscopy. Then several critical parameters for 
microinjection including the DNA concentration and the injection pressure were 
evaluated based on the use of a fluorescent reporter protein.  
 
6.1 Results 
6.1.1 Quantification of the injection volume 
The injection volume is a function of several parameters including the viscosities of 
the injected solution and the recipient cellular compartment as well as the injection 
time and pressure. Since the viscosity of the cell cannot be directly controlled and the 
injection time was kept constant, the volume and thus the number of plasmid copies 
delivered to each cell was varied by altering either the DNA concentration or the 
injection pressure. To estimate the injection volume, a solution of 0.5% FITC-dextran 
was injected into cells with varying injection pressures, and the fluorescence was 
quantified with LabView software. 
6.1.1.1 Establishment of the standard fluorescence/volume 
The standard fluorescence per volume for the FITC-dextran solution was quantified 
using fluorescence measurements based on two dimensional pixel intensity analysis on 
still images acquired by LabVIEW IMAQ Vision software. Images of fixed volumes 
of the FITC-dextran solution were acquired using the same settings, magnification, 
and exposure time that were later used for the images of the microinjected cells. To 
define the measured volume, the surface was determined using the pixel number in 
LabVIEW. To maintain a constant height, beads of a known size were used. FITC-
dextran was mixed with 6 µm calibrated beads and 4 µl droplets were distributed on 
the glass slide. A coverslip was pressed on the glass slide to define a constant height. 
The beads were then visualized using Axiovision software to ensure that they were not 
deformed by the pressure. With this approach the height was kept constant at 6 µm for 
the image acquisition of the solutions having different FITC-dextran concentrations. 
With this approach a standard curve of fluorescence per unit volume was established 
and used for injection volume quantification (Fig. 18). The FITC-dextran 
concentration used for the establishment of this curve ranged from 0.8 to 5 g/l. 
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Fig. 18. Standard curve for FITC-dextran fluorescence. The formula defining the curve is shown inside 
the graph. 
 
6.1.1.2 Quantification of the injection volume 
The injection volume was estimated by microinjecting adherent CHO DG44 cells in 
DMEM/F12 medium with a solution containing 0.5% FITC-dextran. The fluorescent 
cells were imaged 10-20 minutes after injection, and the resulting intracellular 
fluorescence was measured based on linear regression analysis of the standard curve. 
Image acquisition took place after the exchange of the culture medium with PBS to 
avoid interference with medium autofluorescence and with FITC-dextran leakage from 
the injection capillary. The injection pressures were varied from 70 to 100 hPa in 10 
hPa steps, and the injection time was kept constant at 0.1 s. The fluorescence intensity 
of each injected cell was then quantified. After injection into the nucleus a weak 
fluorescence was usually observed in the cytoplasm (Fig. 19A, B). However, the level 
of cytoplasmic fluorescence varied from cell to cell and was only visible on the 
images taken with high sensitivity settings. It was not visible in the microscope 
without amplification of the signal. For imaging, a high exposure time (2000 ms) was 
used in order to obtain visible fluorescence for all the cells, especially those injected 
with small volumes. When higher injection pressures were used for nuclear injection, 
damage to the nuclear membrane was occasionally observed. In these cases, a 
homogenous distribution of the fluorescence throughout the cell was seen (Fig. 19B). 
When the nucleus was not damaged, a clear difference in fluorescence intensity 
between the nucleus and the cytoplasm was observed, indicating that the 
microinjection was successful (Fig. 19A, B). For determination of the nuclear 
injection volume, only the fluorescence in the nucleus was quantified. Furthermore, 
the cells with damaged nuclear membranes were not taken into consideration. For cells 
injected in the cytoplasm the nucleus usually remained nonfluorescent (Fig. 19C, D). 
A successful injection could be predicted under phase contrast by the presence of a 
stream with a brighter contrast than the cell itself. After microinjection into the 
cytoplasm, a weak wave throughout the cell was visible. An increase in the volume of 
either the nucleus or the cytoplasm due to microinjection usually indicated that the 
cells would die or at least would not be able to divide. In general dark areas in the cells 
were difficult to inject, often resulting in an obstruction of the capillary. 
 
 
Results and Discussion 
69 
 
Fig. 19. Cells injected with FITC-dextran in the nucleus (A and B) or the cytoplasm (C and D). 
Injection pressure was either 70 hPa (A and C) or 100 hPa (B and D). Images were acquired 
immediately after microinjection using identical exposure times. Scale bar is equivalent to 20 µm and is 
the same for all the images.  
 
Over the range of injection pressures tested (70-100 hPa) the average injection volume 
was found to be 180 fl for nuclear injection and 180 to 350 fl for cytoplasmic injection 
(Fig. 20). The bars in Fig. 20 represent the average values of the quantified volumes. 
The upper error bars represent the value for the upper quartile (the data value located 
halfway between the median and the largest value) and the lower error bars represent 
the value for the lower quartile (the data value located halfway between the median 
and the smallest data value). Thus, the injection volumes of 50% of the cells were 
contained between the two error bars. For injection into the cytoplasm, an increase in 
the injection pressure resulted in higher injection volumes, but no major variation of 
injection volume with increasing pressure was observed for microinjection into the 
nucleus. At 100 hPa the homogenous distribution of the FITC-dextran throughout the 
cell was observed frequently following nuclear injection. This indicated probable 
damage to the nuclear membrane resulting in a reduction of the upper quartile of 
injection volumes (Fig. 20). For nuclear microinjection 200 fl corresponded to 34% of 
the total nuclear volume based on a nuclear diameter of 10 µm and a nuclear volume 
of 520 fl. For cytoplasmic microinjection volumes corresponding to 15% and 30% of 
the cytoplasmic volume were injected at low (70 hPa) and high pressure (100 hPa), 
respectively. 
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Fig. 20. Quantification of injection volume by fluorescence measurement after microinjection of FITC-
dextran into the nucleus or the cytoplasm. The injection time was kept constant at 0.1 s and the injection 
pressure was varied from 70 to 100 hPa. Each bar represents the average of 20-50 injected cells. 
Between the upper and lower error bars are the fluorescence values for 50% of the injected cells. 
 
The microinjections with plasmid DNA described below were performed with pMYK-
EGFP-puro (5’429 bp). For each plasmid DNA concentration and estimated injection 
volume, the plasmid copy number was calculated (Table 8). The number of plasmid 
molecules expected to be delivered into nuclei (injection volume of 180 fl) ranged 
from 400 for the lowest DNA concentration up to 7’000 for a DNA concentration of 
30 µg/ml. For cytoplasmic microinjection, the injection pressure and the DNA 
concentration influenced the number of copies expected to be delivered. The lowest 
value was 440 copies for an injection volume of 180 fl (70 hPa) and a DNA 
concentration of 1.8 µg/ml and the highest value was 13’700 copies for an injection 
volume of 350 fl (100 hPa) and a DNA concentration of 30 µg/ml. 
 
Table 8. Calculated plasmid copy number based on the estimated injection volume and the plasmid 
DNA concentration. 
DNA [µg/ml] Injection volume [fl] 
 180 240 300 350 
30 7’000 9’400 11’700 13’700 
15 3’500 4’700 5’800 6’800 
7.5 1’700 2’350 3’100 3’400 
3.7 880 1’180 1’540 1’700 
1.8 440 590 770 860 
 
 
6.1.2 Effect of injection pressure and DNA concentration on gene transfer 
  efficiency by microinjection 
 
The effect of DNA concentration on the efficiency of gene transfer by microinjection 
was determined by injecting adherent CHO DG44 cells in the cytoplasm or nucleus 
with pMYK-EGFP-puro at a range of DNA concentrations from 1.8 µg/ml to 30 
 
Results and Discussion 
71 
µg/ml. The injection pressure was also varied from 70 to 100 hPa in increments of 10 
hPa. At pressures lower than 70 hPa, little reporter gene expression was observed (data 
not shown) and at pressures higher than 100 hPa most of the cells were damaged by 
the injection. Cells were always injected with an injection time of 0.1 sec. One day 
after injection, the efficiency of gene transfer was determined as the percentage of 
GFP-positive cells in the population of injected cells which survived the procedure.  
 
For cytoplasmic microinjection the highest efficiency of gene transfer was observed at 
70-90 hPa at a DNA concentration of 30 µg/ml (Fig. 21A). At this concentration, an 
increase in the injection pressure to 100 hPa resulted in a reduction of the percentage 
of GFP-positive cells. For DNA concentrations of 7.5 and 15 µg/ml, about 70-80% of 
the microinjected cells expressed GFP following microinjection at 70, 80 or 90 hPa 
(Fig. 21A). Further decreases in the DNA concentration generally resulted in a lower 
percentage of GFP-positive cells. By visual inspection of the cells at 1 day post-
injection, it was evident that the decrease in GFP-positive cells at the lower DNA 
concentrations was accompanied by a decrease in GFP expression (Fig. 22A-C). After 
microinjection of cells with DNA concentrations of 7.5 and 15 µg/ml, most of the 
positive cells were expressing GFP at a high level (Fig. 22A, B). After microinjection 
with DNA at a concentration of 3.7 µg/ml, only a few cells expressed GFP and many 
of these showed only weak fluorescence (Fig. 22C). In general, low efficiencies of 
gene transfer were observed at 100 hPa injection pressure of (4A). 
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Fig. 21. Cytoplasmic (A) and nuclear microinjection (B) of CHO DG44 cells with pMYK-EGFP-puro. 
The cells were microinjected at injection pressures ranging from 70 to 100 hPa and at DNA 
concentrations ranging from 1.8 to 30 µg/ml. The number of injected cells surviving microinjection and 
expressing GFP was determined at one day post-microinjection. Each bar represents the average 
number of positive cells from a total of 50-100 injected cells from three to four independent 
experiments.  
 
In contrast to the results obtained by cytoplasmic microinjection, the highest DNA 
concentrations (15 and 30 µg/ml) resulted in the lowest gene transfer efficiencies 
(about 20% GFP-positive cells) for nuclear microinjection (Fig. 21B). GFP-positive 
cells resulting from injection at the highest DNA concentrations did not retain the 
typical morphology of CHO DG44 cells and they did not divide (Fig. 22D). By 
reducing the DNA concentration to 7.5 µg/ml, the efficiency of gene transfer increased 
to 60% (Fig. 21B), and the GFP-positive cells retained a more typical morphology 
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(Fig. 22E). However, microinjection at this DNA concentration had a negative effect 
on the cell cycle. Many GFP-positive cells started to divide but were blocked in 
mitosis as judged by the rounding of the cells and the loss of adherence. GFP-positive 
cells resulting from microinjection at a DNA concentration of 3.7 µg/ml were usually 
able to divide. For nuclear microinjection the highest percentage of GFP-positive cells 
(nearly 90%) was obtained with an injection pressure of 70 hPa at a DNA 
concentration of 3.7 µg/ml DNA (Fig. 21B). GFP expression was detected as early as 
2 h post-injection and was higher than that observed following microinjection into the 
cytoplasm under any conditions tested (data not shown). At injection pressures higher 
than 70 hPa, the percentage of GFP-positive cells was reduced to 60% at a DNA 
concentration of 3.7 µg/ml (Fig. 21B). For the other DNA concentrations tested, 
varying the injection pressure in the range of 70-100 hPa did not significantly alter the 
gene transfer efficiency (Fig. 21B). 
 
 
Fig. 22. GFP expression in CHO DG44 cells after microinjection into the cytoplasm (A-C) or the 
nucleus (D-F) with varying concentrations of pMYK-EGFP-puro. The cells were injected with DNA at 
15 µg/ml (A,D), 7.5 µg/ml (B,E), or 3.7 µg/ml (C,F). The injection pressure was 70 hPa and the 
injection time was 0.1 s. The exposure time for image acquisition was kept constant at 300 msec. The 
scale bar is equal to 20 µm and is the same for all the images. 
 
6.1.3 Living cell microscopy 
Different time lapse image acquisitions were performed following co-microinjection 
of CHO DG44 cells with 0.5% FITC-dextran and pDsRed-Express encoding the red 
fluorescent protein (RFP). Thus, the localization of the injection site and the 
estimation of the injection volume were performed in parallel with the real-time 
observation of RFP expression. 
  
Initially, four cells were injected in the nucleus and one in the cytoplasm at a DNA 
concentration of 15 µg/ml (Fig. 23, Exp. no. 1). The cytoplasmic injection resulted in 
fusion between this cell and a neighboring cell that had been injected in the nucleus. 
RFP expression in the fused cells was observed at 2.5 h post-microinjection (Fig. 23). 
For the other three cells that were injected in the nucleus, variations in the injection 
volume were observed (Fig. 23). Surprisingly, for the two cells which received the 
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lowest amount of FITC-dextran and thus a lower plasmid copy number than for the 
third cell, RFP expression was observed 1.5 h after microinjection (Fig. 23). For the 
cell injected with the highest amount of FITC-dextran, RFP expression was first 
observed 5.5 h after microinjection. Furthermore, this cell started dividing but was 
then blocked in mitosis. 
 
In the second experiment, several cells were injected in the cytoplasm and four cells 
were injected in the nucleus with a DNA concentration of 7.5 µg/ml (Fig. 23, Exp. no 
2). One cell did not survive the injection into the nucleus. 3.5 h after microinjection, 
two cells injected in the nucleus expressed RFP at different levels. In this time lapse 
image acquisition a fusion between one cell injected into the cytoplasm and another 
injected into the nucleus was again visible (Fig. 23). This cell with two nuclei was also 
expressing RFP (within the circle). The arrows indicate cells undergoing division after 
injection into the cytoplasm (Fig. 23). These cells started expressing RFP after cell 
division. The delay between RFP expression in cells injected in the nucleus and those 
injected in the cytoplasm was about 4 h.  
 
The third experiment was similar to the second except the DNA concentration was 30 
µg/ml instead of 7.5 µg/ml (Fig. 23, Exp. no. 3). As with the previous experiments the 
cells injected in the nucleus began to express RFP 1.5 h after gene transfer (data not 
shown). For the cells injected in the cytoplasm RFP expression was observed at 3.5 h 
after gene delivery (Fig. 23). Interestingly, these cells did not divide. By 7 h after 
microinjection, 4 cells were expressing the RFP without prior cell division (Fig. 23). 
  
Overall, independent from the DNA concentration, cells injected in the nucleus 
showed protein expression within two hours following gene delivery. Surprisingly, a 
high plasmid number in the nucleus was not related to a high protein expression level, 
rather this caused a delay in gene expression and an inhibition of the cell cycle. In 
contrast, after cytoplasmic microinjection with a high DNA concentration the cells 
showed RFP expression 4 h earlier than for cells injected in the cytoplasm with a 
lower DNA concentration. Furthermore at the lower DNA concentration, RFP 
expression was visible only after cell division.  
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Fig. 23 (on the previous page). Time lapse image acquisition after microinjection of CHO DG44 cells 
with 0.5% FITC-dextran and varying concentrations of pDsRed-Express. For Experiment No. 1 cells 
were microinjected at 70 hPa with a DNA concentration of 15 µg/ml. For Experiment No. 2 cells were 
microinjected at 70 hPa with a DNA concentration of 7.5 µg/ml. For Experiment No. 3 cells were 
microinjected at 70 hPa with a DNA concentration of 30 µg/ml. The size of the scale bar for each set of 
images is indicated. The arrows indicated cells going through one cell division cycle.  
 
6.2 Discussion 
One microinjection parameter to be controlled is the volume of injection. Information 
on this parameter allows the quantification of the number of plasmid molecules 
delivered into individual cells. Several studies have described methods to quantify 
injection volume. Usually a radioactive molecule is injected, and the volume of 
injection is estimated by determining the average level of radioactivity per cell 
(Capecchi 1980; Pollard et al. 2001). The average injection volume can also be 
determined by injection of a purified protein followed with an average quantification 
over a cell population (Liu et al. 2003). Since the intracellular viscosity, an important 
parameter for quantitating microinjection, may be very different from cell to cell, the 
injection volume may vary by a factor of 5 and more (Minaschek et al. 1989). Such 
differences, however, are not noticeable when the quantification is averaged over a 
cell population. We proposed in this work a fluorescence based injection volume 
quantification in order to quantify the volume in individual cells. A similar method 
based on determination of the cell volumes by measurement of the detached cell 
diameter using confocal microscopy following injection of a fluorescent probe, 
purified GFP (Ilegems et al. 2002). Since we were quantifying fluorescence on a two-
dimensional surface rather than a three-dimensional volume, our injection volume 
should be considered an estimate. It should be pointed out, however, that our estimates 
were in a similar range as those measured by other methods. As described in this 
work, the volume injected into the nucleus was around 180 fl and that in the cytoplasm 
ranged from 200 to 350 fl. With the radioactive method the average volume for 
nuclear microinjection in COS cells was 923 ± 191 fl (Pollard et al. 1998). For 
cytoplasmic microinjection of CV1 cells the injection volume ranged from 100-300 fl 
and for cytoplasmic microinjection of HeLa and COS cells it was 222 ± 91 fl 
(Lechardeur et al. 1999); Escriou et al., 1998). Based on injection of purified 
luciferase into the cytoplasm and the nucleus of human HUH-7 cells, the average 
injection volume was estimated at 565 ± 86 fl (Liu et al. 2003). In contrast to these 
values, injection volumes of 10-50 fl have also been determined using the radioisotope 
method described above (Ansorge and Pepperkok 1988; Capecchi 1980; Zhang et al. 
2002). In summary, the comparison of injection volumes by different methods remains 
difficult as different injection parameters and cells were used in each publication. 
 
The injection volume is a function of the injection time and pressure, the cell and 
DNA viscosity, and the DNA concentration. In our experiments the injection time was 
kept constant at 0.1 s, the lowest practical value. It has been determined that the 
viscosity of plasmid DNA of 5.4 kbp remains approximately constant for 
concentrations lower than 0.5 mg/ml for circular DNA and 0.4 mg/ml for linear DNA 
(Goodman et al. 2002). It is therefore to be expected that the volume injected into the 
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cell is not a function of the DNA concentration used for microinjection. Since we can 
not control the cell viscosity, we conclude that the injection volume in this work is 
mainly a function of the injection pressure applied.  
 
We observed an increase of the injected volume into the cytoplasm with an increase in 
injection pressure in the range of pressures from 70 to 100 hPa. CHO DG44 has an 
average cytoplasmic volume of 1’240 fl given a cell diameter of 15 µm and a nuclear 
diameter of 10 µm. Thus, a cytoplasmic injection volume of 180 fl corresponds to 
15% of the volume of the cytosol. With the highest injection pressure used, a volume 
corresponding to 30% of the cytosol was injected. We observed at this pressure (100 
hPa) a broader distribution of the injection volume (Fig. 20). Additionally, a dramatic 
increase of the smallest injection volume (lower error bar) was observed (Fig. 20). It is 
possible that cell membrane damage was caused by the high injection pressure. Thus, 
the FITC-dextran may have been released into the culture medium resulted in a 
decrease of the lower quartile for the injection at 100 hPa. 
  
The injection volume into the nucleus was identical to that injected into the cytoplasm 
for lowest pressure (70 hPa). However, the volume in this case did not vary with 
increasing injection pressure. This was assumed to be due to the high viscosity of the 
nucleus compared to that of the cytoplasm. Chondrocytes are reported to have nuclei 
that are twice as viscous as their cytoplasm (Guilak et al. 2000). Furthermore, 
depending on the site of injection within the nucleus, there was local variation of the 
viscosity resulting in greater variation in the injection volume as compared to injection 
into the cytoplasm (personal observations). The injection volume observed here for 
nuclear delivery at all pressures tested (180 fl) corresponds to 34% of the nuclear 
volume. With an injection pressure of 100 hPa we often observed a homogenous 
distribution of the fluorescence throughout the cell (Fig. 19). This probably indicated a 
disruption of the nuclear membrane. Since these cells were not considered in the 
injection quantification, this may explain the reduction of the upper quartile (data 
value located halfway between the median and the largest value) observed at an 
injection pressure of 100 hPa (Fig. 20).  
 
As a general rule, we observed that the concentration of DNA injected into the cells 
had a dramatic impact on the gene transfer efficiency as well as on the reporter gene 
expression level. The same effect of DNA concentration was observed for each 
injection pressure, and the percentage of GFP-positive cells decreased with higher 
injection pressures. This was probably due to increased cell death with increased 
pressure (Fig. 21). The highest percentage of GFP-positive cells was achieved after 
cytoplasmic microinjection with the highest DNA concentration (Fig. 21). Indeed, 
cytoplasmic injections with 30 µg/ml DNA concentrations also resulted in higher GFP 
expression levels (Fig. 22). In contrast, nuclear microinjection, where the most 
successful injections were executed with a 10 fold lower DNA concentration than for 
cytoplasmic microinjection (Fig. 21). One major difference between nuclear and 
cytoplasmic microinjection is that DNA introduced into the nucleus is immediately 
transcribed while DNA introduced into the cytoplasm must first be transported into the 
nucleus. Three main factors have an effect on DNA transport into the nucleus from the 
cytoplasm. The first is DNA degradation in the cytoplasm. Free plasmid DNA in the 
cytoplasm is subjected to enzymatic degradation (Lechardeur et al. 1999; Neves et al. 
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1999; Pollard et al. 2001). However, increasing the DNA amount within the cytoplasm 
may saturate the nucleases (Pollard et al. 2001). The second factor influencing 
transport is the cell cycle. There is evidence from studies of CaPi- and PEI-mediated 
gene delivery that DNA transport into the nucleus takes place after the breakdown of 
the nuclear membrane during mitosis (Brunner et al., 2000; Grosjean et al., 2002). 
Thirdly, active transport of the DNA from the cytoplasm to the nucleus may also play 
a role. Dean and collaborators have presented evidence of the cell-specific nuclear 
transport of non-viral vectors (Vacik et al., 1999). Nuclear localization of plasmids 
bearing a specific promoter sequences was facilitated following microinjection into 
the cytoplasm of smooth muscle cells (Vacik et al., 1999). Our results in Fig. 21A 
showed a gene transfer efficiency of 70% after cytoplasmic microinjection. In contrast 
different authors reported no expression after cytoplasmic microinjection into either 
mouse or human cells (Capecchi 1980; Mirzayans et al. 1992). Since expression of 
GFP was driven by a murine CMV promoter and that the recipient cells were CHO, 
we speculate that a more efficient nuclear transport of the cytoplasmic injected 
plasmids may explain the observed results.  
  
The time lapse image acquisitions also supported the importance of these three factors 
in the transport of DNA from the cytoplasm to the nucleus. With 2’000 copies of the 
plasmid injected into the cytoplasm, protein expression was observed only after cell 
division (Fig. 23, Exp. no. 3). For the injection of 9’000 plasmid copies, RFP was 
expressed as early as 7 h after cytoplasmic injection. Furthermore, with higher 
injection pressures and thus larger injection volumes, we observed an increase of the 
percentage of GFP-positive cells using a DNA concentration of 1.8 µg/ml DNA. If 
cytoplasmic microinjection occurred after cell division, the number of DNA copies 
delivered into the cytoplasm should be high in order to i) saturate nuclease activity, ii) 
have enough copies to be actively transported into the nucleus, or iii) remain in the 
cytoplasm until the breakdown of the nuclear membrane.  
 
A last parameter that may have an important effect on the efficiency of gene delivery 
by microinjection is the mobility of the DNA in the cytoplasm. For plasmid DNA in 
the cytoplasm, an 80 fold decrease of the diffusion coefficient for linear DNA 
molecules larger than 2’000 bp as compared to water was observed (Lukacs et al. 
2000). In addition, the diffusion of linear DNAs of 3’000 bp or greater was too slow to 
measure (Lukacs et al. 2000). Thus, it may be possible that higher plasmid copy 
numbers delivered into the cytoplasm by microinjection increased the probability of 
having more copies enter the nucleus. 
 
Based on the results of nuclear microinjection, we can also speculate on the minimal 
number of copies that enter the nucleus after cytosolic injection. About 900 copies of 
pEGFP-N1 were required in the nucleus for high GFP expression levels without any 
negative impact on cell growth. If we injected about 9’000 copies of the plasmid into 
the cytoplasm to get a similar level of GFP expression, then we can assume that about 
10% of the DNA delivered into the cytoplasm reached the nucleus while 90% was 
degraded or remained in the cytoplasm. 
 
Theoretically, nuclear microinjection should result in a gene transfer efficiency of 
100%. In practice the highest efficiency of about 80% was achieved for a DNA 
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concentration of 3.7 µg/ml and an injection pressure of 70 hPa (Fig. 21B). Some cells 
may not have survived the microinjection. Additionally, some injected cells were 
blocked during cell division (Fig. 23 Exp. no. 1) and often were dying within 10 h 
post-injection (data not shown). Since transient gene expression was only observed 
one day after gene transfer into the nucleus, dead cells were easily identified and 
therefore excluded from the calculation of gene transfer efficiency. The cell cycle may 
have also had a major impact on protein expression after nuclear microinjection. 
Nuclear injection of plasmid DNA during early S phase results in association of the 
DNA with acetylated histones (transcriptionally active chromatin) (Zhang et al. 2002). 
In contrast, microinjection of plasmid into the nucleus during late S phase results in 
the association of hypoacetylated histones with the DNA (transcriptionally inactive 
chromatin) (Zhang et al. 2002). 
  
Surprisingly, the delivery of a high plasmid number into the nucleus had a negative 
impact on gene expression and on cell division. Protein expression in cell containing a 
high plasmid copy number was delayed as compared to cells with a lower number of 
plasmid copies (Fig 23, Exp. no. 1). Furthermore, the cells were blocked during 
mitosis (Fig 23, Exp. no. 1). Different blocks of the cell cycle were observed. The first 
one was during mitosis (Fig 23, Exp. no. 1). In the second case, the cells survived up 
to 15 days after microinjection without any cell division (data not shown). In the last 
case, cells were able to go through one to 3 cell divisions before cell cycle inhibition 
was observed (data not shown). A high level of plasmid DNA in the nucleus may have 
a dramatic impact on various nuclear activities including DNA synthesis and mitosis. 
The regulation of DNA replication implicated involves the binding to replication 
origins by licensing proteins (Rui 1999), but the exact mechanism of the function of 
these proteins is not fully understood. In addition, various proteins are involved in 
mitosis. The presence of a high level of plasmid DNA in the nucleus may result in the 
sequestration of one or more of these essential proteins resulting in an inhibition of 
DNA synthesis or mitosis.  
 
In conclusion, we reported in this chapter the optimization of the microinjection 
conditions for adherent CHO DG44cells. Similar work has been performed for human 
vascular smooth muscle cells (Nelson and Kent 2002). In those studies the DNA 
concentration, injection pressure and injection time were optimized (Nelson and Kent 
2002). These authors also observed a negative impact of high injection pressure on 
transfection efficiency (Nelson and Kent 2002). In addition, others have reported very 
low gene transfer efficiencies after cytoplasmic microinjection into a variety of 
mammalian cells (Capecchi 1980; Mirzayans et al. 1992; Neves et al. 1999). In 
contrast, we observed a gene transfer efficiency of up to 75% for cytoplasmic injection 
after the optimization of several parameters including DNA concentration and 
injection pressure. For microinjection the optimal conditions were found to be a DNA 
concentration of 30 µg/ml and 3.7 µg/ml for cytoplasmic and nuclear injection, 
respectively, and an injection pressure of 70 hPa applied during 0.1 s.  
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7. Establishment of recombinant cell lines 
Several recombinant cell lines were established using microinjection to transfer 
plasmid DNA directly into the nucleus or the cytoplasm. In parallel, recombinant cell 
lines were also isolated following CaPi transfection. Either circular or linear pMYK-
EGFP-puro was transferred in each case. Different selection strategies were used for 
each method, and the efficiency of each with regard to the recovery of recombinant 
cell lines was determined.  
 
7.1 Results 
7.1.1 Strategy for the establishment of recombinant cell lines 
7.1.1.1 Microinjection 
The first question to be addressed to achieve a successful microinjection for the 
establishment of stable recombinant cell lines was the preparation of the cells. 
Injecting cells plated in a dish, even at a low cell density, was problematic. The non-
injected cells overgrew the injected cells so that cell identification was difficult. To 
solve this problem, the dishes were prepared using a droplet strategy described in 
Materials and Methods. Briefly, the cells were diluted to 5 cells per 20 µl. Then 
several 20 µl droplets were deposited on the surface of a Petri dish (Fig. 24). This 
method presented several advantages. It was easier to identify the cell to be injected, 
and the cell density was low enough to avoid overgrowth by the non-injected cells. 
Since only one cell was injected in each droplet, the GFP-positive colonies were not 
mixed with non-injected cells. The main difficulty in this approach was to initiate 
growth of the cells after injection. This problem was partially solved by the addition of 
conditioned medium derived from 3 to 4 day-old CHO DG44 cell cultures.  
 
 
Fig. 24. Preparation of CHO DG44 cells for microinjection. Each 20 µl droplet contained a maximum 
of 5 cells. After the cells adhered (4-5 h) culture medium was added, and one cell in each area was 
injected. 
Based on an earlier attempt to establish a recombinant cell line (see Chapter 6), 
selection pressure (3 µg/ml puromycin) was started at 4 days post-injection when 
colony formation was evident. At 8 days after gene transfer the GFP-positive cells 
were transferred into a 96-well microtiter plate and allowed to grow for two weeks 
under selective pressure. A frozen cell bank was established and GFP expression was 
analyzed by flow cytometry about 22 days after injection. At the same time the 
selection pressure was removed. 
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7.1.1.2 CaPi 
The transfections with CaPi were performed as described in Materials and Methods 
with either circular or linear DNA in 12-well microtiter plates. Briefly suspension 
growing CHO DG44 cells were plated 4 h prior to transfection in DMEM/F12 medium 
supplemented with 5% FBS. The CaPi-DNA was allowed to incubate 1 min at room 
temperature before addition to the cells. After 3 to 4 h, the cells were exposed to 10% 
glycerol solution in PBS for 1 min. After removal of the glycerol, the cells were 
washed once with 5 mM EGTA for 1 min. Finally, the EGTA was replaced with 
DMEM/F12 supplemented with 5% FBS. At two days post-transfection the GFP 
expression level in the adherent cultures was quantified by fluorometry. The highest 
GFP expression level was 11’200 RFU for transfections with circular DNA and 7’000 
RFU for transfections with linear DNA. For each transfection two cultures of adherent 
cells were prepared in plates and exposed to either low (3 µg/ml puromycin) or high 
selection pressure (6 µg/ml puromycin). Twice as many cells were plated in the dishes 
that were exposed to high selection pressure. Colonies selected with 3 µg/ml 
puromycin were transferred into 96-well microtiter plates at 9 days after plating and 
those exposed to 6 µg/ml puromycin after 12 days. The colonies were chosen based on 
their visual fluorescence intensity. The cells were then grown for 14 days under 
selection pressure as before. After the establishment of frozen cell banks and the 
analysis of GFP expression by flow cytometry the selection pressure was removed. 
The time required to prepare a cell line for the analysis of the stability of recombinant 
protein expression was 25-28 days. 
 
7.1.2 Efficiency of stable gene transfer 
7.1.2.1 Microinjection 
The results from several independent experiments to establish recombinant cell lines 
following microinjection are summarized in Table 9. GFP expression was observed at 
one day post-injection in about 30 to 50% of the injected cells (Table 9). This 
percentage of GFP-positive cells was less than that seen in the experiments on the 
optimization of microinjection described in Chapter 6 (Section 6.1.2). About 30 to 
100% of the cells positive for GFP expression were able to divide within 4 days of 
injection (Table 9). Only 25-40% achieved a colony size of greater than 20 cells after 
8 days of culture. Furthermore, not all the colonies that survived to 8 days became 
stable cell lines. Thus, the efficiencies of recovery of stable cell line were between 3.4 
and 7.7% (Table 9). Those values were calculated based on the results from each 
single experiment. By considering all the microinjections performed without any 
success in terms of stable expression, this percentage will decreased. Overall, the 
efficiency of recombinant cell line recovery following the injection of linear DNA in 
the nucleus was 3%. The efficiency was slightly less (2%) for injection in the 
cytoplasm. Injection of circular DNA into the nucleus was performed only once and 
no attempts were made to inject circular DNA into the cytoplasm.  
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Table 9. Analysis of the efficiency of gene transfer and recombinant cell line recovery by 
microinjection.  
DNA aNo. and 
site of 
injection 
GFP-
positive 
cells 
at day 1 
1-3 cell 
divisions
at day 4 
>20 cells 
at day 8 
No. of 
stable 
cell lines 
bEfficiency 
of stable 
cell line 
recovery 
Linear 30 N 16 5 3 1 3.4% 
Linear 13 N 6 3 2 1 7.7% 
Linear 25 N 11 4 3 1 4% 
Linear 23 C 7 7 3 1 4.3% 
Circular 28 N 12 ndc 3 1 3.6% 
aNuclear (N) or cytoplasmic injection (C) 
bThe efficiency was defined as the number of stable cell lines recovered from the total number of cells 
injected 
cNot determined (nd) 
 
7.1.2.2 CaPi 
From the CaPi transfection performed with circular DNA, about 1’000 colonies were 
observed in a dish of 10’000 transfected cells grown in the presence of 3 µg/ml 
puromycin for 10 days and about 2’000 colonies arose in a dish of 20’000 transfected 
cells grown in the presence of 6 µg/ml puromycin for 10 days. Of these puromycin-
resistant colonies only 57 were GFP-positive in the presence of low selective pressure 
and 100 were GFP-positive in the presence of high selective pressure. Therefore, the 
efficiency of recovery of recombinant cell lines, as defined as the percentage of GFP-
positive colonies in the population of transfected cells, was 0.5% regardless of the 
level of selection pressure. 
 
Transfection with linear pMYK-EGFP-puro resulted in a transient GFP expression 
level that was two times lower than that with circular DNA at 2 days post-transfection 
(data not shown). By 11 days post-transfection 10% of the cells inoculated into dishes 
survived the presence of 3 µg/ml puromycin. Of a total of 1’900 antibiotic-resistant 
colonies only 39 were positive for GFP expression. From the 40’000 transfected cells, 
only 700 survived selection with 6 µg/ml puromycin. Of these 627 were expressing 
GFP. Therefore the efficiency of stable expression in this experiment was 0.2% for a 
low level of selection pressure and 1.5% for a high level of selection pressure. 
 
7.1.3 Early GFP expression following gene delivery 
Early GFP expression was defined as the level of expression determined by 
fluorometry when clonal cells transfected or microinjected with pMYK-EGFP-puro 
were still being cultivated under selection pressure. For microinjected cells the 
analysis was performed about 22 days after gene delivery. For transfected cells the 
analysis for GFP expression was performed after expansion into 24-well microtiter 
plates.  
 
For each experiment the three highest producers obtained at each selection pressure 
were maintained in culture for analysis by flow cytometry and FISH. A high producer 
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was defined as a cell line with a specific fluorescence over 6. The specific 
fluorescence for medium and low producers was set at 3-6 and less than 3, 
respectively. 
 
7.1.3.1 Microinjection 
All of the cell lines obtained by microinjection were high or medium producers of 
GFP (Table 10). The three CHU-BK cell lines were established after nuclear injection 
with linear DNA (Table 10). Unfortunately, CHU-BK3 was lost due to a 
contamination before cell banking. D2R1 and D2R2 were recovered from nuclear 
microinjection with circular DNA. Finally 6PO was established after cytoplasmic 
injection with linearized DNA. For D2R1 and D2R2, the selection pressure was 
applied for 18 to 24 days with 2 to 3 µg/ml puromycin. The selection procedure for the 
isolation of D2R1 and D2R2 is described in Chapter 8. 
 
Table 10. Early specific GFP fluorescence of recombinant cell lines established by microinjection of 
CHO DG44 cells with pMYK-EGFP-puro. 
Cell line name 
 
DNA 
form 
Injection site Specific fluorescence 
[RFU/cell]∗100 
CHU-BK Linear Nucleus 12 
CHU-BK 2 Linear Nucleus 3 
CHU-BK 3 Linear Nucleus 7 
6PO Linear Cytoplasm 8 
D2R1 Circular Nucleus 4 
D2R2 Circular Nucleus 4 
 
7.1.3.2 CaPi 
After transfection of CHO DG44 cells with circular pMYK-EGFP-puro 20 colonies 
from each condition of selection pressure were recovered for further analysis. Only 5 
clones expressing GFP survived selection with 3 µg/ml of puromycin for 3 weeks 
(Table 11). For the higher selection pressure 7 GFP-positive clones survived. All of 
the high GFP producers were selected at 6 µg/ml puromycin. Only medium and low 
producers were recovered following selection in 3 µg/ml puromycin. Six of the twelve 
surviving clones were named (Nono 1-6) and kept for further analysis by Southern 
blot and FISH (Table 11). 
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Table 11. Early specific GFP fluorescence of recombinant cell lines established by CaPi transfection 
with circular pMYK-EGFP-puro. 
Name Puromycin 
concentration [µg/ml] 
Specific fluorescence 
[RFU/cell]∗100 
 6 3.5 
 6 6 
 6 6 
 6 7 
Nono 1 6 8 
Nono 2 6 11 
Nono 3 6 14 
 3 1 
Nono 4 3 2 
 3 2 
Nono 5 3 4 
Nono 6 3 5 
 
After transfection of CHO DG44 cells with linear pMYK-EGFP-puro, 18 colonies 
from each condition of selection pressure were recovered for further analysis. Only 6 
clones survived selection with 3 µg/ml of puromycin after transfer into a 96-well 
microtiter plate (Table 12), and 11 clones survived selection with 6 µg/ml puromycin 
(Table 12). As for the transfection with circular pMYK-EGFP-puro, the high GFP-
producing cell lines were recovered following selection with 6 µg/ml puromycin 
(Table 12). However, the specific fluorescence of the highest GFP producers was as 
much as 30% lower than observed after transfection with circular plasmid DNA 
(compare Table 11 and 12). For selection with 6 µg/ml puromycin the number of 
surviving cell lines after 3 weeks of selection was two times higher after a transfection 
with linear DNA as compared to circular DNA. Indeed 60% of the GFP-positive 
colonies recovered from the transfection with linear DNA survived, while only 35% of 
the colonies recovered from the transfection with circular DNA survived after 3 weeks 
of selection with 6 µg/ml puromycin. Six cell lines were named (Yoyo 1-6) and 
selected for further analysis by southern blot and FISH (Table 12). 
 
Overall, high producers were established exclusively after exposure to high selection 
pressure (Fig. 25). Surprisingly, almost 60% of the clones isolated in 6 µg/ml 
puromycin after transfection with circular DNA were high producers, while under 
identical selection conditions only 10% of the colonies recovered from the transfection 
with linear DNA were high producers (Fig. 25). Furthermore, 25% of the colonies 
selected with a high puromycin concentration following transfection with linear DNA 
were low producers, whereas following transfection with circular DNA and 
subsequent selection with 6 µg/ml puromycin only medium and high producers were 
recovered (Fig. 25). 
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Table 12. Early specific fluorescence of recombinant cell lines established by CaPi transfection with 
linear pMYK-EGFP-puro.  
Name Puromycin 
concentration [µg/ml] 
Specific fluorescence 
[RFU/cell]∗100 
 6 2 
 6 3 
 6 3 
 6 3 
 6 4 
 6 5 
 6 5 
 6 6 
Yoyo 2 6 7 
Yoyo 1 6 9 
Yoyo 3 6 9 
 3 1 
 3 1 
 3 2 
Yoyo 5 3 2.5 
Yoyo 4 3 3 
Yoyo 6 3 6 
 
 
 
 
0
20
40
60
80
100
3 ug circ 6 ug circ 3 ug lin 6 ug lin
<3
3-6
>6
P
er
ce
nt
ag
e 
of
 c
lo
ne
s
Transfection and selection conditions  
Fig. 25. Specific fluorescence of recombinant cell lines recovered following CaPi transfection with 
linear (lin) or circular (circ) pMYK-EGFP-puro after 3 weeks of selection in either 3 µg/ml (3 µg) or 6 
µg/ml (6 µg) puromycin. High producers were defined as having a specific fluorescence higher than 6 
RFU/cell*100, medium producers had a specific fluorescence between 3 and 6 RFU/cell*100, and low 
producers had a specific fluorescence below 3 RFU/cell*100.  
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7.2 Discussion 
Gene transfer into recipient cells is one of the first steps in the establishment of 
recombinant cell lines. In this chapter we compared two different gene transfer 
methods to establish recombinant cell lines. Linear and circular plasmids were either 
delivered into individual cells with microinjection or to cell populations with CaPi 
transfection. 
 
Four days post-microinjection, cells showing expression and cell growth were exposed 
to puromycin selection. Different cell populations were transfected with CaPi. Two 
days post-transfection, the cell population with the highest GFP level was diluted into 
dishes and selection pressure was applied. In this study high transient gene expression 
was related to a greater probability of isolating high producing cell lines. It has 
previously been shown that only colonies expressing GFP at a significant level two 
days posttransfection were able to maintain GFP expression after two weeks (Batard et 
al. 2001). Earlier studies performed on synchronized CHO cells showed very low 
efficiency of recombinant cell line recovery after transfection in the G0/G1 cell cycle 
phase where transient expression level was very low (Derouazi 2000).  
 
We observed that transient GFP expression levels after CaPi transfection with circular 
DNA were two fold higher than with linear DNA. To explain this difference three 
factors should be considered. First, there may have been differences at the level of 
CaPi particle formation or cellular entry of these particles for the two forms of the 
plasmid. Second, the intracellular stability of linear DNA may differ from that of 
circular DNA. Third, the transcriptional activity of the two different DNA templates 
may differ. Our laboratory has reported that the level of transient gene expression 
correlated with the intracellular plasmid copy number (Batard et al. 2001). 
Accordingly, more copies of pMYK-EGFP-puro copies may have entered cells 
following transfection with circular DNA than with linear DNA. Less linear DNA may 
have entered the cells or it may have been more rapidly degraded than circular DNA 
after cellular entry. It has been reported that 70% of plasmid DNA, circular or linear, 
was degraded within the 8 h after microinjection into the cytoplasm of COS cells 
(Pollard et al. 2001). However, the kinetics of degradation were different in the first 4 
h for the two different forms of the DNA. Approximately 60% of the circular DNA 
but only 20% of the linear DNA was degraded during this period (Pollard et al. 2001). 
In a separate study, a half life of 50-90 min was reporter for circular DNA in the 
cytoplasm of COS and Hela cells (Lechardeur et al. 1999). There is no evidence that 
linear plasmid is more rapidly degraded in the cytoplasm than circular DNA. 
Nucleases preferably cut plasmid DNA within polyadenosine regions and some 
bacterial replication origins (Ribeiro et al. 2004). Thus, the replacement of these labile 
sequences may increase plasmid stability in the cytoplasm. With regard to the third 
point described above, there is evidence that linear and circular plasmid DNA 
molecules are transcribed at different rates in mammalian cells. After microinjection 
into the nucleus of COS cells, reporter gene expression was 5-10 fold higher from 
linear DNA with hairpin ends than from circular DNA (Kamiya et al. 2002). In 
contrast, the percent of mesenchymal stem cells expressing the reporter protein was 5 
fold higher after microinjection with circular DNA compared to linear DNA (Tsulaia 
et al. 2003). Similar results were observed after nuclear microinjection of quail cells 
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with either circular and linear plasmid DNA (Kopchick and Stacey 1984). Since the 
amount of circular and linear DNA was not systematically analyzed in the present 
study, it cannot be excluded that there was a difference in transcriptional activity due 
to DNA topology following microinjection and CaPi transfection. It should be noted, 
however, that we did not observed a dramatic difference in the transient reporter 
protein expression level between nuclear microinjection with circular and linear DNA 
in contrast to CaPi transfection. 
  
In the study described here the percentage of GFP-positive cells after nuclear 
microinjection into cells plated using the droplet strategy was 30% lower (Table 9) 
than that achieved in a previous study to optimize gene delivery (Fig. 21). Indeed 90% 
of the cells were expressing the reporter protein using the same microinjection 
parameters as described here (Fig 21). The cell culture conditions for the 
establishment of recombinant cell lines described in this chapter may explain this 
difference. The low cell density employed here had an important impact on cell 
morphology. Often, the cells were less spread out and more viscous than those plated 
at a higher density as for the experiments described in Chapter 6. This made 
microinjection more difficult. Despite this problem the efficiency of gene transfer with 
microinjection was still higher than with CaPi. Visual estimation of the percentage of 
GFP-positive cells one day posttransfection gave values between 30 and 40%. Such a 
difference was similar to a previous report (Shen et al. 1982). They observed 
transfection gene transfer efficiencies between 3 and 33% for CaPi transfection and 
between 60 and 90% for nuclear microinjection in several different cell lines (Shen et 
al. 1982).  
 
The efficiency of stable transfection or stable cell line recovery is a matter of 
definition. For microinjection this was easier, since the number of cells injected was 
known and each injected cell was analyzed for GFP expression. For CaPi transfection 
the situation was different. By considering the number of colonies resulting from each 
transfection, we determined the efficiency of stable transfection to be around 10%. 
Since the recombinant protein (GFP) was visually detectable, we could redefine the 
stable transfection efficiency as the percentage of GFP-positive colonies in the 
population of transfected cells. In this case, the efficiency was 10 times lower than if 
all the colonies surviving selection during 10 days were counted. Since recombinant 
proteins are usually not fluorescent ones, the definition of stable transfection 
efficiency needs be defined carefully. In the experiments described here, cells may 
have survived selection for more than one week due to high transient expression and 
the subsequent accumulation of puromycin acetyl transferase. The decrease in survival 
rate of colonies after transfer into 96-well plates supports this idea. Indeed, less than 
40% of the colonies transferred survived a longer period of selection. An exception to 
this observation was in the case of colonies resulting from transfection with linear 
pMYK-EGFP-puro and selected with 6 µg/ml puromycin. In this case, the survival 
rate was 60%. 
  
From our results it was not clear which parameter, DNA topology or the level of the 
selection pressure, had a greater impact on the efficiency of recovery of high 
producing cell lines. We observed high producers exclusively after administration of 
the higher selection pressure (Fig. 25). On the other hand, at the higher selection 
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pressure low producing cell lines were isolated after the transfection with linear DNA 
but not after transfection with circular DNA.  
 
After microinjection, the main difficulty in the recovery of recombinant cell lines 
came from the cell culture conditions. Between 30-50% of the GFP-positive cells were 
able to pass through 1 to 3 cell divisions, but less than 30% of the cells injected in the 
nucleus and less than 40% of the cells injected in the cytoplasm grew to form small 
colonies. In a separate study from this laboratory, only 26-38% of CaPi transfected 
CHO DG44 cells remained viable and/or were able to grow after high plasmid uptake 
(Batard et al. 2001). Mesenchymal stem cells also demonstrated limited cell 
proliferation after nuclear microinjection (Tsulaia et al. 2003). It is not clear if the 
inhibition of cell growth was related exclusively to the microinjection or if the culture 
conditions blocked cell proliferation. The addition of conditioned medium to cultures 
of microinjected cells did improve cell growth. The use of a smaller cultivation dish 
for the droplet strategy may also provide better conditions for cell growth and survival 
after microinjection. 
 
In conclusion, 5 recombinant GFP cell lines were established after nuclear or 
cytoplasmic microinjection of either linear or circular pMYK-EGFP-puro. The cells 
were plated with the droplet strategy with an injection pressure of 70 hPa for 0.1 s and 
a DNA concentration of 3.7 µg/ml. Puromycin at 3 µg/ml was applied as a selection 
condition for at least 22 days. None of the recombinant cell lines established after 
nuclear or cytoplasmic microinjection was a low GFP-producer. In addition, 12 
recombinant GFP cell lines were isolated after CaPi transfection with either circular 
(Nono) or linear (Yoyo) pMYC-EGFP-puro. For each transfection two different 
selection strategies were used, one with a low (3 µg/ml) and one with a high 
puromycin concentration (6 µg/ml). High producers were established exclusively after 
exposition to high selection pressure. The number of plasmid copies integrated into the 
genome and site of integration were determined for the 17 recombinant cell lines 
(Chapiter 9). 
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8. Recombinant cell lines established with microinjection: 
D2R1 and D2R2 
The subclonal cell lines D2R1 and D2R2 were established by nuclear microinjection 
of circular pMYK-EGFP-puro into CHO DG44 cells. Since several studies were done 
with these two cell lines, an entire chapter will be dedicated to their characterization. 
The procedure used for selection of the clones and the time frame required to recover 
the recombinant cell populations after microinjection are described in detail. D2R1 
and D2R2 were generated from the microinjection of a single cell. The resulting 
colony of clonal cells was divided into two populations which were then cultivated 
under selective pressure in two different ways to establish two distinct subclonal 
populations (D2R1 and D2R2). Eventually D2R1 and D2R2 were adapted to serum-
free suspension culture. Importantly, the stability of recombinant GFP expression over 
time was determined for adherent and suspension cultures of both D2R1 and D2R2.  
8.1 Results 
8.1.1 Cell line establishment 
The cells were prepared for microinjection as described in Chapter 7. Circular pMYK-
EGFP-puro at a concentration of 3.7 µg/ml was injected into the nucleus of cells using 
an injection pressure of 70 hPa. Four days post-microinjection a colony of about 30 
cells expressing GFP was observed. At this point, the culture medium was 
supplemented with 2 µg/ml puromycin to apply a weak selection pressure (Fig. 26). 
After 4 days of culture in the presence of puromycin, the colony was removed from 
the plate, and the cells were divided into two wells of a 96-well microtiter plate. A 
different selection strategy was then applied to the two populations (Fig 26). One 
designated D2R1 was cultivated for five days in the absence of puromycin (Fig. 26). 
The selective agent was then added to the medium at a concentration of 3 µg/ml for 18 
days. The other population designated D2R2 was continuously cultivated in medium 
containing 3 µg/ml puromycin for 23 days. Four weeks after gene transfer, a frozen 
stock of each population was prepared. In addition, each subclone was adapted to 
growth in serum-free suspension culture 24 days after microinjection. 
 
8.1.2 Stability of recombinant gene expression over three months 
D2R1 and D2R2 were analyzed by flow cytometry prior to removal of the selective 
agent. At this time point, the adherent and suspension cultures had already been 
cultivated for one and a half weeks (3 passages) and one week (2 passages), 
respectively. Surprisingly, the two subclones exhibited differences in the percentage of 
GFP-expressing cells and in the level of GFP expression per cell. For D2R2, which 
was under selective pressure for 28 days, 100% of the cells were GFP-positive, but for 
D2R1 4% of the cells did not express GFP (Fig. 27). Furthermore, GFP expression per 
cell was about 10% higher for D2R2 than for D2R1 (Fig. 27). The mean fluorescence 
from adherent D2R2 cells was 3,200 units in comparison to 2,800 units for D2R1. 
Furthermore, the distribution of the fluorescence intensity was smaller for D2R2 than 
for D2R1. The coefficients of variation (CV) were 6.8 and 7.7 for D2R2 and D2R1, 
respectively. As compared to adherent cells, suspension-adapted cells (D2R1s and 
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D2R2s) had 40% less fluorescence (Fig. 28). The mean levels of fluorescence for 
D2R2s and D2R1s were 1,800 units and 1,700 units, respectively. This difference 
between the two suspension cultures was less that that observed for the two adherent 
cultures. A similar analysis by flow cytometry was performed once a month for 3 
months. Since a different instrument was used for each analysis, it was not possible to 
directly compare the mean fluorescence from measurement to measurement. For this 
reason the histograms are not shown here. For D2R1s and D2R2s the percentage of 
GFP-positive cells was reduced by 40% after two months in culture (Table 13). In 
addition, a broad distribution of the fluorescence intensities was observed for the 
suspension cultures as compared to the adherent cultures (data not shown). For the 
adherent D2R2 culture the percentage of GFP-positive cells remained fairly stable for 
3 months (Table 13). In contrast, 30% of the adherent D2R1 cells were GFP-negative 
after the same time in culture (Table 13). 
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Fig. 26 (on the previous page). Flow chart describing the cultivation procedures and the timeline for the 
establishment of recombinant cell lines following gene delivery by microinjection. Four weeks after 
microinjection, frozen cell banks were generated. The cells were eventually maintained as both adherent 
and suspension cultures. The red borders indicate the presence of selection pressure. The scale bars in 
the top and bottom photographs are equal to 20 µm and 50 µm, respectively. Abbreviations: puromycin 
(puro) and microinjection (MI). 
 
 
Fig. 27. Results from the analysis of GFP expression in adherent (with serum) and suspension (serum-
free) cultures of D2R2 (A) and D2R1 (B) by flow cytometry. GFP fluorescence from control CHO 
DG44 cells is shown in grey. 
 
Table 13. Summary of the percentage of GFP-positive cells for adherent and suspension (s) cultures of 
D2R1 and D2R2 as determined by flow cytometry after different cultivation periods 
 Cultivation period 
 P 3 (2 weeks) P 11 (6 weeks) P 23 (12 weeks) 
D2R1 96% 91% 70% 
D2R2 100% 98% 94% 
D2R1s 98% 65% 62% 
D2R2s 100% 65% 60% 
 
Parallel to the monthly flow cytometry, the specific fluorescence of each cell 
population was quantified weekly by fluorometry. For adherent cultures, the 
fluorescence of both nonlysed and lysed cell monolayers was determined (Fig. 28A, 
B). The inclusion of data from lysed monolayers allowed a comparison with the 
specific fluorescence of suspension cells since they were also measured after lysis 
(Fig. 28C). After 4 weeks in culture, cells were frozen. Aliquots of these were thawed 
and used for data acquisition during weeks 5-12 in the experiment described below. 
The frozen cells were also used for the flow cytometry studies described above for 
month 2 and month 3.  
  
As already observed by flow cytometry, the specific fluorescence for D2R1 was 20% 
lower than for D2R2 (Fig. 28). Furthermore, GFP expression in adherent D2R2 cells 
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was stable over for three months of cultivation whereas GFP expression in adherent 
D2R1 cells decreased slightly during the same period (Fig. 28A, B). 
  
The specific fluorescence observed in suspension growing D2R1s and D2R2s cells 
was already about 30% less than in adherent D2R1 and D2R2 cells in the first week of 
culture. The relative fluorescence of cell lysates was always lower than that of 
adherent cultures. Almost a two fold difference was observed between the specific 
fluorescence in adherent culture (Fig. 28A) and the specific fluorescence in cell lysates 
(Fig. 28B). For D2R2s and D2R1s GFP expression decreased continuously from a 
specific productivity of about 2 to about 0.3 RFU/cell*100 during the 3 months of the 
experiment, a 70% reduction in expression (Fig. 28C).  
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Fig. 28. Specific fluorescence (RFU/cell*100) of different cells population over 12 weeks of culture for 
adherent D2R1 and D2R2 (A and B) and for suspension D2R1s and D2R2s (C). Relative fluorescence 
was measured for adherent cultures either directly (A) or after cell lysis (B) and for suspension cells 
after cell lysis (C). For each graph the vertical line between 4 and 5 weeks indicated the time that the 
cell lines were frozen. Frozen cells were returned to culture to acquire the data shown for weeks 5 
through 12.  
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8.1.3 Influence of the serum in the culture medium 
The specific fluorescence of D2R2s and D2R1s decreased dramatically over time in 
serum-free suspension culture (Fig. 28). To determine whether this decrease was 
related to the absence of serum in the medium, D2R2s cells were grown in the 
presence or absence of 2% serum in ProCHO5 CDM medium. The cells used in the 
experiment had been in serum-free culture for 12 weeks (24 passages) prior to this 
change. The specific fluorescence of the cells was determined over a four-week 
period. As shown in Fig. 29A, GFP expression was higher in D2R2s cells grown in the 
presence of serum than in its absence. Surprisingly, the cells cultivated in the presence 
of serum did not grow as fast as cells cultivated in the absence of serum despite a high 
cell viability (90-100%) in each case (Fig. 29B). Cell growth was determined by 
measuring the biomass of the cultures over a period of 8 days using mini-PCV tubes 
(Fig. 29B). The growth rate of D2R2s cells was obviously reduced in the presence of 
serum (Fig. 29). This result must be regarded carefully because the cell size was not 
determined. Serum may have had an influence on the cell size and consequently on the 
cell mass. On the other hand, the cell growth curves shown in Fig. 29B correlated well 
with the results obtained with manual counting (data not shown). 
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Fig. 29. Specific fluorescence of D2R2s cultivated in suspension with and without serum (FCS) during 
4 weeks (A). Growth of D2R2s cultivated in medium with and without serum (B). Cell counting was 
done manually with a haemocytometer (A). The packed cell volume (PCV) was determined using a 
mini-PCV tube (B). 
 
8.1.4 Gene silencing analysis 
To clarify if the decrease in GFP expression observed in D2R2s following adaptation 
to suspension culture was due to the deacetylation of histones associated with the GFP 
gene, the cells were exposed to three different inhibitors of histone deacetylation 
including sodium butyrate (NaBut), Trichosatin A (TSA), and the adenoviral Gam1 
protein. In addition, the effect of the DNA methylation inhibitor azacytidine (AzaC) 
on GFP expression in D2R2s was also investigated. D2R2s cells cultivated for 34 
passages were seeded at 1∗106 cells/ml in 50 ml centrifuge tubes in the presence of 4 
or 6 mM NaBut, 3 or 5 µM TSA, or 5 or 10 µM Aza C. Alternatively, the cells at a 
density of 2∗106 cells/ml were transfected with pMCGAM1 in the presence of PEI. At 
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48 h after treatment GFP expression was determined by fluorometry and the cell mass 
was determined using mini-PCV tubes. The presence of TSA, AzaC, and Gam1 
increased GFP expression about 10% to 30% relative to the untreated control cells 
(Fig. 30). All of these treatments had a slight negative effect on cell mass (Fig. 30). 
Similar results were observed at 72 h after treatment (data not shown). In the presence 
of NaBut a 2 fold increase in GFP expression was observed compared to the control 
culture (Fig. 30). There was also a 2.5 fold decrease in cell mass in the presence of 
NaBut (Fig. 30). The increase in fluorescence, therefore, may have resulted from GFP 
accumulation in cells after growth arrest. 
 
Fig. 30. Growth and GFP expression in D2R2s cells in the presence of inhibitors of histone 
deacetylation or DNA methylation. Suspension–adapted D2R2s cells were exposed to NaBut, TSA, or 
Aza C or transfected with pMCGAM1. At 48 h after treatment the cell mass was assessed using a mini-
PCV tube (grey bar) and the fluorescence of lysed cells was measured (red square) by fluorometry. 
Each value is the average from three independent experiments.  
 
8.1.5 Culture system 
The results shown in Fig. 28 and Fig. 29 demonstrated that the stability of a clonal 
population may be affected by the culture system and the medium composition. To 
determine if returning suspension-adapted cells to an adherent cultivation system 
altered GFP expression levels, D2R2s cells in culture for 18 weeks were either 
cultivated in suspension in either square- or round-shaped bottles in serum-free 
medium (ProCHO 5) for an additional 4 weeks or were grown as an adherent culture 
in the presence of serum (DMEM/F12) for 4 weeks. For each culture the specific 
fluorescence was determined once per week for four weeks. The cell growth for the 
two suspension cultures in either square- or round-shaped bottles was similar. The 
cells grown in an agitated square-shaped bottle reached a density of 3.5∗106 cells/ml 
after 3 days of culture while the cells grown in an agitated round-shaped bottle 
reached a density of 3.3∗106 cells/ml in the same time period. For the two cultures the 
specific fluorescence remained relatively constant (Fig. 31). The adherent cells 
reached densities of 1-1.5∗106 cells/ml but the growth was limited by the size of the 
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cultivation surface. The specific fluorescence of the adherent cells was 2.5 fold higher 
than observed for the cells grown in suspension (Fig. 31).  
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Fig. 31. GFP expression in D2R2s cells maintained in different cultivation systems. D2R2s cells were 
cultivated in suspension for four weeks in the absence of serum in either square- or round-shaped 
bottles. In parallel D2R2s was grown as an adherent culture in the presence of serum. The specific 
fluorescence from GFP was measured of lysed cells once per week. 
 
After four weeks, cells from the three cultures were analyzed by flow cytometry (Fig. 
32). There was a nearly perfect overlay of the fluorescence histograms for the cells 
from the two suspension cultures (Fig. 32). In both cases, the GFP-positive cells 
represented about 41% of the population, and a broad distribution of the fluorescence 
intensities was observed (Fig. 32). The CV was above 30 for each. For the adherent 
culture, the fluorescence distribution was narrower than observed for the suspension 
cultures (Fig. 32). The fluorescence intensity of the cells from the adherent culture was 
ten fold higher than for the cells from the suspension cultures (Fig. 32). Nevertheless 
the percentage of GFP-positive cells was 47%. 
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Fig. 32. Flow cytometry of adherent and suspension cultures of D2R2s cells. The suspension cultures 
were grown in a square-shpaed bottle (black histogram) or in a round-shaped bottle (green histogram) in 
the absence of serum. The adherent culture (blue histogram) was grown in the presence of serum. The 
cells were maintained for 53 passages under each condition. The fluorescence of control CHO DG44 
cells is shown in grey. The analysis was performed with two different settings allowing visualization of 
all the GFP-negative cells (A) or all the GFP-positive cells (B). 
 
8.2 Discussion 
The two subclonal cell lines D2R1 and D2R2 were established after nuclear 
microinjection with circular pMYK-EGFP-puro. They have several interesting and 
surprising characteristics. First, despite the fact that both cell lines were were 
generated by microinjection of a single cell they exhibited different behavior. The 
unique difference between the two cell lines was an additional 5 days of selection for 
D2R2 as compared to D2R1. Surprisingly, at the time of removal of puromycin from 
the culture medium D2R1 already had a lower specific fluorescence than D2R2. 
Furthermore, adherent D2R2 cells expressed GFP at a constant level over 3 months of 
culture. In comparison, the number of GFP-positive D2R1 cells decreased by 30% 
over the same time period. Many studies on recombinant gene amplification have been 
published (Fann et al. 2000; Kim et al. 1998; Omasa 2002; Sanders and Wilson 1984; 
Wurm et al. 1996), but to our knowledge, the effect of the duration of genetic selection 
on the level of recombinant protein expression has not been described. During transfer 
to 96-well microtiter plates, we cannot exclude the possibility that some GFP-negative 
cells were transferred with the GFP-positive D2R1 cells. After release of antibiotic 
selection for 5 days, these cells may have developed resistance to purmoycin. 
Compared to human cells, CHO cells exhibit between a 10-50 fold higher resistance to 
different drugs such as puromycin (Gupta 1988). It is possible that the GFP-negative 
cells in the D2R1 population at the time of removal of puromycin may have been 
resistant to the antibiotic. On the other hand, transcriptional silencing due to chromatin 
modifications including histone hypoacetylation and loss of methylation at lysine 9 of 
histone 3 or CpG methylation within the promoter may have occurred in a small 
percentage of the cells (Bird and Wolffe 1999; Heard et al. 2001; Mutskov and 
Felsenfeld 2004). After 5 days in culture in 96-well microtiterplates, all of the 
 
Results and Discussion 
99 
adherent D2R2 cells were GFP-positive while many GFP-negative cells were present 
in the D2R1 culture. The 4% of GFP-negative cells in the D2R1 culture at the 
beginning may have increased to become up to 30% of the culture after 3 months if 
they had a faster growth rate than the GFP-positive cells. Since these observations are 
from a single experiment it is difficult to draw conclusions about the differences 
between D2R1 and D2R2. Nevertheless, we would like to point out an underestimated 
parameter in the establishment of recombinant cell lines. Our results suggest that the 
exposure time to the selective agent may affect the productivity of recombinant cell 
lines.  
 
Adaptation of recombinant cell lines to serum-free suspension growth is important for 
recombinant protein production. The elimination of serum from the culture medium 
reduces both costs and the probability of product contamination, avoids the variability 
inherent in different batches of sera composition, and facilitates downstream 
processing. We adapted D2R1 and D2R2 cell lines to suspension growth 4 weeks 
post-microinjection, the time to produce a sufficient amount of cell mass. The re-
adaptation to serum-free suspension culture was performed easily, perhaps because the 
CHO DG44 cells were originally cultivated in suspension. One morphological change 
due to the cultivation in the absence of serum was the cell size as determined by flow 
cytometry. The approximate size distribution recorded on the forward scatter (FS) was 
between 50 and 190 for adherent D2R1 and D2R2 cells and for suspension growing 
CHO DG44. For suspension D2R1s and D2R2s cells the FS was between 90 and 240 
(data not shown). Analysis with CASY®1 TTC cell counter yielded a mean diameter 
of 13 µm for adherent cells and 15 µm for suspension cells. Those data should be 
considered carefully as variations in cell size with culture age have been observed in 
our laboratory. The mean cell diameter decreased when high cell densities were 
reached (unpublished data Sébastien Sart). 
 
For both cell lines the GFP expression level decreased immediately after adaptation to 
serum-free cultivation (Fig. 27). Similar results have been reported by others 
Suspension-adapted CHO cells expressing human growth hormone (HGH) exhibited a 
25% decrease in the HGH level after adaptation to serum-free medium (Haldankar et 
al. 1999). Suspension-adapted D2R1s and D2R2s cells already demonstrated a 
dramatic decrease in the level of GFP expression within the first 6 weeks of culture. 
The changes in GFP expression were gradual rather than sudden during this period. 
Furthermore, the cell growth was constant despite the variation in productivity. 
Usually after three days of culture a cell density of 2.7∗106 cells/ml was achieved. For 
the same seeding density and the same cultivation period, CHO DG44 grew to 3.5∗106 
cells/ml. The reasons for the decrease in GFP level and instability of expression have 
not been elucidated. If the decrease in GFP expression is due to transcriptional 
silencing, then these results indicate that chromatin modification events may be 
dependant on other factors in addition to the location of the plasmid integration site. 
 
To study the role of serum and cultivation conditions on the GFP expression level, 
D2R2s cells were cultivated in different vessels with and without serum. Interestingly 
when the suspension medium ProCHO 5 CDM was supplemented with serum cell 
growth was inhibited (Fig. 29). We expected the opposite effect since serum has been 
identified as an anti-apoptotic agent (Goswami et al. 1999). Nevertheless, in adherent 
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and suspension cultures, an increase in specific fluorescence was observed in D2R2 
cells after addition of serum. The mechanism by which serum increased transgene 
expression is not clear. Serum might contribute to an enhancement of the 
transcriptional activity of the mCMV promoter (Brightwell et al. 1997). Although the 
specific fluorescence increased in the presence of serum, the percentage of GFP-
positive cells did not increase, and serum did not restore silenced gene expression. In 
order to better control the influence of serum, medium, and culture vessel on 
recombinant protein expression similar experiments to those reported here should be 
performed using cells that have only been cultivated for a short time.  
 
We investigated the effect of chromatin modifications on the decrease in GFP 
expression in D2R2 cells using inhibitors of histone deacetylation including NaBut 
(Candido et al. 1978), TSA (Yoshida et al. 1990) and the protein Gam1 (Chiocca et al. 
2002). Previous results from our laboratory demonstrated 2-6 fold increases in 
recombinant protein expression from various cell lines in the presence of NaBut and 5-
20 fold increases in the presence of Gam1 (Hunt et al. 2002; Hacker et al.). For 
D2R2s, no major increase in GFP expression was observed following the different 
treatments. Since gene silencing correlates with histones hypoacetylation and DNA 
methylation (Mutskov and Felsenfeld 2004), it is possible that agents acting on both 
histone deacetylases and DNA methylases were necessary to accomplish a change in 
the level of GFP expression in this cell line. It is also possible that the decrease in GFP 
expression in D2R2s resulted from an alteration in a pathway involving the activation 
or inactivation of transcription factors. In order to test this alternative, an experiment 
similar to the one described in Fig. 30 should be performed using adherent cells.  
 
In conclusion, two subclonal populations were established after nuclear microinjection 
with circular pMYK-EGFP-puro. The two populations were recovered from the 
injection of a single cell. After different selection strategies, the established cell lines 
exhibited different recombinant protein expression levels over time. The length of the 
period under genetic selection may have had a dramatic impact on the stability of 
transgene expression in the recombinant cell lines, as did the cultivation conditions. 
The suspension-adapted cells had a lower specific fluorescence than the adherent cells, 
and after 3 months of cultivation in suspension, 40% of the cells were GFP-negative. 
In addition, the presence of serum in the culture medium of suspension growing cells 
resulted in an increase of the specific fluorescence without changes in the percentage 
of GFP-positive cells.  
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9. Characterization of the established recombinant cell lines 
The various cell lines established by either microinjection or CaPi transfection were 
characterized in terms of the stability of GFP expression over time, the copy number, 
and the number of integration sites. For some cell lines GFP expression levels were 
analyzed over two months. During this period the specific fluorescence was 
determined each week by fluorometry and in the first and last months by flow 
cytometry. The number of integrated copies of the GFP gene in the genome of each 
cell line was quantified by Southern blot. In order to analyze genomic stability or 
instability, the number of chromosomes in 20 metaphase spreads from each cell line 
was counted. The number of integration site(s) for each recombinant cell line was 
determined by FISH. 
 
9.1 Results 
9.1.1 Characterization of recombinant protein expression stability 
 
9.1.1.1 Cell lines generated by microinjection 
All the cell lines established with microinjection (Chapter 7) were characterized for 
the stability of GFP expression as described in Section 9.1.3 of this chapter. 
 
9.1.1.2 Cell lines generated by CaPi transfection 
After transfection with circular DNA, 6 cell lines were established based on their 
specific fluorescence (see Chapter 7, Tables 11 and 12). The cells were analyzed by 
flow cytometry (Fig. 33). For each cell line the values obtained for the percentage of 
GFP-positive cells, the mean fluorescence and the coefficient of variation (CV) are 
summarized in Table 14. The mean fluorescence intensity denotes the level of 
fluorescence of the cell population. The higher the value of the mean fluorescence, the 
more cytochrome (in this case GFP) is present in the cell population. The CV is a 
measure of fluorescence distribution.  
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Table 14. Analysis by flow cytometry of Nono cell lines transfected with circular pMYK-EGFP-puro 
using CaPi. 
Cell line 
 
Positive 
cells (%) 
Mean 
fluorescence CV 
 
Nono 1 
 
98 1010 22 
 
Nono 2 
 
98 300 33 
 
Nono 3 100 1150 7 
 
Nono 4 0.5 52 85 
 
Nono 5 99 61 38 
 
Nono 6 100 760 22 
Fig. 33. Analysis by flow cytometry 
of Nono cell lines (1 to 6). GFP-
negative CHO DG44 cells (CHO) 
were used as a control. 
 
Two of the six cell lines, one subjected to high selection pressure (Nono 1-3) and the 
other to low selection pressure (Nono 4-6), were selected for further analysis to 
determine the stability of GFP expression, the integrated plasmid copy number, and 
the number of integration sites. The two major criteria for selection were a high GFP 
expression level and a homogenous population. Since Nono 4 no longer expressed 
GFP and Nono 2 and 5 had a broad distribution of the fluorescence (high CV), they 
were eliminated from consideration. Additional studies were therefore performed with 
Nono 1 and Nono 6. The latter, however, was not ideal because it contained two 
populations one with low and the other with high fluorescence intensity that 
containing 15% and 85% of the cells, respectively (Fig. 33). Nono 1 had a mean 
fluorescence for the main peak (85% of the cells) of 1’570 units with a CV of 7 while 
for Nono 6 the mean fluorescence of the main peak was 1’320 units and the CV was 7. 
Nono 1 was the cell line with the highest mean fluorescence. These mean fluorescence 
values don’t match the values given in Table 14 because here exclusively the mean 
peak was considered. For Nono 1 and Nono 6 the main peak contained about 85% of 
the cells.  
 
The Yoyo cell lines established after transfection with linear pMYK-EGFP-puro were 
selected with either a high (Yoyo 1-3) or a low puromycin concentration (Yoyo 4-6). 
These six cell lines were also analyzed by flow cytometry (Fig. 34). For each cell line 
the values obtained for the percentage of positive cells, the mean fluorescence and 
coefficient of variation (CV) are summarized in Table 14. The cell lines showing the 
highest fluorescence with the lowest CV were Yoyo 3 and Yoyo 6 (Fig. 34). The rest 
of the Yoyo cell lines showed a broader distribution of fluorescence, and Yoyo 5 had 
two distinct subpopulations (Fig. 34). Yoyo 3 and 6 were kept in culture for the 
analysis of the stability of GFP expression. 
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Table 15. Flow cytometry analysis of Yoyo cell lines transfected with linear DNA. 
Cell line 
 
Positives 
cells (%) 
Mean 
fluorescence CV 
 
Yoyo 1 100 460 26 
 
Yoyo 2 99 1140 25 
 
Yoyo 3 100 2060 11 
 
Yoyo 4 99 1140 17 
 
Yoyo 5 99 520 26 
 
Yoyo 6 100 1280 7 
Fig. 34. Analysis by flow 
cytometry of Yoyo cell lines (1 to 
6). GFP-negative CHO DG44 cells 
(CHO) were used as a control. 
 
9.1.2 Stability of GFP within a cell 
 
Since GFP is not secreted in the culture medium and is a stable protein with a half life 
of 24 h (Xiaoning Zhao et al. 2000), we determined whether or not GFP accumulated 
in cells during exponential growth and stationary phase. Two different cell lines, Yoyo 
3 and 6PO were plated in 12-well microtiter plates at 3.5∗105 and 3∗105 cells/ml, 
respectively. Every day the fluorescence in one well was measured and the cells were 
counted (Fig. 35). The initial cell density was high so that GFP expression could be 
determined in both growing and confluent cells. This resulted in a decrease of the 
viability after 4 days of culture for Yoyo 3 and after 4-5 days for 6PO (Fig. 35). 
During the growth phase, the GFP fluorescence was directly correlated with an 
increase of the cell number for both cell lines (Fig. 35). The fluorescence of Yoyo 3 
reached a plateau when the cell density decreased (Fig. 35A), whereas for 6PO the 
GFP increased during growth arrest and reached a plateau when the mortality 
increased (Fig. 35B).  
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Fig. 35. Cell number and GFP expression of Yoyo 3 (A) and 6PO (B) over time. Cell number was 
determined with the Casy. Fluorescence was determined by fluorometry. 
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9.1.3 Stability of GFP expression over 2 to 3 months of culture 
The chosen cell lines derived from gene transfer by either microinjection or CaPi 
transfection were maintained as adherent cultures for at least two months. The cell 
lines resulting from microinjection were also grown as suspension cultures. GFP 
expression was monitored weekly by fluorometry. In addition, after both the first and 
the last cell passages during this two month period an analysis by flow cytometry was 
performed. 
 
9.1.3.1 Cell lines generated by microinjection 
For the cell lines 6PO, CHU-BK and D2R2 GFP expression was constant over the 9 
weeks of adherent culture (Fig. 36). For 6PO and CHU-BK, two cell lines generated 
by injection of linear pMYK-EGFP-puro, the average specific fluorescence over this 
time period was 9 and 10 RFU/cell*100, respectively. These values were estimated to 
correspond to about 15-20 mg/l of intracellular protein (Girard 1997). D2R2, a cell 
line generated by injection of circular pMYK-EGFP-puro, had an average specific 
fluorescence of 5 RFU/cell*100 (Fig. 36). A third cell line that was generated by 
injection with linear DNA (CHU-BK2) had the lowest initial specific fluorescence 
(about 2.5 RFU/cell*100) (Fig. 36). After 7 weeks in culture, however, GFP 
expression was just above the level of detection for CHU-BK2 (Fig. 36).  
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Fig. 36. Specific fluorescence of 4 adherent cell lines generated by microinjection of CHO DG44 cells 
with pMYK-EGFP-puro. Over a two month period GFP was quantified in unlysed cells by fluorometry, 
and the cell density was determined with the CASY®1 TTC. Each analysis was performed on cells at 3 
days after passage. 6PO was generated by cytoplasmic injection of linear pMYK-EGFP-puro, CHU-BK 
and CHU-BK2 were generated by nuclear injection of linear pMYK-EGFP-puro, and D2R2 was 
generated by nuclear injection of circular pMYK-EGFP-puro.  
 
Both 6PO and CHU-BK were adapted to serum-free suspension culture and 
maintained in parallel with the adherent cultures. The fluorescence was quantified in 
cell lysates of both the suspension and adherent cultures. For suspension growing 
cells, the cell number was determined manually. For adherent cultures, the cell number 
was determined using the CASY®1 TTC cell counter. As observed for the suspension-
adapted D2R1s and D2R2s cell lines (Chapter 8, Section 8.1.2), the suspension 
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cultures CHU-BKs and 6POs had a specific fluorescence that was 2-3 times lower 
than that of the same cell lines grown as adherent cultures (Fig. 37). 
  
The specific fluorescence of CHU-BKs was fairly constant over 9 weeks of 
cultivation, but the specific fluorescence of 6POs decreased during the first two weeks 
of culture and then remained constant at a low level (Fig. 37). In the analysis by flow 
cytometry of adherent and suspension cell lines, we observed a one log shift in the 
fluorescence intensity between 6PO and 6POs (Fig. 38). The mean fluorescence of 
6PO was 13 fold higher than that of 6POs, and the fluorescence distribution was 
broader for 6POs than for 6PO (Fig. 38). In contrast, the difference in GFP expression 
between CHU-BK and CHU-BKs was not as great (Fig. 38). CHU-BKs had a mean 
fluorescence that was 40% lower and a CV that was 40% higher than for CHU-BK 
(Fig. 38). The flow cytometry analysis was performed on adherent cells after 15 
passages (P15, 8 weeks) and on suspension cells after 10 passages (P10, 5 weeks). 
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Fig. 37. Specific fluorescence for adherent and suspension cultures of 6PO and CHU-BK. The 
suspension cultures are denoted as 6POs and CHU-BKs. GFP was quantified in lysed cultures by 
fluorometry, and the cell density assessed with the CASY®1 TTC cell counter for adherent cells and 
manually for suspension cells. Analyses were performed on cells at 3 days after passage. 6PO was 
generated by cytoplasmic injection of linear pMYK-EGFP-puro, CHU-BK by nuclear injection of linear 
pMYK-EGFP-puro. 
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Fig. 38. Analysis by flow cytometry of adherent and suspension cultures of CHU-BK (A) and 6PO (B). 
The suspension cultures are denoted as CHU-BKs and 6POs. CHO DG44 cells (CHO) were used as a 
negative control. Adherent cells were in culture for 15 passages (P15, 8 weeks) and suspension cells for 
10 passages (P10, 5 weeks). 
 
The results of the flow cytometry analysis of CHU-BK, CHU-BK2, 6PO, and 6POs 
performed at the initiation of the cultures and after 8 weeks of culture (except for 
6POs, which was kept in culture for 15 weeks) are shown in Fig. 39. Since the 
fluorescence intensities of these cell lines were very high, it was not possible to have 
the histograms for negative and positive cells on the same graph. The percentage of 
GFP-positive cells, the mean specific fluorescence, and the CV for each cell line at the 
two time points is provided in Table 16. For CHU-BK and 6PO the histograms from 
passage 1 (P1) and passage 15 (P15) cells were very similar (Fig. 39 A,B). For CHU-
BK the percentage of GFP-positive cells and the CV did not change over time while 
the mean specific fluorescence increased by 15% (Table 16). For 6PO the percentage 
of GFP-positive cells did not vary over the 8 weeks of cultivation, but the mean 
specific fluorescence increased by 45% and the CV decreased (Fig. 39B, Table 16). 
These observed differences may be attributable to the use of different flow cytometers 
for the analyses done at different times even though the same settings were used for all 
of the analyses. 
 
For CHU-BK2 only 14% of the cells were still GFP-positive after 8 weeks of culture 
(7C, Table 16). The mean specific fluorescence decreased by 90% while the CV 
increased by 56% (Table 16). Similar results were observed for the weekly specific 
fluorescence analysis by fluorometry (Fig. 36). For 6POs there was a 10% decrease in 
the number of GFP-positive cells over the course of the experiment (Fig. 39D, Table 
16). A one log decrease of the fluorescence intensity was observed (Fig. 39D). The 
mean fluorescence decreased by 85% and the CV increased by 45% (Table 16).  
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Fig. 39. Analysis by flow cytometry of GFP expression in adherent cultures of CHU-BK (A), 6PO (B), 
CHU-BK2 (C) and in a suspension culture of 6POs (D). GFP fluorescence from control CHO DG44 
cells (CHO) is shown in the filled black histograms. For the analysis of CHU-BK2 (C) the y-axis was 
modified to allow all the profiles to be visible on one graph. Passage number (P).  
 
Table 16. Flow cytometry of cell lines established after microinjection of pMYK-EGFP-puro.  
Cell line 1 week in culture 8 weeks in culture 
 Positive cells 
Mean 
fluorescence CV 
Positive 
cells 
Mean 
fluorescence CV 
CHU-BK 100 2050 4.5 98 2400 4.5 
6PO 97 1180 15 97 2600 9.5 
CHU-BK2 90 220 35 14 20 62 
6POs 100 280a 18 90 40b 40 
a6POs was in culture 5 weeks at this time point. b6POs was in culture 15 weeks at this time point. 
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9.1.3.2 Cell lines generated by CaPi transfection 
Two cell lines established after CaPi transfection with circular pMYK-EGFP-puro 
(Nono 1 and Nono 6) and two cell lines with linear pMYK-EGFP-puro (Yoyo 3 and 
Yoyo 6) were analyzed for stability of GFP expression over two months of culture. 
With the exception of Yoyo 3, the cell lines established from CaPi transfections had 
lower specific fluorescence than the cell lines generated by microinjection. However, 
for Yoyo 3 the fluorescence was continuously decreasing over the time course of the 
experiment (Fig. 40). Likewise, Nono 6 and Nono 1 showed a continuous decrease in 
specific fluorescence during the 8 weeks of cultivation (Fig. 40). For Yoyo 6 the GFP 
expression was stable during the course of the experiment (Fig. 40). 
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Fig. 40. Specific GFP fluorescence of 4 adherent cell lines generated by CaPi transfection of pMYK-
EGFP-puro. Nono 1 and Nono 6 were transfected with circular pMYK-EGFP-puro. Yoyo 3 and Yoyo 6 
were transfected with linear pMYK-EGFP-puro. Nono 1 and Yoyo 3 were selected with 6 µg/ml 
puromycin whereas Nono 6 and Yoyo 6 were selected with 3 µg/ml puromycin. GFP in unlysed 
cultures was quantified by fluorometry, and the cell density assessed with a CASY®1 TTC cell counter. 
Cells were analyzed at three days after passage. 
 
The decrease in GFP expression observed for Nono 1, Nono 6, and Yoyo 3 may have 
been due to a decrease of the number of GFP-positive cells as shown by flow 
cytometry of these three cell lines and Yoyo 3 (Fig. 41). The analysis was performed 
at week 1 and week 9 of the cultures. Information on the percentage of GFP-positive 
cells, the specific fluorescence, and the CV for each cell line are summarized in Table 
17. For Nono 1 only about 20% of the cells were still GFP-positive after two months 
of cultivation (Fig. 41A, Table 17). In contrast, for Nono 6 the percentage of GFP-
positive cells decreased only 10%. For Nono 6 the presence of two distinct 
subpopulations of cells was more distinct after 8 weeks of culture in comparison to the 
results after 1 week of culture (Fig. 41B). Initially, the Nono 6 subpopulation with 
lower fluorescence constituted only 10% of the total population. After 8 weeks of 
culture this subpopulation increased to 50% (Fig. 41B). For Yoyo 3, we observed a 
40% decrease in the number of GFP-positive cells after 8 weeks of culture (Fig. 41C). 
In contrast, little change in GFP fluorescence was observed for Yoyo 6 from week 1 to 
week 8 (Fig. 41D). 
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Fig. 41. Flow cytometry of GFP expression in adherent cultures of Nono 1 (A), Nono 6 (B), Yoyo 3 (C) 
and Yoyo 6 (D). GFP fluorescence from control CHO DG44 cells (CHO) is shown in the filled 
histogram. The analyses were performed after one week of culture (passage 1 (P1)) and after 9 weeks of 
culture (passages 17 (P17) and 18 (P18), respectively). 
 
Table 17. Flow cytometry of cell lines established after CaPi transfection with pMYK-EGFP-puro. 
Cell lines Initial After 2 monthts 
 Positive cells Mean CV 
Positive 
cells Mean CV 
Nono 1 98 1010 22 17 460 32 
Nono 6 100 760 22 90 70 43 
Yoyo 3 99 2060 11 62 41 42 
Yoyo 6 100 1280 7 100 1020 10 
 
 
Results and Discussion 
111 
9.1.4 Cytogenetic study of recombinant cell lines 
9.1.4.1 Copy number of GFP gene 
The GFP copy number was quantified by Southern blot analysis (data courtesy of 
Martin Bertschinger, Laboratory of Cellular Biotechnology, EPFL). Genomic DNA 
was prepared from each cell line listed in Table 18 and  19. The GFP gene from 
pMYK-EGFP-puro was isolated after digestion with XbaI and EcoRI and used as a 
probe. The genomic DNA was digested with SphI and BamHI, two restriction 
enzymes which are not sensitive to DNA methylation. The cell lines established after 
gene transfer of pMYK-EGFP-puro with microinjection had from 1.5 to 51 copies of 
the GFP gene (Table 18). For the cell lines recovered following CaPi transfection of 
cells with pMYK-EGFP-puro the GFP gene copy number ranged from 0.3 to 13.4 
(Table 19). 
  
Table 18. Copy number of GFP gene in cell lines established by microinjection of pMYK-EGFP-puro. 
Cell lines GFP copy number 
D2R1 1.5 
D2R2 1.5 
CHU-BK 3 
CHU-BK2 51 
6PO 13 
 
Table 19. Copy number of GFP gene in cell lines established by CaPi transfection with pMYK-EGFP-
puro. 
Cell lines GFP copy number 
Nono 1 1.7 
Nono 2 15 
Nono 3 3.1 
Nono 4 0.3 
Nono 5 1.9 
Nono 6 8.6 
Yoyo 1 13.4 
Yoyo 2 4.7 
Yoyo 3 3.5 
Yoyo 4 12 
Yoyo 5 4.3 
Yoyo 6 1.5 
 
9.1.4.2 Ploidy study 
In order to characterize the ploidy of the genome of each cell line generated in this 
study, the chromosome number in 20 metaphase spreads were counted for each cell 
line. These studies were performed by Danielle Martinet and the Laboratory of 
Cytogenetic at the CHUV. An example of a metaphase chromosomes spread from 
D2R2 is shown in Fig. 42. 
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Fig. 42. Spread of chromosomes in metaphase from the D2R2 cell line.  
 
The numbers of chromosomes in 20 similar spreads as in Fig. 42 were assessed for 
each cell line. The results of the analysis are reported in Table 20 for cell lines 
established with microinjection and in Table 21 for the cell lines resulting from 
transfection with CaPi. This data is also presented graphically in Fig. 43 and Fig. 44.  
 
CHO cells themselves are not highly heteroploid as they usually have 20 or 21 
chromosomes (Worton et al. 1977). Likewise, the cell lines generated by 
microinjection had the tendency to be stable with an average 20 chromosomes (Table 
20, Fig. 43). On average, D2R2 had 20 chromosomes, CHU-BK had 18, CHU-BK2 19 
and 6PO had 21. After 26 weeks of culture (53 passages), D2R2 no genetic instability 
in D2R2 was observed (Table 20, Fig. 43). This experiment was performed only for 
D2R2.  
 
Table 20. Number of chromosomes found in 20 metaphase spreads from cell lines established by 
microinjection. 
Cell lines Chromosome number and frequency 
D2R2 9x20 3x18 4x19 1x21 1x36 1x40 
D2R2 P53 10x20 3x18 4x19 2x21 1x17  
CHU-BK 8x20 3x18 5x19 1x21 1x23 1x39 
CHU-BK2 4x20 5x18 10x19 1x21   
6PO 12x20 1x18 3x19 3x21 1x36  
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Fig. 43. Number of chromosomes counted in 20 metaphase spreads. The different numbers of 
chromosomes (e.g. 17, 18, 19, 20) are represented for the cell lines (D2R2, CHU-BK, CHU-BK2 and 
6PO) established by microinjection. D2R2 was analyzed at the beginning and after 53 passages (D2R2 
P53). This represents 23 weeks in culture. 
 
In general, the distribution of the number of chromosomes observed in the cell lines 
established after CaPi was broader than in the cell lines generated by microinjection. 
Yoyo 3 and Yoyo 4 were stable cell lines with exactly 20 chromosomes in every 
metaphase spread (Table 21, Fig. 44). In contrast, Nono 3, Yoyo 1 and Yoyo 6 showed 
strong aneuploidy (Table 21, Fig. 44). On average Nono 1, Nono 2, Nono 3, Nono 4, 
Nono 5 and Nono 6 had respectively 20, 21, 37, 19 and 23 chromosomes (Table 21, 
Fig. 44). For the cell lines established after CaPi transfection with linear DNA, the 
averaged number of chromosomes was 32, 21, 21, and 26 for Yoyo 1, Yoyo 2, Yoyo 5 
and Yoyo 6, respectively (Table 21,  Fig. 44). 
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Fig. 44. Number of chromosomes counted in 20 metaphase spreads. The different numbers of 
chromosomes (e.g. 17, 18, 19, 20) are represented for the Nono and Yoyo cell lines established after 
CaPi transfection with circular and linear pMYK-EGFP-puro, respectively. 
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Table 21. Number of chromosomes from 20 metaphases spreads for cell lines established after CaPi 
transfection with pMYK-EGFP-puro. 
Nono                                 Chromosome number and frequency 
1 15x20 1x18 1x19 1x21 1x40      
2 9x20 2x18 5x19 2x21 1x36 1x38     
3 2x36 3x34 1x26 1x28 2x37 11x40     
4 14x20 1x18 3x19 1x21       
5 4x20 1x18 10x19 1x16 2x37 1x39 1x40    
6 17x20 3x19         
Yoyo  
1 6x20 1x19 1x21 4x40 3x38 1x39 2x42 1x48 1x44  
2 19x20 1x40         
3 20x20          
4 20x20          
5 11x20 1x19 3x21 1x22 1x23 2x40     
6 6x20 2x17 1x19 1x22 2x36 1x34 2x32 2x38 1x37 1x40 
 
9.1.4.3 Integration site 
For each cell line mentioned in Table 20 and 21 the localization of the pMYK-EGFP-
puro integration site(s) was determined by FISH. pMYC-EGFP-puro was used as 
probe. CHO DG44 cells were tested as a negative control and no hybridization was 
observed (data not shown). Independent of the gene transfer method and the number 
of copies of the GFP gene integrated, we observed one integration site for each cell 
line except for Nono 3. Two dots were observed on each chromosome, corresponding 
to one integration site on each sister chromatid. The results from for cell lines 
generated by microinjection are shown in Fig. 45. For D2R2 FISH was performed 
after 1 month of culture and then again after 6 months of culture. No change in the 
integration site was observed (data not shown). Since 6PO and CHU-BK2 had more 
copies integrated than D2R2 and CHU-BK, the resulting hybridization signal was 
proportionally stronger (Fig. 45). The results of FISH analysis for the cell lines 
generated by CaPi transfection of circular pMYK-EGFP-puro are shown in Fig. 44 
and for those generated by transfection of linear pMYK-EGFP-puro are shown in Fig. 
47. Three different integration patterns were found in Nono 3. In some cases one 
single integration site was found (Fig. 46). In some other cases two to four integration 
sites on one chromosome were identified (Fig. 46). For Nono 1, Nono 4 and Yoyo 6, 
which had respectively 1.7, 0.3 and 1.5 GFP copies integrated, FISH was performed 
several times without success. 
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Fig. 45. FISH of 4 cell lines established by microinjection of pMYK-EGFP-puro. D2R2 was obtained 
from a nuclear injection with circular DNA. 6PO was obtained from a cytoplasmic injection with linear 
DNA, and CHU-BK and CHU-BK2 were established after nuclear injection with linear DNA. The cell 
lines were in culture 2 to 3 weeks at the time of analysis. The probe was pMYK-EGFP-puro. The DNA 
was stained with DAPI. In each panel the arrow marks the integration site. 
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Fig. 46. FISH of 4 cell lines established after CaPi transfection with circular DNA. Nono 2 and 3 were 
selected with 6 µg/ml puromycin. Nono 5 and 6 were selected with 3 µg/ml puromycin. The cell lines 
were in culture for 2 to 3 weeks at the time of analysis. The probe was pMYK-EGFP-puro. The DNA 
was stained with DAPI. In each panel the arrow marks the integration site. For Nono 3 three different 
integration patterns were observed. In some cases, there were multiple integration sites on one 
chromosome (top right panel) or a single integration site on one chromosome (middle right panel). In 
other cases there were two integration sites on one chromosome (middle left panel).  
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Fig. 47. FISH of 5 cell lines established after CaPi transfection with linear pMYK-EGFP-puro. Yoyo 1, 
2 and 3 were selected with 6 µg/ml puromycin, and Yoyo 4 and 5 were selected with 3 µg/ml 
puromycin. The cultures were for 2 to 3 weeks in culture at analysis. The probe was pMYK-EGFP-
puro. The DNA was stained with DAPI. The arrows indicate the sites of integration. 
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9.2 Discussion 
The use of GFP as model protein for the establishment of recombinant cell lines 
allowed detection and quantification of protein expression in a non-invasive manner, 
allowing efficiencies of stable gene transfer to be evaluated. Furthermore, it was 
possible to monitor changes in GFP expression over time. One major concern with the 
use of GFP as a marker was its stability. However, since the GFP half-life is around 24 
hours, intracellular accumulation of the protein may result in artifacts when simply 
measuring fluorescence (Corish and Tyler-Smith 1999). As reported by this 
laboratory, there was a correlation between cell growth and fluorescence for two 
recombinant cell lines expressing GFP (Hunt et al. 1999). GFP did not accumulate in 
the cells. The interaction between cell growth and GFP expression could be explained 
by the transcriptional activity of the CMV promoter. Its activity is cell cycle-
dependent with the highest level of activity observed during S phase of the cell cycle 
(Brightwell et al. 1997; de Boer et al. 2004). This may explain why we observed a 
plateau of GFP expression in resting cells (Fig. 35). In the studies described in this 
chapter, GFP analysis was performed on cells undergoing exponential growth.  
 
At an early stage after gene delivery, GFP expression allowed the visual evaluation of 
the homogeneity of the recombinant protein expression of a clonal population of cells. 
This was an accurate predictor of long-term stability of recombinant protein 
expression for a cell line. The majority of cell lines established after CaPi transfection 
had a broad distribution of fluorescence intensity as compare to cell lines resulting 
from microinjection (Fig. 27, Fig. 34, Fig. 35, Fig. 39). This may have be due to the 
possibility that a single colony resulting from transfection with CaPi may have 
originated from more than one cell whereas the cell lines established by microinjection 
clearly originated from a single cell. In addition, CaPi transfection may induce 
mutations in the plasmid DNA level. Point mutations have been observed in plasmid 
DNA after DEAE-dextran transfection (Kopchick and Stacey 1984). These mutations 
occurred exclusively after transfection but not after nuclear or cytoplasmic 
microinjection (Kopchick and Stacey 1984). Another alternative to explain variations 
of recombinant protein expression levels within cells of a clonal cell line is chromatin 
modifications as previously discussed (section 8.2).  
 
The recombinant GFP cell lines made it possible to easily study recombinant protein 
expression levels over time. The results from fluorometry and flow cytometry 
correlated with each other. Except for 6POs, a decrease of specific fluorescence 
corresponded to a decrease in the number of GFP-positive cells. All of the cell lines 
established with microinjection and cultivated as adherent cells with the exception of 
CHU-BK2 were stable for GFP expression for at least two months. In contrast, GFP 
expression was stable over time for only one of four cell lines transfected with CaPi. 
For two cell lines resulting from a transfection with circular DNA (Nono 1 and Nono 
6), a decrease of fluorescence was already observed after 2 weeks of culture. For Yoyo 
3, a cell line established by transfection with linear DNA, GFP expression decreased 
after 4 weeks of culture. For Nono 6 the instability of GFP expression was predictable 
because a subpopulation of weakly expressing cells was visible early during 
cultivation. This subpopulation increased from 15% to 58% of the total population in 2 
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months. We also observed different rates of cell growth for different cell lines. In 
general, high producers grew more slowly than low producers. Therefore, the low 
producing cells in the Nono 6 population probably overgrew the higher producing 
cells. Overgrowth of producing cell by nonproducing cells has been reported for 
hybridoma cell lines (Frame and Hu 1990). A similar phenomenon may have been 
responsible for the high level (over 99%) of GFP- negative cells in the Nono 4 
population. Negatives cells may have been transferred into multiwell plates along with 
GFP-positive colonies during the initial transfer in this case (section 7.1.1). Within 2 
weeks of culture they could have overgrown the GFP-positive cells. This may explain 
the observation of only 0.3 copies per cell of the GFP gene per cell in this cell line. On 
the other hand, loss of a recombinant gene(s) has been reported for CHO cell lines 
(Kim et al. 1998; Pallavicini et al. 1990) and may have occurred in Nono 4 cells. At 
the beginning of the cultivation of Nono 1, 2% of the cells were GFP-negative and 8% 
were not in the major peak of positive cells. After two months of cultivation, only 17% 
were GFP-positive. In the case of Yoyo 3, instability of GFP expression was not really 
predictable despite a higher CV than Yoyo 6. Yoyo 6 showed stable GFP expression 
over a period of two months in adherent culture.  
 
In general, the specific fluorescence of suspension cultures was lower than for 
adherent cultures of the same cell line. GFP expression was fairly stable in CHU-BKs. 
Unfortunately, flow cytometry could not be performed after 2 months of culture. The 
stability assessment was based exclusively on fluorometry values. Nevertheless, after 
5 weeks of culture 100% of the cells were still GFP-positive and there was little 
change of the mean fluorescence (Fig. 38). Interestingly, the dramatic decrease of the 
fluorescence in 6POs was not related to an increase in the number of GFP-negative 
cells. After 15 weeks in culture, 90% of the cell population remained GFP-positive 
(Table 16). However, there was a one log decrease in the mean fluorescence (Fig. 39). 
This meant a 100 fold decrease of the mean fluorescence. The transcription of the GFP 
gene in suspension growing 6PO may have been reduced due to the serum dependence 
of the CMV promoter (Brightwell et al. 1997).  
 
In general, the number of copies of the GFP gene integrated in each cell line was less 
than 10. CHO cells are known for their ability to integrate exogenous DNA into their 
genome (Hoeijmakers et al. 1987). In comparison to various human cell lines, the 
average quantity of exogenous DNA integrated into CHO cells was 20-100 fold higher 
(Hoeijmakers et al. 1987). In our hand, the highest number of GFP genes integrated 
was observed after nuclear microinjection with linear DNA. CHU-BK 2 had 50 copies 
of the GFP gene. Up to 100 plasmid copies (20 kbp) have been found integrated into 
the genome of CHO-9 cells (Hoeijmakers et al. 1987). By comparison, 50 copies of 
the GFP gene or pMYK-EGFP-puro DNA (40-270 kbp) were integrated into CHU-
BK2. 
 
With the exception of Nono 1, we observed stable expression for cell lines with a low 
copy number of the GFP gene. D2R1, D2R2, CHU-BK and Yoyo 6 with number of 
GFP genes below 2 copies each were stable for GFP expression. Yoyo 3 and Nono 6 
having 3.5 and 8.6 plasmid copies integrated, respectively, were not stably expressing 
GFP over a cultivation period of 2 months. In contrast, 6PO had 13 plasmid copies 
integrated and showed stable GFP expression for two months. Based on these results, 
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we cannot conclude that high stable recombinant gene expression was exclusively 
related to the number of genes integrated in the host genome. However, it is expected 
that a clone with a high recombinant protein expression level and a low plasmid copy 
number would be a promising candidate for a stable and highly productive cell line. 
An additional argument for choosing low plasmid copy number clones is the 
possibility of tandem repeat-induced gene silencing. It has been demonstrated that the 
recombinant protein expression level in cells carrying a single copy of the 
recombinant gene was higher than in cells with multiple copies of the gene (Wirth et 
al. 1988; McBurney et al. 2002). DNA methylation was associated with multiple 
copies of the recombinant gene in transcriptionally silencing cell lines (McBurney et 
al. 2002). This may explain the dramatic decrease of specific fluorescence and of the 
number of GFP-positive cells for CHU-BK2. Finally, for industrial applications, 
considering the requirement of regulatory agencies to verify the integrated sequence 
encoding the product, it would be easier to establish high producing cell lines with low 
plasmid copy numbers (FDA 1996). 
 
All the cell lines isolated after microinjection had roughly 20 chromosomes. In 
contrast 30% of the cell lines transfected with CaPi exhibited strong aneuploidy. 
Similar effects have been observed after amplification of recombinant CHO cells with 
methotrexate (Wurm et al. 1992). In this study of amplified cell lines, 30% were 
tetraploid with more than 40 chromosomes in each metaphase spread (Wurm et al. 
1992). Another difference between microinjected and transfected cells was the 
stability of the expression. Indeed for adherent growing cells only one of four 
transfected cell lines was stably expressing GFP whereas one of five microinjected 
cell lines was unstable for GFP expression.  
 
For all but one of the cell lines described here, we observed a single integration site of 
the recombinant DNA independent of the gene delivery method or the topology of the 
DNA. Similar results have previously been published (Chen and Chasin 1998; 
Huberman et al. 1984; Wurm et al. 1992). For our cell lines integration appeared to 
occur randomly on different chromosomes (Fig. 45, Fig. 46, Fig. 47). Nono 3 was the 
exception to this rule, and several explanations are possible to explain the different 
integration patterns found in this cell line. First, the population may have originated 
from a number of different transfected cells. This is unlikely since the population 
exhibited a narrow distribution of the fluorescence at the early screening stage (Fig. 
33). Spontaneous amplification of the GFP gene with subsequent translocation may 
also be an explanation for this pattern (Pallavicini et al. 1990). The amplification of 
recombinant genes was been observed in mouse cells in the absence of drug exposure 
(Huberman et al. 1984). Amplification had to have occured within two weeks of 
selection since the Southern blotting and FISH analysis were performed on cells at this 
point of cultivation. Another possibility may have been the fragmentation of plasmid 
DNA prior to integration. The Southern blotting was performed with only the GFP 
gene as a probe and FISH was performed with the entire plasmid. Therefore, with 
FISH we may have observed the integration of different regions of pMYK-EGFP-puro 
which were not detected by Southern blot.The stability of clonal populations based on 
the location of integrated plasmid DNA has been observed (Yoshikawa et al. 2000; 
Yoshikawa et al. 2000). For stable GFP-expressing cell lines such as D2R2 and 6PO, 
integration of the plasmid occurred near the end of the chromosome. For Nono 6 and 
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Yoyo 3, cell lines that were unstable for GFP expression, the plasmid integration site 
was not near a chromosome end. In contrast, even though plasmid integration occurred 
in an internal region of a large chromosome in CHU-BK, GFP expression of this cell 
line was stable for over 2 months. Therefore we could not conclude that exclusively 
clones with gene located near chromosome ends would yield stable production of the 
recombinant protein. The surrounding region of the integration site is also expected to 
have a dramatic impact on the stability of recombinant gene expression. In one study 
stable amplified plasmid sequences were always surrounded with (TTAGGG)n 
sequences which are often found near telomers (Kim and Lee 1999). 
 
The mechanism of exogenous DNA integration into mammalian genome remains 
unclear. Once in the nucleus, the mobility of plasmid DNA is very limited (Mearini et 
al. 2004). Then, depending on the cell cycle, plasmid DNA become associated with 
acetylated or hypoacetylated histones (Zhang et al. 2002). Therefore plasmid 
integration is possible without any gene expression. Different published works have 
given indications about the mechanism of exogenous DNA integration. 
Topoisomerase II is indirectly involved in homologous and non-homologous 
recombination in mammalian cells (Aratani et al. 1996). Type II DNA topoisomerase 
catalyzes the breakage and rejoining of the two strands of DNA. This could explain 
how circular DNA becomes linearized within the nucleus. Higher levels of 
recombination have been observed after inhibition of topoisomerase II activity 
(Aratani et al. 1996). Thus, DNA topoisomerase II may function to suppress 
recombination events and to maintain chromosomal integrity (Aratani et al. 1996). 
This could explain the very low stable transfection efficiencies below 1% (Wurm et al. 
1992). Plasmid DNA is often integrated as a concatamer (Folger et al. 1982; 
Huberman et al. 1984). Three models for concatamerization have been proposed 
(Folger et al. 1982). In the first model the plasmid first integrates in the host genome 
and then is amplified by DNA replication. In the second model, one plasmid becomes 
integrate and then others recombine by homologous recombination at the same site. In 
the third model, homologous recombination of plasmid occurs first to form a 
concatamer which then integrates the host genome. In all cases, the integration is 
expected to occur randomly within the genome. It has been proposed that transfected 
DNA may preferentially integrate at unstable mammalian loci (Merrihew et al. 1996). 
It has been reported that a high integration frequency when specific sequences were 
present on the plasmid, such as the SV40 enhancer, the SV40 origin of replication, or 
the long terminal repeat of avian sarcoma virus (Berg and Anderson 1984; Folger et al. 
1982). Interestingly, the co-transfection of restriction enzymes including BamHI, 
BglII, EcoRI and KpnI increased the efficiency of linearized plasmid integration into 
CHO cells (Manivasakam et al. 2001). 
 
In conclusion, microinjection appeared to be a promising gene transfer method for the 
establishment of stably producers of recombinant protein. The efficiency of recovery 
of stable cell lines was higher than after CaPi transfection, and most of the resulting 
recombinant cell lines were high GFP producers. Furthermore, the stability of 
production during prolonged culture was higher for these cell lines than for cell lines 
transfected with CaPi. Likewise, the genetic stability of cell lines generated by 
microinjection was better than for cell lines recovered from CaPi transfected cells. 
Determination of the plasmid copy number and the location of the integration site 
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were helpful for evaluating the long-term stability of recombinant protein expression. 
Cell lines with a low plasmid copy number integrated near the end of a chromosome 
that express recombinant proteins at a high level are expected to be excellent 
candidates for stable recombinant protein production. This information is expected to 
facilitate the labor intensive screening and the analysis of growth and protein 
production over extended periods of cultivation.  
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10. Conclusions and perspectives 
Two different approaches were evaluated for the establishment of recombinant cell 
lines, affinity cell sorting and microinjection. The former allowed an increase in the 
number of positive transfectants (e.g. clones) to be screened. After transfection of 
large cell populations in serum-free medium, cells expressing the reporter protein and 
an epitope-tagged surface receptor could be enriched with an antibody bound to 
magnetic beads. Microinjection allowed targeted delivery of plasmid DNA directly 
into the nucleus or cytoplasm of single cells, resulting in an increase in the frequency 
of stable chromosomal integration.  
 
10.1 Conclusions 
For affinity cell sorting, transient gene expression in suspension cultures of CHO 
DG44 cells in serum-free medium was optimized using linear 25 kDa PEI as a DNA 
delivery vehicle. PEI-mediated transfection offers a high efficiency of DNA delivery, 
simple operation, and rapid DNA transfer into the nucleus without the need for an 
osmotic shock. These features make PEI a more suitable transfection vehicle than 
liposomes or CaPi for large-scale transient gene expression with CHO DG44 cells. 
The affinity cell sorting was not be fully optimized in this work. Still, an enrichment 
of positive cells for recombinant protein expression was achieved with the anti-FLAG 
antibody M2. Even if the binding to the M1 antibody was not realizable, the affinity 
cell sorting remains an interesting approach for the establishment of recombinant cell 
lines. Since good cell growth was observed even with the microbeads bound to the 
cells, several affinity cell sorting steps can be performed at different stages of 
selection. On the other hand, fractional elution of cell populations expressing the 
reporter protein at different levels can also be considered after binding of the beads 
coated with the M2 antibody. Since the binding of the receptor to M2 is not calcium 
dependant, the removal of the beads from the cell surface may be achieved by 
competitive elution using the FLAG peptide. After several enrichment steps, limited 
dilution in serum-free medium would be performed in order to guarantee clonality of 
the recombinant cell lines. This approach is therefore less tedious and expensive than 
fluorescence activated cell sorting (FACS). Furthermore, affinity cell sorting can be 
scaled-up to surpass the screening capacity of FACS. 
 
Microinjection allowed control of the amount of DNA delivered into a specific 
subcellular compartment. Transient gene expression following microinjection was 
optimized to have a high recombinant protein expression level with good cell 
proliferation. Recombinant cell lines were isolated 22 days after microinjection of 
single cells. The efficiency of stable gene transfer was 3-6 fold higher than with CaPi 
transfection. The large majority of the established cell lines showed stable GFP 
expression over two months of cultivation. Less variation in the chromosomal number 
was observed in the cell lines resulting from microinjection as compared to those 
generated by transfection with CaPi. Therefore, we propose that variations in 
chromosome number are more likely due to the gene transfer method than to the 
genetic selection method. Further optimization of microinjection as a gene transfer 
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method should include injection on a glass support and at different times of the cell 
cycle. The major drawback of this approach is that it requires adherent cells.  Loss of 
specific productivity may occur when the cells are adapted to growth in serum-ree 
suspension culture.  
 
10.2 Perspectives 
With both approaches, recombinant cell lines can be established after random 
integration of recombinant genes into the host genome. We had no control on the 
chromosomal site of insertion, on the number of copies integrated, or on the level of 
recombinant gene expression. Recently, two novel strategies, episomal replication of 
plasmid DNA in mammalian cells and genomic targeting, have been developed which 
may allow these roadblocks to be overcome. Both approaches can be applied with 
either affinity cell sorting or microinjection. 
 
Mammalian origins of replication have not been fully characterized. Episomal 
replication has been achieved using the origin of replication elements from simian 
virus 40 (SV40) and Epstein-Barr virus (EBV). Recognition and activation of the ori 
elements requires the SV40 large T antigen and the EBV EBNA1 protein, 
respectively. In each case, the viral protein can be expressed from the replicating 
plasmid. Alternatively, a stable cell line that expresses the protein can be generated 
and then transfected with the expression vector containing the appropriate origin of 
replication. Recently Piechaczek and co-workers developed an episomal vector that 
replicates in CHO cells (Piechaczek et al. 1999). The SV40 gene coding for the large 
T antigene was replaced by the chromosomal scaffold/matrix attached region from the 
human interferon β-gene (Piechaczek et al. 1999). This vector was stably replicated 
during CHO cell division in the absence of large T antigen (Baiker et al. 2000; Jenke 
et al. 2004). Interestingly this episomal vector was not subject to silencing by cytosine 
methylation of the CMV promoter (Jenke et al. 2004). Episomal replication was 
performed in some cells including COS and HEK cells but not in rodent cells (Yates et 
al. 1985). 
 
An alternative approach for efficient establishment of recombinant cell lines is site-
specific gene integration using a recombination system. Two systems are gaining in 
importance, the Cre/loxP system derived from bacteria and and FLP/FRT derived from 
yeast (Bode et al. 2000). Cre is a recombinase from the bacteriophage P1 that 
recombines DNA at specific 34 bp sites termed loxP. This technology was used with 
high efficiency in human osteosarcoma cells (Baubonis and Sauer 1993) and in CHO 
cells to allow gene targeting (Fukushige and Sauer 1992). The FLP recombinase from 
the 2-µm circlular DNA of Saccharomyces cerevisiae recognizes FRT sequences. 
Different cell lines including BHK, CHO, 3T3, Jurkat, 293 and CV-1 having FRT 
sites in highly transcribed regions are commercially available for establishment of 
stable cell lines (Invitrogen, Carslbbad, Ca). The targeted transfection of a vector 
carrying the FRT sites ensure for rapid identification of high producing cell lines in 
the presence of the FLP recombinase.  
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11. Annexe      
       
     Last update: 21.04.04 
Name Galenic Principle active Application 
First 
commercial
ization 
In Switzerland 
produced by Cell line 
Actilyse  Injektions- 
präparat 
ALTEPLASUM ADNr Thrombolytische Therapie 
bei akutem Herzinfarkt, 
akuter massiver 
Lungenembolie, akutem 
ischämischem Hirnschlag 
9/19/1988 Boehringer Ingelheim 
(Schweiz) 
CHO 
Advate Lyophilisat OCTOCOGUM alfa Hämophilie A 2/17/2004 Baxter AG CHO 
Aranesp Injektions- 
lösung 
DARBEPOETINUM ALFA Stimulierung der 
Erythropoese 
9/13/2002 Amgen Switzerland 
AG 
CHO 
Avonex Lyophilisat INTERFERONUM beta-1a 
ADNr 
Multiple Sklerose 3/7/1997 Biogen-Dompé AG CHO 
BeneFIX  Trockensub
stanz 
NONACOGUM ALFA Hämophilie B 2/26/1998 Baxter AG CHO 
Beromun Infusionsprä
parat 
TASONERMINUM Weichteil-Sarkom 11/16/2000 Boehringer Ingelheim 
(Schweiz) 
Unknown 
Betaferon Lyophilisat INTERFERONUM beta-1b 
ADNr 
Multiple Sklerose 8/29/1995 Schering (Schweiz) 
AG 
E. coli 
Cerezyme  Pulver IMIGLUCERASUM Typ I Gaucher Krankheit 3/1/1999 Genzyme 
Pharmaceuticals 
CHO 
Enbrel Injektions- 
präparat 
ETANERCEPTUM Rheumatoide Arthritis 2/1/2000 AHP (Schweiz) AG CHO 
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Eprex  Injektions- 
lösung 
EPOETINUM alfa ADNr Stimulierung der 
Erythropoese 
7/27/1988 Janssen-Cilag AG CHO 
Erbitux Infusionslös
ung 
CETUXIMABUM Kolorectalkarzinom 12/1/2003 Merck (Schweiz) AG Unknown 
Erypo  Injektions- 
lösung 
EPOETINUM alfa ADNr Stimulierung der 
Erythropoese 
7/16/1991 Tavolek AG Unknown 
Fabrazyme Pulver AGALSIDASUM beta Enzymersatz-Therapie bei 
Patienten mit Morbus 
Fabry 
7/25/2003 Genzyme 
Pharmaceuticals 
CHO 
Fasturtec Injektions- 
präparat 
RASBURICASUM Hyperurikämie 4/5/2002 Sanofi-Synthélabo 
(Suisse) SA 
CHO 
Forcaltonin  Injektions- 
lösung 
CALCITONINUM 
SALMONIS 
RECOMBINATUM 
Morbus Paget; 
Hyperkalzämie; 
Algodystrophie; 
postmenopausale 
Osteoporose bei 
Nichtdurchführbarkeit 
anderer Therapien 
9/13/2001 Cosan GmbH Unknown 
Forsteo Injektions- 
lösung 
TERIPARATIDUM ADNr Postmenopausale 
Osteoporose bei Frauen; 
primäre und 
hypogonadale 
Osteoporose bei Männern 
8/8/2003 Eli Lilly (Suisse) SA Unknown 
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Genotropin  Injektions- 
präparat 
SOMATROPINUM ADNr Hypophysärer 
Zwergwuchs; 
Minderwuchs bei Turner-
Syndrom; chronische 
Niereninsuffizienz beim 
Kind; Prader-Willi 
Syndrom; SGA; 
Wachstumshormonmange
l bei Erwachsenen infolge 
hypothalamischer oder 
hypophysaerer 
Erkrankung 
6/2/1988 Pfizer AG E.coli 
GlucaGen 
Novo 
Injektions- 
präparat 
GLUCAGONUM ADNr Insulin-Hypoglykämie; 
Ruhigstellung des 
Intestinaltraktes bei 
Endoskopie und 
Röntgenuntersuchungen 
2/2/1991 Novo Nordisk 
Pharma AG 
E. coli 
Gonal-F  Injektions- 
präparat 
FOLLITROPINUM ALFA Stimulierung der 
Follikelreifung bei 
anovulatorischen 
Zuständen und bei ärztlich 
assistierten 
Reproduktionsprogramme
n; Stimulierung der 
Spermatogenese 
11/23/1995 Serono Pharma 
Schweiz 
CHO 
Granocyte  Injektions- 
präparat 
LENOGRASTIMUM 
ADNr 
Neutropenie 6/25/1993 Aventis Pharma AG CHO 
Helixate 
NexGen  
Lyophilisat OCTACOGUM alfa Hämophilie A 6/12/1997 Aventis Behring AG BHK 
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Herceptin  Lyophilisat TRASTUZUMABUM Mammakarzinom 7/29/1999 Roche Pharma 
(Schweiz) AG 
CHO 
Humatrope  Injektions- 
präparat 
SOMATROPINUM ADNr Hypophysärer 
Zwergwuchs; 
Minderwuchs bei Turner-
Syndrom; chronische 
Niereninsuffizienz beim 
Kind 
8/21/1989 Eli Lilly (Suisse) SA E. coli 
Humira Injektions- 
lösung 
ADALIMUMABUM Rheumatoide Arthritis 4/16/2003 Abbott AG Unknown 
Imukin Injektions- 
lösung 
INTERFERONUM 
HUMANUM gamma-1b 
ADNr 
Chronische 
Granulomatose 
4/2/1993 Boehringer Ingelheim 
(Schweiz) 
E. coli 
Insulin 
Aventis 
Insuman 
Injektions- 
präparat 
INSULINUM HUMANUM 
(GT) ADNr  
Diabetes mellitus 3/26/1999 Aventis Pharma AG E. coli 
Insulin Lilly 
Humalog  
Injektions- 
präparat 
INSULINUM LISPRUM Diabetes mellitus 11/23/1995 Eli Lilly (Suisse) SA E. coli 
Insulin Lilly 
Huminsulin  
Injektions- 
präparat 
INSULINUM HUMANUM 
ADNr  
Diabetes mellitus 6/28/1983 Eli Lilly (Suisse) SA E. coli 
Insulin 
NovoNordis
k  
Injektions- 
präparat 
INSULINUM HUMANUM 
ADNr  
Diabetes mellitus 11/30/1984 Novo Nordisk 
Pharma AG 
S. cerivisiae 
Insulin 
NovoNordis
k Levemir 
Injektions- 
lösung 
INSULINUM 
DETEMIRUM 
Diabetes mellitus 11/10/2003 Novo Nordisk 
Pharma AG 
S. cervisiae 
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Insulin 
Novo- 
Nordisk 
NovoRapid 
/ NovoMix 
Injektions- 
präparat 
INSULINUM ASPARTUM Diabetes mellitus 6/15/1999 Novo Nordisk 
Pharma AG 
S. cerivisiae 
Intron A Injektions- 
präparat 
INTERFERONUM alfa-2b 
ADNr 
Haarzell-Leukämie; CML; 
multiples Myelom; 
Basaliom; Melanom; 
chronische Hepatitis C; 
chronisch aktive Hepatitis 
B; Kaposi-Sarkom; 
Condylomata acuminata 
6/24/1986 Essex Chemie AG E. coli 
Kogenate 
SF 
Lyophilisat OCTACOGUM alfa Hämophilie A 2/28/1994 Bayer (Schweiz) AG BHK 
Lantus Injektions- 
lösung 
INSULINUM 
GLARGINUM 
Diabetes mellitus 5/16/2002 Aventis Pharma AG Unknown 
Leucomax  Injektions- 
präparat 
MOLGRAMOSTIMUM 
ADNr 
Neutropenie 10/30/1992 Essex Chemie AG E. coli 
Luveris Injektions- 
präparat 
LUTROPINUM alfa Follikelreifung bei LH- 
und FSH-Mangel 
9/27/2002 Serono Pharma 
Schweiz 
S. cerivisiae 
Mab- 
Campath 
Infusions-
lösung 
ALEMTUZUMABUM Chronisch lymphatische 
B-Zell-Leukämie 
12/7/2001 Schering (Schweiz) 
AG 
CHO 
Mabthera Infusions-
konzentrat 
RITUXIMABUM Keimzentrum-Lymphom 
(B cell-NHL) 
11/27/1997 Roche Pharma 
(Schweiz) AG 
CHO 
Metalyse  Injektions- 
präparat 
TENECTEPLASUM Thrombolytische Therapie 
bei akutem Herzinfarkt 
6/29/2000 Boehringer Ingelheim 
(Schweiz) 
CHO 
Neulasta Injektions- 
lösung 
PEGFILGRASTIMUM Neutropenie 9/1/2003 Amgen Switzerland 
AG 
E. coli 
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Neupogen 
Amgen 
Injektions- 
lösung 
FILGRASTIMUM ADNr Neutropenie 10/11/1991 Amgen Switzerland 
AG 
E. coli 
Neupogen 
Roche 
Injektions- 
lösung 
FILGRASTIMUM ADNr Neutropenie 5/9/2003 F. Hoffmann-La 
Roche AG 
E.coli 
Norditropin  Injektions- 
präparat 
SOMATROPINUM ADNr Hypophysärer 
Zwergwuchs; 
Minderwuchs bei Turner-
Syndrom; chronische 
Niereninsuffizienz beim 
Kind; 
Wachstumshormonmange
l bei Erwachsenen infolge 
hypothalamischer oder 
hypophysaerer 
Erkrankung  
8/29/1988 Novo Nordisk 
Pharma AG 
E. coli 
NovoSeven  Injektions- 
präparat 
EPTACOGUM ALFA Hemmkörperhämophilie 12/28/1995 Novo Nordisk 
Pharma AG 
BHK 
Ovitrelle Injektions- 
präparat 
CHORIOGONADOTROPI
NUM ALFA 
Induktion der Ovulation 8/16/2002 Serono Pharma 
Schweiz 
Unknown 
Pegasys  Injektions- 
lösung 
PEGINTERFERONUM 
alfa-2a 
Chronische Hepatitis C 7/5/2001 Roche Pharma 
(Schweiz) AG 
E. coli 
PegIntron Injektions- 
präparat 
PEGINTERFERONUM 
alfa-2b 
Chronische Hepatitis C 9/12/2001 Essex Chemie AG Unknown 
Proleukin Injektions- 
präparat 
ALDESLEUKINUM Metastasierendes 
Nierenkarzinom 
9/12/1995 Roche Pharma 
(Schweiz) AG 
E. coli 
Pulmozyme Inhalationsl
ösung 
DORNASUM ALFA Zystische Fibrose, in 
Kombination mit einer 
Standardtherapie 
4/28/1994 Roche Pharma 
(Schweiz) AG 
CHO 
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Puregon  Injektions- 
präparat 
FOLLITROPINUM BETA 
ADNr 
Stimulierung der 
Follikelreifung bei 
anovulatorischen 
Zuständen und bei ärztlich 
assistierten 
Reproduktionsprogramme
n; Stimulierung der 
Spermatogenese 
12/20/1996 Organon AG CHO 
Rapilysin Lyophilisat RETEPLASUM Thrombolytische Therapie 
bei akutem Herzinfarkt 
12/20/1996 Roche Pharma 
(Schweiz) AG 
Unknown 
Raptiva Pulver EFALIZUMABUM Mittelschwere bis schwere 
Plaque-Psoriasis bei 
Erwachsenen 
3/9/2004 Serono Pharma 
Schweiz 
Unknown 
Rebif  Injektions- 
lösung 
INTERFERONUM beta-1a 
ADNr 
Multiple Sklerose 12/23/1998 Serono Pharma 
Schweiz 
CHO 
Recombi- 
nate  
Lyophilisat OCTOCOGUM alfa Hämophilie A 1/16/1996 Baxter AG CHO 
Recormon  Injektions- 
präparat 
EPOETINUM beta ADNr Stimulierung der 
Erythropoese 
8/29/1991 Roche Pharma 
(Schweiz) AG 
CHO 
ReFacto  Lyophilisat MOROCTOCOGUM 
ALFA 
Hämophilie A 9/26/2000 AHP (Schweiz) AG CHO 
Refludan Lyophilisat LEPIRUDINUM Heparin-assoziierte 
Thrombozytopenie 
(HAT), Typ II 
6/27/1997 Schering (Schweiz) 
AG 
S. cerivisiae 
Regranex 
Gel  
Gel BECAPLERMINUM Chronisch diabetische 
Ulcera 
12/16/1999 Janssen-Cilag AG S. cervisiae 
Remicade Lyophilisat INFLIXIMABUM Rheumatoide Arthritis; 
Morbus Crohn; Morbus 
Bechterew 
12/21/1999 Essex Chemie AG SP2/0 
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ReoPro Injektions- 
lösung 
ABCIXIMABUM Perkutane 
Koronarintervention 
10/17/1995 Eli Lilly (Suisse) SA SP2/0 
Replagal Infusions-
konzentrat 
AGALSIDASE alfa Enzymersatz-Therapie bei 
Patienten mit Morbus 
Fabry 
12/28/2001 Drac AG Unknown 
Revasc Injektions- 
präparat 
DESIRUDINUM Prophylaxe 
thromboembolischer 
Komplikationen nach 
orthopädischen 
Operationen 
12/5/1997 Aventis Pharma AG Unknown 
Roferon-A  Injektions- 
lösung 
INTERFERONUM alfa-2a 
ADNr 
Haarzell-Leukämie; CML; 
kutanes T-Zell Lymphom; 
Kaposi-Sarkom; Nieren-
Carcinom; Melanom; 
chronische Hepatitis C; 
chronische Hepatitis B 
6/24/1986 Roche Pharma 
(Schweiz) AG 
E. coli 
Saizen  Injektions- 
präparat 
SOMATROPINUM ADNr Hypophysärer 
Zwergwuchs; 
Minderwuchs bei Turner-
Syndrom; chronische 
Niereninsuffizienz beim 
Kind; 
Wachstumshormonmange
l bei Erwachsenen infolge 
hypothalamischer oder 
hypophysaerer 
Erkrankung 
6/12/1989 Serono Pharma 
Schweiz 
CHO 
Simulect  Injektions- 
präparat 
BASILIXIMABUM Nierentransplantation 4/7/1998 Novartis Pharma 
Schweiz AG 
NSO 
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Synagis  Injektions- 
präparat 
PALIVIZUMABUM RSV-Prophylaxe 12/15/1999 Abbott AG NSO 
Virbagen 
Omega ad 
us.vet. 
Injektions- 
präparat 
INTERFERONUM omega 
ADNr 
Parvovirose bei Hunden 5/8/2002 Virbac (Switzerland) 
AG 
Unknown 
Xigris  Infusions-
lösung 
DROTRECOGINUM 
ALFA 
Schwere Sepsis 6/27/2002 Eli Lilly (Suisse) SA HEK 
Zenapax Infusions-
konzentrat 
DACLIZUMABUM Nierentransplantation 3/3/1998 Roche Pharma 
(Schweiz) AG NSO 
Zevalin Markierung
sbesteck 
IBRITUMOMABUM 
TIUXETANUM 
Rezidivierendes oder 
refraktäres indolentes, 
follikuläres oder 
transformiertes B-Zell 
non-Hodgkin's Lyphom 
4/19/2004 Schering (Schweiz) 
AG 
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